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1OUTLINE OF THE THESIS
Outline of the thesis
Gait disorders and freezing of gait
Gait disorders are common and often devastating companions of ageing, leading to 
reductions in quality of life and increased mortality.328;375;387 A curious feature of some 
gait disturbances is their fluctuating or frank episodic nature. An example of an 
incapacitating episodic gait disorder is freezing of gait (FOG), where patients feel like 
their feet are ‘glued to the floor’. FOG is frequently seen in patients with Parkinson’s 
disease (PD: Box 1), with unexpected episodes during which patients experience an 
inability to start walking or to continue moving forward.150 Because of this sudden and 
unpredictable nature, FOG is an important cause of falls and injuries.201;219
Vignettes
A remarkable observation in a single patient can sometimes help to advance the field, 
by generating new ideas for further research. Therefore, each chapter of this thesis 
starts with a short vignette presenting an intriguing video, as a source of inspiration 
and contemplation.
This thesis will start with a general introduction of gait disorders in Chapter 2.1, 
discussing its pathophysiology, core clinical features and assessment. We propose a 
Box 1  Parkinson’s disease
Parkinson’s disease (PD) is a degenerative disorder with abnormalities of movement, 
behaviour, learning and emotions, mainly due to dopaminergic deficiency of the 
striatum (caudate nucleus and putamen in the basal ganglia). The pathognomonic 
pathological feature of PD is the presence of intraneuronal inclusions (pale bodies 
and Lewy bodies), mainly containing α-synuclein. This pathology affects not only 
the dopaminergic neurons, but also noradrenergic, cholinergic, serotonergic and 
other central neurotransmitter systems. The main motor features of PD result from 
dopaminergic deficiency in the striatum (caudate nucleus and putamen): tremor, 
rigidity, bradykinesia (slowing down of movements) and hypokinesia/akinesia 
(scarcity/absence of movements). However, non-motor signs and symptoms are 
increasingly recognized in PD, including fatigue, hyposmia, pain, autonomic 
dysfunctions, mood disorders, sleep disorders and cognitive deficits. Mainstay of 
treatment are levodopa, dopamine agonists and deep brain stimulation. All these 
therapies are symptomatic treatments: they do not stop the neurodegeneration 
itself. To date, there is no treatment that cures the disease. Also, there is no evidence 
for neuroprotective medications to slow down the disease.1;53;322
14
CHAPTER 1
practical three-step approach to categorise gait disorders and we present a simplified 
classification system based on clinical signs and symptoms. Then, I will give a general 
overview of freezing of gait in Chapter 2.2. 
Provoking freezing of gait
FOG is an unusual gait disorder because of its “episodic” character: the gait problem 
is sometimes there, but often it is not. This makes FOG a challenge for clinicians. Many 
patients inadvertently deny having FOG gait because they do not properly know 
what actual freezing looks like. Even when patients report having FOG at home, the 
phenomenon is notoriously difficult to elicit in the clinical setting.288 Apparently, 
excitement associated with the doctor’s visit or the patient’s extra attention to gait 
during physical examination can temporarily suppress FOG (a form of “kinesia 
paradoxa”). Another explanation is that FOG, which is typically provoked while walking 
in tight quarters,329 is less likely to occur in a widely spaced hospital corridor than at 
home in a crammed living room. This failure to demonstrate the problem that hinders 
Box 1  Continued
( From: Bear, M. F., Connors, B.W. & Paradiso M. A., Neuroscience: Exploring the Brain, Second Edition, 
Lippincott Williams & Wilkins, 2001, pp 473-482.)
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them so much at home is very frustrating for patients and carers. It is also inconvenient 
for doctors who need to base their clinical management decisions based on 
observations in the examination room. Besides, it hinders patient inclusion in research 
studies.
Hence, we have tried to find ways to provoke FOG. In the section “Provoking freezing 
of gait” we start with Chapter 3.1, a review on the clinimetry of FOG. Then Chapter 3.2 
deals with the best way to clinically provoke FOG, followed by Chapter 3.3 and 3.4 on 
the provocation and detection of FOG on a treadmill. 
Understanding freezing of gait
The mechanisms leading to FOG remain poorly understood, and this hampers 
development of improved treatment strategies. In Chapter 4, we used motor imagery 
of gait in combination with fMRI (Box 2) to study the cerebral correlates of gait 
planning in patients with and without FOG.
Box 2  fMRI and motor imagery
fMRI: functional Magnetic Resonance Imaging is a type of specialized MRI scan. It 
measures the hemodynamic response (change in blood flow) related to neural 
activity in the brain. To do so, it measures the blood-oxygen-level dependence 
(BOLD), the MRI contrast of blood deoxyhemoglobin. Advantages are its relatively 
low invasiveness, absence of radiation exposure, wide availability and high spatial 
resolution. Still, images must be interpreted carefully, as correlation does not imply 
causality. Rigorous statistical analyses are needed to avoid false positives. In 
addition, temporal resolution in poor. 
Motor imagery: During motor imagery a particular movement is imagined but 
not executed.193 There is a large functional and neural overlap between motor 
planning and motor imagery.77;193;251 Several issues are important when using motor 
imagery to study real movement in PD:
- Motor imagery relies on the current physical configuration of a subject. For 
example, motor imagery in patients with amputated limb is delayed,282 and 
hand position influences the ability to mentally rotate hands.89 
- Motor imagery is sensitive to motor control variables. For example, performing 
an imagined arm movement with an added mass (4kg) attached to the wrist 
increases duration of imagined movements.138
- Motor imagery relies on similar neural processes as performance and planning 
of the same movement. This is not only true for hand movements352 but also for 
walking.213
16
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Box 2  Continued
- There is a tight behavioural association between imagined and actual gait.29 
When imagining to walk along a narrow path, it takes longer to reach your goal 
compared to walking along a broad path: just as would be expected during real 
walking. Also, when more time is needed to reach a certain goal in real life, also 
imagining to get to the goal takes more time (high temporal correspondence 
between imagined and actual walking).
Hence, the internal simulation of an action - as during motor imagery - probably 
represents the core element of a motor plan. Although motor imagery of gait is 
likely to engage only a portion of the cerebral circuits controlling walking, it has 
several advantages for investigating FOG. 
- Motor imagery specifically provides opportunities for studying alterations in the 
planning of gait, which may be a crucial element in FOG pathophysiology.76;187 
Meaningful cerebral comparisons between patients and controls require matched 
behavioural performance.311 During real motor performance it will be difficult to 
match behavioural performance between patients with PD and controls. 
However, with motor imagery of gait there can be a matched performance of 
the test between groups
- If cerebral responses are measured during a real FOG episode, there is different 
motor performance (namely FOG instead of walking) and the patients feels his 
body moving differently. In addition, the FOG may provoke emotions in the 
patient. With motor imagery of gait cerebral responses related to walking can 
be isolated, distinct from alterations in motor performance and somatosensory 
feedback produced by actual FOG episodes.12 
17
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Cycling and freezing of gait
The section “Cycling and freezing of gait” starts with the presentation of a fascinating 
case: a patient with longstanding PD and severe FOG, who showed a remarkably 
preserved ability to ride a bicycle. In Chapter 5.1, the scientific and clinical implications 
of this single case observation are discussed, and the video of a similar case is shown. 
Chapter 5.2 shows that these cases do not stand alone, but ‘abasia sine abicyclia’ is a 
more widespread phenomenon in PD patient with FOG.
Treatment of freezing of gait
Levodopa (Box 3) generally alleviates FOG, both with respect to severity and frequency. 
However, freezing is sometimes resistant to dopaminergic therapy.153 This does not 
necessarily exclude a role for dopamine deficiency in the underlying pathophysiolo-
gy, because the threshold for therapeutic relief may simply be higher for freezing 
than for other symptoms, falsely creating the impression of ‘levodopa-resistance’. 
More puzzling is the observation that dopaminergic therapy can paradoxically cause 
or aggravate FOG. We deal with this FOG during ‘ON-state’ in the case description in 
Chapter 6.1. 
Another hallmark of the current treatment of FOG is cueing (Box 1.4). However, 
determining the right cue parameters is important for obtaining the best effect on 
FOG. Chapter 6.2 deals with a patient with severe FOG who responded well to three-
dimensional cues, but not to two-dimensional visual cues.
In chapter 7 we give a general summary of this thesis and discuss the results. This 
chapter ends with a short review on the current state-of-art treatment of FOG.
Finally, Chapter 8 is in Dutch, with a Dutch review on gait disorders (Chapter 8.1) and 
a clinical lesson on patients who fall -due to FOG- (Chapter 8.2). Chapter 8.3 gives a 
Dutch summary of the results of this thesis in Chapter 8.3, written to also be 
understandable for ‘lay’ people. The final Dutch chapter (8.4) is a short review on the 
current state-of-art treatment of FOG.
18
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Box 3  Levodopa53
Levodopa or LEVODOPA (L-3,4-di-hydroxy-phenylalanine) is the cornerstone of 
treatment in Parkinson’s disease. Levodopa is a precursor of dopamine and is able 
to pass the blood-brain barrier (unlike dopamine itself ). Therefore, it can be used to 
treat dopamine-depletion as seen in Parkinson’s disease. It was developed in the 
1960s, and still successfully relieves symptoms and dramatically improves quality of 
life. At first, very high doses of levodopa were needed to treat Parkinson’s disease, 
due to peripheral breakdown of levodopa by the enzyme dopa-decarboxylase. 
This lead to peripheral side effects such as nausea and vomiting. The addition of a 
peripheral dopa-decarboxylase inhibitor to levodopa made it possible to reduce 
the dosage and decrease peripheral side-effects. Unfortunately, long-term use of 
levodopa is associated with motor complications (motor fluctuations and 
dyskinesias). Natural progression of the disease leads to narrowing of the 
therapeutic window. In addition, the short half-life of the drug leads to pulsatile 
stimulation, and the absorption of levodopa may be a problem. 
http://epda.eu.com/medinfo/levodopa/
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Box 4  Cueing284;312
Movement in parkinsonism has been long known to improve on cues. A cue is an 
external stimulus that helps improving movement. This cue can aimed to improve 
the timing of steps (temporal cue) or to improve the amplitude of steps (spatial 
cue). There are three different cue modalities:
- Visual cues (e.g. stripes on the floor)
- Auditory cues (e.g. rhythmical tones, for example from metronome)
- Tactile cues (e.g. rhythmical small vibrations) 
Internal stimuli may also improve walking. Examples are:
- Attention to regular and big stepping
- Singing a rhythmical song or counting without speaking aloud
The specific information a cue provides (cue parameter) partly defines the effect of 
a cue. For example, when the frequency of auditory cueing is too high, patients 
with FOG do not improve their walking. This effect of the cue parameters was 
already described by Martin in 1967: He described transverse lines were helpful to 
improve gait. However, zigzag lines or lines without contrast of color were 
somewhat less effective. Very narrow lines closely together or lines parallel to the 
line of movement did not have any effect.

General introduction to gait disorders 
and freezing of gait
 2|

Neurological gait disorders in the elderly
Published as:
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Summary
Gait disorders are common and often devastating companions of ageing, leading to 
reductions in quality of life and increased mortality. Here, we present a clinically 
oriented approach to neurological gait disorders in the elderly population. We also 
draw attention to several exciting scientific developments in this specialty. Our first 
focus is on the complex and typically multifactorial pathophysiology underlying 
geriatric gait disorders. An important new insight is the recognition of gait as a 
complex higher order form of motor behaviour, with prominent and varied effects of 
mental processes. Another relevant message is that gait disorders are not an 
unpreventable consequence of ageing, but implicate the presence of underlying 
diseases that warrant specific diagnostic tests. We next discuss the core clinical 
features of common geriatric gait disorders and review some bedside tests to assess 
gait and balance. We conclude by proposing a practical three-step approach to 
categorise gait disorders and we present a simplified classification system based on 
clinical signs and symptoms.
25
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Introduction
Gait disorders are common in elderly populations and their prevalence increases with 
age. At the age of 60 years, 85% of people have a normal gait, but at the age of 85 
years or older this proportion has dropped to 18%.48;355 Gait disorders have devastating 
consequences. Perhaps the most notorious corollary is falling, which is often caused 
by an underlying gait problem. Injuries caused by accidental falls range from relatively 
innocent bruises to major fractures or head trauma. Another important consequence 
is reduced mobility, which leads to loss of independence. This immobility is often 
compounded by a fear of falling, which further immobilises patients and affects their 
quality of life.195 Importantly, gait disturbances are also a marker for future development 
of cardiovascular disease and dementia.47;241;376 These associations suggest that gait 
disturbances—even when they present in isolation - can reflect an early, preclinical, 
underlying cerebrovascular or neurodegenerative disease. Finally, gait disorders are 
associated with reduced survival, which can be attributed to a combination of fatal 
falls, reduced cardiovascular fitness, and death from underlying disease.328;375;387
Elderly patients regularly present with complex gait disorders, with concurrent 
contributions from multiple causal factors.8 To describe specific gait disorders 
accurately is often difficult. Here, we provide a practical approach that may support 
clinicians in their everyday management of neurological gait disorders in elderly 
people. We briefly address the pathophysiology of gait disorders and discuss the 
effects of mental function and normal ageing on gait. We conclude by describing a 
practical clinical approach and simplified classification system to differentiate gait 
disorders in everyday practice, based on clinically discernable gait patterns. Treatments 
for geriatric gait disorders are not reviewed.
Pathophysiology of gait disorders
Normal gait requires a delicate balance between various interacting neuronal systems 
(figure 1) and consists of three primary components: locomotion, including initiation 
and maintenance of rhythmic stepping; balance; and ability to adapt to the 
environment. Dysfunction in any of these systems can disturb gait. Most ambulatory 
problems in elderly people are caused by concurrent dysfunction of multiple systems. 
Virtually all levels of the nervous system are needed for normal gait.264;267;283;299
 
Recent studies have drawn attention to pattern generators in the spinal cord that 
generate rhythmic stepping.100 Neuroimaging studies point to the role of the frontal 
cortex in controlling gait and in coordinating automatic and voluntary movements.327 
One interesting study used functional MRI to identify patterns of brain activity while 
26
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participants imagined standing, walking, or running while lying in the scanner.189 With 
running (automated locomotion), spinal pattern generators and the cerebellum were 
involved, whereas slow walking evoked activity in the parahippocampal region, 
presumably because spatial navigation becomes more important.
Figure 1   Levels of the central and peripheral nervous system required  
for normal gait
Feedback:
Vestibular system
Visual system
Sensory nerves
Execution:
Frontal cortex
planning
Basal ganglia
initiation, automatisation
Brainstem
integration
Cerebellum
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Spinal cord
spinal pattern generators
Nerve roots
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Gait and mental function
Walking is traditionally seen as an automatic motor task that requires little, if any, 
higher mental functions. In the past decade, new insights have drawn attention to the 
importance of cognition in daily walking.391 Normal walking requires strategic 
planning of the best route, as well as continuous interaction with the environment 
and with internal factors. Failing to understand the significance of an obstacle, 
choosing an inappropriate route, or misinterpreting one’s own physical abilities can 
all lead to falls. The safety and efficacy of normal walking rely not only on sensorimotor 
systems, but also critically depend on the interaction between the executive control 
dimension (integration and decision of action) with the cognitive dimension (eg, 
navigation, visuospatial perception, or attention) and the affective dimension (mood, 
cautiousness, and risk-taking). A common situation where such an integration is 
challenged is when people must walk while performing one or more secondary tasks. 
Lundin-Olsson and colleagues233 were the first to note the significance of a failure to 
maintain a conversation while walking (“stop walking while talking”) as a marker for 
future falls. The ability to maintain normal walking while performing a secondary task 
(dual task paradigm) has become the classic way to assess the interaction between 
cognition and gait.52 In elderly people, this dual task ability deteriorates because 
central resources decline, secondary to subclinical disease processes or medication. 
This deterioration leads to a mismatch between the limited personal resources of 
elderly people and the complexity of the demand (the combined walking and 
secondary task). As a consequence, elderly people slow down or have an increased 
stride variability (suggesting reduced automaticity) while performing a secondary 
task during walking.105 Gait becomes less secure and the risk of falling increases. In 
patients with overt disease, such as stroke or Parkinson’s disease (PD), gait deteriorates 
even more during dual tasking.51;56;393 
Another form of dual task impairment is when elderly people fail to get their priorities 
right.46 Under complex circumstances, young healthy people begin to neglect the 
secondary task and lend more priority to walking safely. This prudent posture-first 
strategy is diminished in elderly people,52 and failure to prioritise gait under difficult 
circumstances is weakly associated with falls.46 Research has shown that frontal 
executive functions are especially important for maintaining walking stability. 
Dysexecutive functions can be the primary cause of falls in a group of idiopathic 
elderly fallers.169;349 The involvement of cognitive control in normal gait could explain 
why falls are so common in patients with dementia and why demented patients are 
so vulnerable to dual task performance while walking.68;335 Interestingly, patients with 
PD whose phenotype is dominated by postural instability and gait disorder have a 
much greater risk of cognitive decline and dementia than do patients with tremor-
dominant PD.15;64 Additionally, adverse effects on cognitive gait control might explain 
28
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the high incidence of falls and injuries in individuals taking psychoactive medication.223 
Affective disorders are also associated with gait problems in elderly people. For 
example, depression, anxiety, and particularly fear of falling are common consequences 
of unsecured gait and falls among elderly people.145;166;174 
In view of these complex interactions between walking, cognition, and mood, new 
interventional strategies should be developed to promote secured mobility of elderly 
people by improving attention, dual task performance, mood, and executive 
functions.203
Effect of normal ageing on locomotion and gait 
Ageing is typically equated with abnormalities, and this association certainly applies 
to gait. Many older people accept their gait difficulty as being normal for their age 
and their doctors often support them in this view. But are gait disorders truly an 
inevitable consequence of ageing itself? This question is illustrated by the evolving 
concepts around the so-called senile gait disorder: the slow, shuffling, and cautious 
walking pattern commonly seen in older age. Because clinical examination reveals no 
apparent cause, normal ageing was long held responsible for this disorder. However, 
recent findings have challenged this concept. Up to 20% of very old individuals walk 
normally, hence gait disorders are certainly not an inevitable feature of old age.48 This 
finding indirectly implies that those who have gait impairment in fact suffer from 
underlying disease. This assumption is lent support by the fact that individuals with a 
senile gait disorder have an increased risk of becoming demented376 and have reduced 
survival compared with age-matched individuals who walk normally at a high age 
(figure 2).47 These findings suggest that senile gait disorders are an early manifestation 
of underlying pathology, most notably subtle white-matter changes, vestibular 
dysfunction, visual changes, or oculomotor changes.32;40;126;199;202;383;389 Such disorders 
might alter gait directly, but may also act in an indirect way by causing a subjective 
sensation of instability and insecurity, forcing individuals to purposely adopt a more 
cautious gait. 
The message for clinicians is that gait disorders in elderly people are not merely the 
unpreventable consequence of ageing. Instead, these gait disturbances more likely 
result from the increased prevalence and severity of (clinical or subclinical) diseases 
with increasing age (figure 3). For this reason, we suggest abandoning the term senile 
gait as a specific gait category.
29
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Differentiation of gait disorders
Only few studies describe the distribution of geriatric gait disorders. Obviously, the 
spectrum of underlying illnesses will depend on the population under consideration 
and the assessment technique. Within a relatively healthy subgroup of 153 community 
residents aged 88 years and older, about 61% reported distinct diseases as a cause of 
gait impairment.48 Non-neurological disorders were the leading causes of gait 
impairment, in particular joint pain (52 of 87 people), whereas many others had 
multiple causes for their gait impairment. Stroke was the most common neurological 
Figure 2   Kaplan-Meier curves showing cumulative survival due to all  
causes of death
Results are shown for patients with a completely normal gait (n=25), those with senile gait disorders 
(n=14), and those with gait disorders due to known disease (n=87). Mean age was 90 years in all groups 
(range 87–97 years). Survival was different between the groups (log-rank p=0.01). All-cause-mortality 
risk was increased in people with senile gait disorders compared with those with a normal gait (RR=2.8; 
95% CI 1.1–7.3, p = 0·03) and was similar to those with gait disorders due to known disease (RR=1.2; 95% 
CI 0.6–2.5, p=0.6). Mortality due to cardiovascular disease also diff ered among the three groups, with a 
two-fold increased risk of cardiovascular death in people with senile gait disorders compared with 
those with normal gait (data not shown). Reproduced with permission from Blackwell Publishing.47
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cause. In another study of 120 elderly outpatients seen in a neurological reference 
practice, the most common causes for gait disorders were sensory ataxia (18%), 
myelopathy (17%), multiple strokes (15%), and parkinsonism (12%).355 Largely the same 
causes dominated in a series of 493 neurological inpatients, 60% of whom had a gait 
disorder.353
Recognition of specific gait disorders
Table 1 summarises the main features of the weak, spastic, and ataxic gait disorders 
(for reviews, see references33;100;142;267). Because these categories usually cause little 
difficulty in clinical practice, we focus next on the remaining gait disorders.
Hypokinetic-rigid gait disorders
Diseases of the basal ganglia and the frontal lobe mostly present with a hypokinetic-
rigid gait. However, frontal pathology can also cause a higher level gait disorder in 
which truncal imbalance and frequent falls are a key feature. Other associated features 
of this higher level gait disorder are depression, frontal release signs, and impaired 
executive function.19 Specific features of gait, posture, or balance can assist in the 
differential diagnosis of these different disorders (table 2). A characteristic feature of 
hypokinetic-rigid gait is shuffling with a reduced step height, often with a reduced 
stride length, leading to slowness of gait. The base of support is typically normal in 
PD, but is often widened in patients with atypical parkinsonism. Other characteristic 
Figure 3   Indirect association between ageing and geriatric gait disorders
This association occurs mainly, if not exclusively, via the intermediate of age-related pathology. Adverse 
consequences of gait disorders in elderly people include reduced quality of life and, eventually, reduced 
survival.
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Table 1  Main features of specific gait syndromes
Gait 
syndrome
Main features of gait Specific clinical 
diagnostic test
Associated  
symptoms & signs
Antalgic gait Reduced stance phase on 
affected limb
Limping
Pain
Limited range of 
movement
Paretic / 
hypotonic 
gait
High-steppage 
Dropping foot
Waddling
Trendelenburg’s sign Lower motor neuron 
features (e.g. weakness; 
atrophy; low to absent 
tendon reflexes)
Spastic gait Circumduction Intermittent 
abduction of  ipsilateral arm 
with each step Foot dragging: 
audible “scuffing toe” Scissoring; 
bilateral circumduction
Pyramidal syndrome
Anterior-medial side of 
the shoe sole worn out
Vestibular 
gait
Deviation to 
one side
Aggravated by eye 
closure
Positive Unterberger 
test
Vestibular features (e.g. 
nystagmus; abnormal 
tilting test)
Sensory 
ataxic gait
Staggering, 
wide based 
Aggravated by eye 
closure
Disturbed 
proprioception
Cerebellar 
ataxic gait
Staggering, 
wide based 
Not aggravated by 
eye closure
Cerebellar ataxia
Dyskinetic 
gait
Extra 
movements that 
affect gait
Can be task-specific 
(e.g. dystonic gait)
Features of dystonia, 
chorea, myoclonus 
or tics
Hypokinetic-
rigid gait
Shuffling (slow speed, short 
stride, rigidity, reduced step 
height)
Improves with 
external cues
Aggravation by 
secondary task
Hypokinetic-rigid 
features (e.g. 
bradykinesia, resting 
tremor)
Cautious gait “Walking on ice”; slow, wide 
base, short steps
Striking improvement by 
external support
None or only minimal
Excessive fear of falling
Higher level 
gait disorder
Severe balance impairment (no 
rescue reactions; “falling like a 
log”)
Inadequate 
synergies
o Inappropriate or bizarre foot 
placement 
o Crossing of the legs
o Leaning into wrong direction 
when turning or standing
Variable performance 
(influenced by environment 
and emotion)
Hesitation and freezing 
(“ignition failure”)
Abnormal 
interaction with 
environment (e.g. 
trouble adapting 
with walking aids;  
no benefit from 
cues)
(Sometimes) 
better able to 
perform cycling leg 
movements while 
recumbent (gait 
“apraxia”)
Frontal executive 
dysfunction
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Table 2   Differential diagnosis of parkinsonian disorders, based on specific features  
of gait, balance, or posture
Main 
anatomical 
substrate
Disease 
process
Characteristic  
features
Associated 
features
Parkinson’s 
disease
Substantia nigra Neuro-
degenerative
Narrow-based gait
Asymmetrical 
Stooped posture
Early freezing and falls 
rare
Good response 
to levodopa
Resting tremor 
hand(s)
Multiple 
system atrophy, 
parkinsonian 
type
Basal ganglia
Cerebellum 
Pyramidal tracts
Autonomic 
nervous system
Neuro-
degenerative
Early phase like PD gait
Later phase more wide-
based
Pisa syndrome
Antecollis
Vertical falls (due to 
syncope)
Cerebellar 
ataxia
Autonomic 
features
Pyramidal signs
Progressive 
supranuclear 
palsy
Diffuse brainstem 
pathology
Neuro-
degenerative
Wide-based gait
Freezing common
Erect posture, 
retrocollis
Early/ spontaneous/ 
backward falls
Motor reckleckness
Frequent and severe 
injuries
Vertical gaze 
palsy
Pseudobulbar 
palsy
Frontal 
dementia
Applause sign
Corticobasal 
degeneration
Basal ganglia
Cortex
Neuro-
degenerative
Asymmetrical 
presentation – eg, 
unilateral leg apraxia, 
dystonia or myoclonus
Later: wide-based gait, 
freezing, shuffling
Apraxia
Alien limb
Cortical sensory 
loss
Dementia with 
Lewy bodies
Basal ganglia
Cortex
Neuro-
degenerative
Like PD gait
More symmetric
Dementia
Fluctuations
Visual 
hallucinations
Subcortical 
arteriosclerotic 
encephalopathy
Subcortical white 
matter
Vascular Small steps
Wide-based gait
Start hesitation
Variable timing and 
amplitude of steps
Urinary 
incontinence
Cognitive 
decline
Stepwise 
progression
Vascular 
parkinsonism
Diffuse white 
matter
Basal ganglia
Vascular Lower body 
parkinsonism
More wide based
Less stooped
Relatively preserved 
arm swing
Urinary 
incontinence
Cognitive 
decline
Stepwise 
progression
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features include reduced arm swing (asymmetrical in PD, but more symmetrical in 
atypical parkinsonism), which can present in isolation and precede the onset of other 
hypokinetic-rigid features by many years. Turning movements become slow and are 
executed en bloc. Festination is a feature of more advanced disease, where patients 
take rapid small steps in an attempt to maintain the feet beneath the forward moving 
trunk. Poorly mobile patients with advanced disease can sometimes respond quickly 
to environmental events - typically emotional or threatening circumstances - and 
move unexpectedly well (kinesia paradoxica). Apparently, patients with PD can use 
such external triggers to engage alternative motor circuits and thereby bypass the 
defective basal ganglia circuitry.392 
Hypokinetic-rigid gait disorders can be classified according to the underlying 
anatomical substrate. One main group involves lesions within the basal ganglia and 
their connections to the frontal cortex, brainstem, or both. Pathological changes in 
the frontal lobe itself can also contribute to a hypokinetic-rigid gait. There are no 
well-defined clinical markers for frontal-lobe contribution, but suggestive features 
include a wide-based or variable stance and truncal imbalance. Some would also 
include gait apraxia here, often defi ned as a marked discrepancy between the 
severity of the gait disorder and the ability to perform other leg movements, such as 
cycling in the air while lying down. Associated features include urinary urgency and 
cognitive changes and a poor response to external cues.
Hypokinetic-rigid gait disorders can also be classified according to the underlying 
disease process. One important group includes neurodegenerative disorders such as 
Table 2   Continued
Main 
anatomical 
substrate
Disease 
process
Characteristic  
features
Associated 
features
Strategic 
vascular lesion
Putamen
Globus pallidus
Thalamus
Dorsal 
mesencephalon
Vascular Lower body 
parkinsonism
Freezing/severe gait 
akinesia
Severe disequilibrium
Drifting to one side
Normal pressure 
hydrocephalus
Frontrostriatal 
(peri-ventricular)
Ventricular 
widening
Wide-based gait, 
freezing, gait apraxia
Truncal imbalance
Preserved arm swing
Urinary 
incontinence
Cognitive 
decline
Drug-induced 
parkinsonism
Basal ganglia 
(postsynaptic) 
Mild gait impairment, 
rarely freezing
Preserved postural 
reflexes
Pisa syndrome
Upper limb 
tremor
Symmetrical 
presentation
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PD and various forms of atypical parkinsonism (eg, multiple system atrophy or 
progressive supranuclear palsy). Another common group includes underlying 
 cerebrovascular disease. Gait disorders with a mixed hypokinetic-rigid and ataxic 
character are a common occurrence in patients with subcortical arteriosclerotic 
encephalopathy.107 A less common feature of cerebrovascular disease is lower body 
parkinsonism, a predominance of symptoms and signs in the legs, with a relatively 
preserved arm swing and little bradykinesia of the hands.388;400 The term lower body 
parkinsonism is a useful descriptive term in clinical practice because it refers to a 
recognisable phenotype that is often associated with underlying cerebrovascular 
disease, including white-matter changes and lacunar infarcts in the basal ganglia. 
However, lower-body parkinsonism is not synonymous with vascular parkinsonism. 
Occasional patients can present with a clinical presentation resembling PD (with 
upper-limb involvement) or even progressive supranuclear palsy. Hypokinetic-rigid 
gait disorders due to cerebrovascular disease can develop acutely or with an insidious 
onset.388 The acute syndrome mainly involves infarcts in the putamen, globus pallidus, 
or thalamus, whereas the gradual form is associated with diffuse white-matter changes.
A third type of underlying disease process is ventricular widening, as occurs in patients 
with normal pressure hydrocephalus. Whether normal pressure hydrocephalus truly 
exists as a separate entity with its own unique pathophysiology is unknown. Typically, 
the disorder presents with a recognisable triad of hypokinetic-rigid gait impairment, 
urinary incontinence, and (frontal) dementia. Gait is characterised by marked slowing 
and small shuffling steps and regular freezing, but usually with largely preserved arm 
movements.153;354 Ataxic elements are also seen, including a broad stance width and 
an increased variability in timing and amplitude of the steps. The pathophysiology 
has not been clarified, but may relate to an excessive volume of intraventricular 
cerebrospinal fluid that is not explained by cerebral atrophy. The classic radiological 
appearance includes widened lateral ventricles (especially affecting the anterior 
horns), often accompanied by periventricular white-matter lesions. An unresolved 
question (yet one with direct implications for treatment) is whether these periven-
tricular white-matter lesions are the cause or consequence of ventricular widening.364
Clinical examination alone cannot always disentangle these different anatomical and 
pathophysiological causes of hypokinetic-rigid gait disorders, especially in early 
stages where overlap is substantial. In such patients, it is best to refrain from confusing 
terminology. It initially suffices to classify the patient as having a hypokinetic rigid gait 
disorder and to base a more definitive anatomical or aetiological diagnosis on ancillary 
investigations (MRI) and sometimes the response to treatment (eg, a trial of levodopa). 
Cautious and careless gaits
Typically, people with a cautious gait move slowly, with a wide base and short strides, 
with little movement of the trunk, while the knees and elbows are bent. Cautious gait 
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is common in elderly people and originates in part from fear of falling, which is 
sometimes present to the degree of panic.145 There are two main subgroups. In the 
first, fear of falling is excessive relative to the degree of actual instability. In fact, 
balance can be fully normal, as in people with a pathological fear of falling (fall phobia) 
caused by a single fall. In these individuals, the remaining neurological examination is 
completely normal, and provision of external support or reassurance can substantially 
improve gait. In the second subgroup, fear of falling is justified by a recent history of 
recurrent falls or by a self-perceived instability due to overt or sometimes otherwise 
subclinical underlying disease. These individuals might show mild freezing of gait, 
occurring mainly with gait initiation and while turning.145 Neurological examination 
can further reveal mild hypokinetic-rigid signs, disturbed postural responses, and 
frontal release signs. With time, these patients may develop other subcortical or 
frontal disturbances, or progress to having a more disabling gait impairment. A 
therapeutic levodopa trial is justifiable, but it has been our clinical impression that 
after a short positive response that could represent a placebo effect, patients with 
cautious gait no longer improve. Fear has to be treated medically or behaviourally.
Careless gait is the counterpart of the cautious gait. Some patients seem overly 
confident and walk inappropriately fast, perhaps because of lack of insight or 
frontal-lobe disinhibition. Notorious examples are patients with progressive 
supranuclear palsy and Huntington’s disease who typically move too abruptly despite 
a severe balance deficit and who seem unable to properly judge the risk of their 
actions. This motor recklessness probably underlies the high incidence of fall-related 
injuries in these disorders.50;155 A similar recklessness contributes to falls and injuries in 
ageing disorders such as Alzheimer’s disease. Confusion and delirium can also 
contribute to a careless gait. A recent study showed that gait velocity should be 
judged in the context of the patient’s physical capabilities. Thus, although frail elderly 
patients with dementia walked slowly, they still walked relatively too fast, given their 
overall degree of physical impairment, which should have warranted an even much 
slower gait.367 For some cognitively impaired patients, restriction of unsupervised 
physical activities is an ultimate measure to prevent wandering behaviour and to 
reduce injurious falls.69
Fluctuating or episodic gait disorders
A curious feature of some gait disturbances is their fluctuating or frank episodic 
nature. The specific provoking factor can differentiate these gait disturbances. Some 
gait disorders fluctuate more or less predictably because of exercise intolerance or 
pain. In elderly people, walking difficulties after exercise are often due to fatigue (car-
diopulmonary or neuromuscular disease), but might also indicate vascular or 
neurogenic claudication. Psychogenic gait disorders can also present with an episodic 
character, for example an aggravation when bystanders are present. 
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Other gait disorders are truly episodic. The sudden and largely unpredictable nature 
of these episodes is incapacitating, commonly leading to falls because patients are 
caught unprepared.49 An example is freezing of gait, where patients suddenly 
experience a characteristic feeling “as if the feet become glued to the floor”. Various 
terms have been used in different contexts, including gait ignition failure or slipping 
clutch phenomenon. We propose to use the term freezing of gait to describe all gait 
initiation disturbances. Although freezing of gait is most often observed when 
initiating gait, it also occurs when walking through a narrow passage, during turning, 
while executing a secondary task (eg, responding to a question), or upon reaching a 
destination. In severely affected patients, it can occur seemingly spontaneously while 
walking in open terrain. Three different clinical presentations are recognised: shuffling 
with small steps; trembling in place, while attempting to overcome the block; or 
being fully unable to start or continue walking, which is relatively rare.329 Freezing of 
gait can present largely in isolation, as occurs in primary progressive freezing gait. This 
usually results from frontal lobe damage, irrespective of the specific disease process.116 
However, freezing of gait is mostly seen as part of a hypokinetic-rigid syndrome, 
including PD and various forms of atypical parkinsonism.147;269
Dyskinetic gait disorders
The term dyskinesias includes all involuntary movements or postures—eg, chorea or 
dystonia. Presence of such involuntary movements during walking suggests a 
dyskinetic gait. A well-known example is the gait in patients with postanoxic 
encephalopathy, in which the positive and negative action myoclonus (Lance-Adams 
syndrome) produces a bouncing gait and stance. Dyskinesias can contribute to falls 
by causing excessive trunk movements beyond the limits of stability, as occurs in 
patients with PD with medication-induced dyskinesias45 or in patients with 
Huntington’s disease.155 Note that dyskinesias might be absent during clinical 
examination because of their fluctuating character or because patients suppress 
them intentionally. Cognitive distractions can help to elicit the involuntary movements 
during examination. 
Patients with dystonia require specific attention because their gait or balance 
impairment can be task-specific.229 For example, patients may have severe gait 
impairment due to leg dystonia, but can easily walk backwards or even run. This is 
easily misinterpreted as a psychogenic sign. Examples of gait dystonia include early 
onset PD presenting with a foot dystonia while walking, or patients with idiopathic 
torsion dystonia who can present with unusual gait patterns. Other forms of gait 
dystonia include retrocollis in patients with progressive supranuclear palsy, antecollis 
or a Pisa syndrome (severe and persistent lateroflexion of the trunk) in patients with 
multiple system atrophy, and an asymmetrical arm or leg dystonia during walking in 
patients with corticobasal degeneration. Many dystonic patients tend to walk on their 
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toes (cock walk). Axial forms of dystonia, including dystonic scoliosis, hyperlordosis, or 
torticollis can also interfere with walking and standing. This is particularly true if 
extensor or flexor spasms are present.
Psychogenic gait disorders
Although suspicion of psychogenic gait disorders is highest in younger patients, they 
can occur in elderly patients. Psychogenic gait is often not compatible with known 
gait patterns and they can take unusual forms (panel).41;356;379 Falls and injuries are 
thought to be rare in patients with a psychogenic gait, but we encountered one such 
patient who sustained severe injuries (epidural haematomas and a skull base 
fracture).379 Care must be taken not to miss underlying organic disease, in particular 
frontal-lobe dysfunction. The differential diagnosis includes organic gait disorders 
that can mimic psychogenic gait disturbances; examples include choreatic gait in 
Huntington’s disease, task-specific dystonic gait, episodic weakness in myasthenia 
gravis, and cataplexy. Gait in stiff person syndrome can also look strange; gait 
abnormalities typically aggravate when patients are instructed to hurry up.248
Gait disorders and falls caused by medication
Gait disorders and falls in elderly people are commonly associated with adverse 
effects of drugs (table 3).7;9;44;111;127;132;175;211;222;222;223;380 The precise underlying pathophysi-
ological mechanism is unclear in many cases. Commonly implicated factors include 
sedation, orthostatic hypotension, behavioural abnormalities, extrapyramidal side-eff 
ects, or ataxia. However, there can also be confouding by indication - ie, falls that are 
Panel 1   Suggestive features of a psychogenic gait disturbance
Incongruous with known gait disorders
Bizarre presentation
Variable, inconsistent pattern
Non-physiological pattern
Rarely falls / injuries
Abrupt onset
Extreme slowness
Unusual / uneconomic postures
Exaggerated effort
Associated features:
· Incongruous affect (belle indifference)
· Secondary gain
· Prior history of psychiatric disease 
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caused by the underlying disorder for which the drugs were prescribed in the first 
place. Thus, falls or a disturbed gait in patients taking anti-diabetic medication might 
simply be caused by an underlying diabetic polyneuropathy. Polypharmacy is 
particularly associated with falls, but only if a patient daily takes at least one drug with 
an established risk of increasing falls.399 A critical review of medication is therefore 
important in elderly people. For example, a recent randomised controlled trial showed 
that when a pharmacist reduced the number of drugs in elderly care-home residents, 
the number of falls was reduced by 40%.397
Assessment of gait disorders
Assessment includes a full physical and neurological examination and a systematic 
gait assessment. Use of standard rating scales, such as the Tinetti mobility index362 or 
gait and balance scale,360 help to score all different elements of gait and balance. Most 
examination rooms are too small, so it is often necessary to examine the patients 
Table 3   Drugs with adverse effects on gait, posture and balance
Medication group Comments
Antipsychotics 175;132 Occurs with both typical and atypical antipsychotics.
Antidepressants 111;132 Occurs with both selective serotonin reuptake inhibitors 
(SSRI’s) and tricyclic antidepressants.
Anticonvulsants 127;132 Occurs with both older anti-epileptic drugs (e.g. 
phenobarbital) and newer anti-epileptic drugs (e.g. 
lamotrigine), but possibly less in the newer drugs.
Antiparkinson drugs 44 Occurs with all classes of antiparkinson drugs. Underlying 
mechanism is complex, but mainly includes excessive 
dyskinesias, orthostatic hypotension and behavioural 
abnormalities.
Benzodiazepines / other hypnotics 9;132 Occurs with both short and long-acting 
benzodiazepines. Newer ‘Z’-compound hypnotics such 
as zopiclone are considered safer.
Analgetics  132;222;380 Occurs with opiates, NSAIDs and paracetamol. Some 
studies find stronger effects of opiates, others of NSAID’s
Antihypertensive 7;222 Diuretics, beta-blockers, ACE inhibitors and nitrates. 
Evidence is stronger for inpatients then for outpatients, 
probably due to a stronger impact of orthostatic 
hypotension after prolonged bed-rest.
Anticholinergics 7;132
Anti-diabetics 211 Perhaps via underlying pathology, e.g. diabetic 
polyneuropathy or cerebrovascular disease.
Anti-arrhythmics 222
Quinine 132 Quinine and derivates 
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while walking in the corridor. Simple undisturbed gait can be informative, but 
additional abnormalities come to light when gait is challenged. For example, walking 
with eyes closed might provoke or aggravate ataxia in patients with a sensory 
neuropathy, or cause a consistent deviation to one side in patients with unilateral 
vestibular loss. Patients suspected of having freezing of gait often walk normally in 
the examination room because excitement associated with the doctor’s visit can 
suppress this sign. In such patients, careful questioning supported by validated 
questionnaires152 is important. Additionally, walking in tight quarters, while turning or 
when doing secondary tasks may provoke freezing of gait. 
Next to challenging gait, observation of whether patients can improve their gait - eg, 
by benefiting from walking aids or provision of external support - is equally instructive. 
Seemingly incapacitated patients with a cautious gait can show striking improvements 
in gait when provided with external support while walking. Similarly, providing 
individuals with external visual, auditory, or mental cues can help to reduce freezing 
of gait.203 By contrast, patients with a higher-level gait disorder typically do not benefit 
from external cues and have troubles adapting with walking aids. Such patients are 
sometimes better able to perform cycling leg movements while lying recumbent, 
suggesting that their loss of control over leg movements is task-specific (gait apraxia). 
As mentioned earlier, this task-specificity can also be seen in patients with dystonia.229
The pull test (or retropulsion test) is commonly used to probe the reactive and 
defensive balance reactions.43;179 Many variants exist, but most commonly the 
investigator, standing behind the patient, suddenly pulls the patient’s shoulders. The 
test is typically used to score the severity of postural instability. However, failure to 
initiate a corrective step - due to freezing of gait - also produces an abnormal test 
result. We usually deliver one shoulder pull without specific prior warning, as this best 
mimics daily life circumstances where falls are usually unexpected events. We then 
repeat the test several times and regard failure to habituate to the test as another sign 
of balance impairment. A recently introduced variant is the push and release test, 
which rates the postural response to a sudden release of a patient pressing backward 
on an examiner’s hands placed on the subject’s back. An advantage is that this test 
allows examiners to apply more consistent perturbation forces to the patients than 
with the conventional pull test, and the outcome seems to correlate better with 
self-reported falls.185
Timed tests can be used to quantify gait velocity (eg, to assess the effect of treatment), 
but these do not accommodate the quality of gait. A commonly used test is the timed 
up and go test, where patients are observed and timed while rising from a high chair 
with arms, walking 3 meters, turning around, walking back, and sitting down again.308 
Cognition and affect should be routinely examined in elderly patients with gait 
problems, with emphasis on frontal cognitive dysfunction. Fear of falling can be 
assessed directly or, preferably, by using a validated questionnaire.195 Finally, it is 
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important to assess footwear and vision (with and without correction), as these 
contribute to gait disorders and falls in the elderly.231;249
A relatively new method is physiological analysis of gait, by use of a treadmill and 
quantitative outcome measures: kinematics (joint motion), kinetics (reactive forces), 
and dynamic electromyography. An important disadvantage is that gait is assessed 
under constrained and highly unnatural circumstances, leading to lack of ecological 
validity.54 Less complex systems can be applied in freely moving individuals. Common 
tools are ambulatory goniometers or accelerometers, to quantify movement of the 
limbs or trunk,11 and shoes with pressure-sensitive insoles167;306 or a carpet with pres-
sure-sensitive sensors280 to measure subtle changes in locomotion rhythmicity, 
variability, or left–right synchronisation. Although this type of gait analysis better 
approaches real-life situations, whether the currently available equipment provides 
any clinically relevant extra information is unknown. We therefore feel that it is 
currently not worth sending elderly patients for a quantitative study of gait in a 
sophisticated gait laboratory. Possible exceptions include a preoperative assessment 
to guide the surgeon before an orthopaedic intervention, detailed electromyography 
studies in spastic or dystonic patients to fine-tune subsequent treatments with 
botulinum toxin or selective surgical denervation, and kinematic gait analyses to 
assist rehabilitation specialists in their choice for specific segmental orthoses or 
adjusted footwear.66;71;95;252;337 Physiological gait analysis is a very useful technique for 
scientific purposes.
Clinical approach and classification of gait disorders
We conclude our contribution by discussing a new, practically oriented approach to 
gait disorders, as well as a simplified modification of the classification originally 
proposed by Nutt and colleagues.296 A broadly accepted classification system would 
assist health professionals when they communicate about patients with gait disorders. 
Research will also benefit from a good classification system, for example to ascertain 
that properly diagnosed patients and homogeneous groups are included in trials or 
gait experiments. 
Different types of gait classifications currently exist, with different and partly 
overlapping starting points (hierarchical, anatomical, aetiological, or phenomenolog-
ical). Every classification system has inconsistencies (table 4). We propose a practical 
three-step approach that begins with a gait classification based on clinical 
phenomenology, as observed in the consultation room (step 1 in figure 4). This first 
step includes three elements: the core features of a patient’s gait; additional clinically 
based gait and balance tests; and associated neurological or physical abnormalities. 
These three elements are all listed systematically in table 1 for each of the main 
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clinically discernable gait patterns. For example, patients with an ataxic gait typically 
have a wide-based, staggering gait (core clinical feature). By itself, this core feature 
can implicate either sensory ataxia or cerebellar ataxia, and this distinction can be 
made with additional gait and balance tests, such as the effect of eye closure 
(aggravates the gait impairment much more in sensory ataxia compared with 
cerebellar ataxia). The distinction between both types of ataxic gait disorders can be 
corroborated by a search for associated neurological or physical abnormalities: 
hypermetria, nystagmus, and cerebellar dysarthria suggest that the wide-based gait 
was in fact caused by cerebellar ataxia, whereas disturbed proprioception would 
suggest sensory ataxia. Taken together, the three elements of this first step thus lead 
to a clinically based classification, determined by recognisable gait features 
(syndromes or possible gait disorders), as listed in the left column of table 1.
Note that this first step of the classification avoids anatomical, pathophysiological, 
and aetiological terminology because it is solely based on clinical impressions 
obtained in the examination room. For that reason, our clinical classification also 
avoids a distinct categorisation of low level and middle level gait disorders as 
proposed in the original Nutt classification296 because this hierarchical distinction 
formally requires ancillary studies to demonstrate the site of the lesion. Also, symptoms 
can overlap between middle level and higher level gait disorders. 
We propose to abandon the anatomically based term frontal gait disorders, as these 
may present with at least three different phenotypes: a shuffling hypokinetic-rigid 
gait; a wide-based ataxic pattern; and an episodic gait disorder, dominated by freezing 
episodes. Furthermore, the frontal phenotype can be seen in a wide variety of 
disorders, including PD, various forms of atypical parkinsonism, or frontal mass lesions.
How can we classify the gait disorders collectively grouped under the original term 
higher level gait disorders? These cannot be captured by a single, dominant, and 
consistently present gait feature, but do share a recognisable phenotype19;110 that can 
be identified using the first step of our approach (table 1). We propose to maintain the 
original term higher level gait disorders until better insights arrive from pathophysiol-
ogy. There is a growing consensus to avoid, for the time being, any further subdivisions 
of the higher level gait disorders, as these have little value in clinical practice.297
A more certain clinical diagnosis (which we would define as a probable gait disorder) 
often requires an additional diagnostic step (step 2 in figure 4). This second diagnostic 
step again involves three elements. First, for some patients, the clinical diagnosis will 
serve as a guide for tailored ancillary investigations, such as structural neuroimaging 
to detect, for example, underlying cerebrovascular disease. Second, the response to 
treatment will further assist in making a definitive diagnosis. For example, a substantial 
improvement of a shuffling gait disorder with levodopa suggests involvement of a 
presynaptic dopaminergic lesion, possibly due to PD. Third, the factor time may 
provide additional clues about the disease course, or reveal newly emerging 
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neurological abnormalities. For example, prolonged follow-up (up to 16 years) of 
patients with a cryptogenic primary progressive freezing gait showed a progression 
to recognisable clinical diagnoses, including pallido nigroluysian degeneration, 
diffuse Lewy body disease, progressive supranuclear palsy, and corticobasal 
degeneration.116
The third and final step of our diagnostic approach will lead to a definitive, aetiology-
based diagnosis (step 3 in figure 4). This step often depends on post-mortem 
examination. Further enhancement of our understanding of particular gait disorders 
by increasing the number of clinicopathological correlations will be a major challenge. 
Our classification does not include gait disorders that are secondary to a clear and 
overriding balance problem. We feel that these should be classified as primary balance 
disorders and managed as such. An example is the astasia-abasia syndrome due to 
thalamic stroke, where gait is severely hampered not due to a defect in the neural 
machinery that is responsible for maintaining gait, but to a severe balance deficit.244
Table 4   Drawbacks to currently available gait classification systems
Classification Examples Drawbacks
Hierarchical Lower level
Intermediate level
Higher level
Term ‘higher level’ often abused as ‘basket’ term 
for any poorly understood gait disorder
Subdivisions of ‘higher level’ gait disorders 
difficult to use in clinical practice
Overlap in symptoms between middle and higher 
level gait disorders
Anatomical Frontal gait
Cerebellar gait
Different anatomical lesions may present with 
similar gait patterns
Any given anatomical lesion may present with 
different gait patterns
Etiological Vascular
Neurodegenerative
Ancillary studies or post-mortem examination 
often required to make definitive diagnosis
Phenomenological See table 1 Pathophysiology not taken into account
Panel 2   Suggestive features of a psychogenic gait disturbance
References for this review were identified by searches of PubMed up to August 2006. 
Papers were also identified from the authors’ own files and from references given in 
relevant articles. Search terms “gait”, “gait disorder”, “locomotion”, “elderly”, “geriatric”, 
and “ageing” were used.
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Conclusions
This review shows that the field of gait disorders is very much on the move, with 
exciting new insights in the underlying pathophysiology. There is an increasing 
awareness that gait disorders in old people are often not due to merely ageing, but 
rather are associated with diseases that are more common in elderly people and 
which are potentially amenable to therapeutic intervention. Clinical assessment of 
geriatric gait disorders may seem difficult, but is facilitated by the practical approach 
proposed here. Modern neuroscience methods such as functional MRI and virtual 
Figure 4   Practical three-step approach for the classification of geriatric  
gait disorders
The first level yields a temporary, clinically based diagnosis, according to phenotype (possible gait 
disorder). Further refinement of the diagnosis can be based on tailored ancillary studies (eg, structural 
neuroimaging, nuclear imaging, or genetics), the response to treatment (eg, response to levodopa, or 
the effect of stopping sedative drugs), and the factor time (disease course). This second level yields a 
probable gait disorder. A definite aetiological diagnosis will often depend on post-mortem examination.
Core gait features Associated symptoms and signsSpecic gait or balance tests
St
ep
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Possible gait disorder (clinically based gait syndrome)
Post-mortem examination
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Ancillary investigations Disease progressionTherapeutic investigations
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reality are now increasingly engaged in gait research, and there is good reason to 
believe that this will enhance our fundamental understanding of geriatric gait disorders, 
thereby opening new avenues to improve the management of this common and 
disabling problem.
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Freezing of Gait: general overview
Parts of this chapter are based on:
Mahabier W, Snijders AH, Delval A, Bloem BR. Freezing of gait. In: Kompoliti K,  
and Verhagen Metman L (eds.) Encyclopedia of Movement Disorders. Oxford: 
Academic Press. 2010; 486-491. 
 2.2

49
2
FREEZING OF GAIT: GENERAL OVERVIEW
Definition 
Freezing of gait (FOG) is a common and disabling feature of Parkinson’s disease(PD). It 
is a remarkable gait disorder, because of its episodic character. Patients with FOG 
experience sudden and often unexpected episodes during which their feet 
subjectively are ‘being glued to the floor’, while their trunk continues to move forward. 
A FOG episode is thus defined as a brief episode during which patients find it 
impossible to generate effective forward stepping movements, in the absence of 
another cause than parkinsonism or higher cortical deficits. It is most commonly 
experienced during turning and step initiation, but also when faced with spatial 
constraint, stress and distraction. Focused attention and external stimuli (cues) can 
overcome the episode. Because of the sudden and unpredictable nature, FOG often 
leads to falls and injuries.150
History
Already in 1817, James Parkinson described in his classical essay ‘The Shaking Palsy’ 
the typical ’propensity to bend the trunk forwards, and to pass from a walking to a running 
pace’.300 This phenomenon is currently known as ‘festination’: taking increasingly rapid 
and small sequential steps during walking, in an attempt to maintain the center of 
gravity above the feet while the trunk leans progressively forward.151 Although 
festination and FOG appear to be closely related, James Parkinson did not specifically 
describe FOG. 
The first description of a FOG episode presumably stems from Charcot, who in 1877 
described gait initiation failure, followed by forward propulsion with festination. “…
elle ne part pas ; il semble, qu’auparavant, elle ait besoin de s’equilibrer: elle est en quelque 
sorte incertaine, ayant le tronc incliné en avant ; enfin elle se décide. Lente tout d’abord, la 
marche progressivement s’accélère…”73 Since then, several terms have been used to 
describe FOG (Box 1). In 1882, the phenomenon was already linked to ‘frost’, although 
with a different meaning: Thomas Buzzard, a neurologist of National Hospital Queen 
Square in London, said in 1882: “William W – an engine-driver-  remains for a time 
unable to start when attempting to walk, his feet beating the ground rapidly as he 
marks time before setting off at a fair pace - the patient likening his condition to ‘the 
wheels of a locomotive failing to bite the rails when they are slippery with frost and making, 
in consequence, ineffective revolutions’.78 
In his 1921 essay on kinesia paradoxicale, Souques described a patient who was glued 
to the floor: ‘Un parkinsonien que j’ai observe, malade depuis dix ans, ne pouvait marcher 
que très péniblement, les pieds collés au sol. Or, parfois, il pouvait courir et même soulever 
les pieds assez haut pour sauter un obstacle.’346
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In 1967, Martin described the remarkable effect of cues in patients with postencepha-
litic parkinsonism. He described patients being ‘stuck to the ground’, whose gait 
improved remarkably with transverse visual cues or when being ‘rocked from side to 
side’.312 The first time the phenomenon was really termed ‘freezing’ was in 1972 by 
Barbeau, where he described that adding a peripheral decarboxylase inhibitor to 
Levodopa lead to less frequent freezing.34 Barbeau compared the episodic freezing of 
gait to the kinesia paradoxica as described by Souques. The classic story presentation 
of kinesia paradoxica is that of a rigid, wheelchair-confined patient who suddenly gets 
up and runs out of the house upon hearing the warning cry of ‘fire’, only to ‘freeze’ 
again on the lawn outside. In contrast, he referred to FOG as ‘akinesia paradoxica’, as 
patients who are suddenly unable to move while they could do so beforehand (“in a 
clear blue sky”).35 However, these two phenomena may not be different really, but just 
two ends of a spectrum, reflecting disease severity and the effect of medication. The 
literature then remained more or less silent for some time, but particularly during the 
last 10 years, interest in the clinical impact, the underlying pathophysiology and the 
various treatment methods of FOG has increased rapidly.
Epidemiology / Risk factors
Epidemiology as related to different etiologies
FOG is common in idiopathic PD; it occurs in 6 - 80% of PD patients, depending on 
disease severity, disease duration and treatment status. Interestingly, some patients 
experience FOG in early stages of their disease, while other patients never develop 
FOG. It is also seen in some 25-60% of patients with atypical parkinsonism caused by 
vascular parkinsonism, normal-pressure hydrocephalus or neurodegenerative 
diseases such as progressive supranuclear palsy or multiple system atrophy147;157;269. 
FOG is less often seen in patients with corticobasal degeneration (8-25%)269 and rarely 
Box 1   Terms used which are (partly) synonymous to freezing of gait
Frozen gait
Akinesia paradoxica
Start hesitation
Marche a petit pas
Piétinement 
Magnetic gait
Ignition failure
Gait apraxia
Arrhythmokinesia
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occurs in neuroleptic-induced parkinsonism.162 Primary progressive freezing of gait is 
an uncommon condition starting with FOG, often with frequent falls. Patients initially 
do not experience bradykinesia, rigidity or tremor and usually do not respond to 
treatment with levodopa. With extended follow-up, this condition may clinically 
progress to progressive supranuclear palsy or corticobasal degeneration.79;116 Post- 
mortem examination in these patients may reveal pallidonigroluysian degeneration 
or diffuse Lewy body disease, underscoring how heterogenic the underlying etiology 
can be.
Table 1 shows the frequency of FOG in different disorders, with references that 
describe the phenomenon. Earlier studies are not included, but FOG was not 
structurally investigated at the time. The wide range of frequencies probably reflect 
the different assessment methods (questionnaires, different questions) and different 
severities / disease durations of the included patient populations.
Table 1   Prevalence of freezing of gait in Parkinson’s disease and other disorders
Disorder Frequency of FOG References
Focal lesions
Dorsal mesencephalon Case reports only. Frequency unknown
· Single case: haemorrhage in pontomesencephalic 
junction and right PPN
· Three cases: unilateral midbrain tegmentum stroke
· Single case with bilateral PPN strokes
· Case of patient with brain lymphoma in dorsal 
mesencephalon, cerebellum and periventricular 
white matter
243
163 
212
184
Frontal lobe lesions Frequency unknown.
There are reports on akinetic mutism in bilateral 
ACA stroke, or in left-sided ACA in combination with 
bilateral lacunar infarcts of the caudate nucleus.
In a series of 100 patients with ACA stroke, 91 had 
motor dysfunction, but only paresis is reported. Three 
had ‘parkinsonian symptoms such as bradykinesia’, but 
FOG is not reported. Probably they didn’t look.
Frontal lobe deficits, such as infarcts or tumors.
Stroke involving the supplementary motor regions of 
both hemispheres. The gait deficit was termed ‘gait 
apraxia’, in the absence of apraxia for other functions.
209;220;281
197
115
91
Hemiparetic stroke 33% (26 of 79 patients) self-reported ‘freezing’. 
Symptoms of hemiparesis not further localized. 
Questionnaire not totally reliable. No difference 
between right or left sided stroke. No CT images 
available.
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Table 1   Continued
Disorder Frequency of FOG References
More diffuse lesions
PD
Mild
                                              
Moderate
Severe
10-20%
52%
6% <7 years
7.1% early PD, 
25% 1.5 years later
32%
40-70%
83% H&Y 2-3
60% (in general)
19% 7-12 years
35% after >12 years
Advanced disease: 53%
71%
70-80%
76% H&Y 4-5
81% after 20 years
234
315
117
148
148
149
234
315
215
117
117
153
230
234
315
173
Delayed adverse 
effect of bilateral STN 
stimulation.
Gait deterioration during the OFF-state occurred in 
42% of subjects.
368
Atypical 
parkinsonism 
MSA
PSP
DLB
CBD
Vascular 
parkinsonism
NPH
46%
Start 24% last 47%
75% (50% MSA-C, 82% MSA-P
40-54%
25-53%
21-54%
8-25%
57%
30% (13 of 37 stroke patients with parkinsonism, but 10 
had lacunar infarcts)
38% (6 of 16)
56%
See 115; earlier studies do not cite FOG as a symptom, 
but did not structurally search for this.
147
269
157
269
269
269
269
147
372
94
147
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Risk factors
In idiopathic PD the most important risk factors for developing FOG include a more 
advanced disease and a longer disease duration.140 A longer duration of levodopa 
treatment is also seen as a risk factor for FOG, although it is difficult to uncouple this 
from disease duration and disease severity. Also, medicated patients may show more 
FOG simply because they can walk for a longer period, increasing the likelihood of 
witnessing FOG episodes. Other risk factors include disturbances in gait, posture, and 
speech, but bradykinesia and rigidity are not related to the occurrence of FOG.36;140 
Remarkably, the presence of tremor is associated with a lower risk of developing 
FOG.36 FOG is further associated with frontal cognitive (executive) deficits, including 
even overt dementia and urinary incontinence (which may also reflect frontal 
dysfunction).18 FOG is itself a strong risk factor for falls and ensuing injuries.201;219 
Clinical features / diagnostic criteria
Circumstances of freezing
FOG episodes most commonly occur in complex environments that necessitate 
integration of multiple sensory stimuli. Therefore, they are typically seen during a shift 
of attention or a circumstantial or directional change. Thus, in daily life FOG particularly 
occurs under specific conditions such as starting, turning, walking in tight quarters 
(e.g. passing a narrow doorway) or upon reaching a destination, but it may occasionally 
Table 1   Continued
Disorder Frequency of FOG References
More diffuse lesions
Primary progressive 
freezing of gait
100% (by definition)
When called pure akinesia: 70% FOG
115;182
Drug induced 
parkinsonism
‘very low risk’ OR 0.1 147;162
Higher level gait 
disorders
20% at baseline; 40% after 3 years 145;146
Cerebral radiotherapy Case report 98
Carbon monoxide 
intoxication
Case report 221
FOG = freezing of gait; PD = Parkinson’s disease; PPN = pedunculopontine nucleus; ACA = anterior cerebral 
artery; CT = computed tomography; H&Y = Hoehn and Yahr stage; STN = subthalamic nucleus;  
MSA = Multiple system atrophy; MSA-P = MSA, parkinsonian subtype; MSA-C = MSA, cerebellar dysfunction 
subtype; PSP = progressive supranuclear palsy; DLB = diffuse Lewy body disease; CBD = corticobasal 
degeneration; NPH = normal pressure hydrocephalus
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also occur during straight walking in open space.150 Turning around appears to be the 
strongest provoking factor.329 Dual tasks or stressful demands may also increase the 
occurrence of FOG. Furthermore, the majority of FOG episodes occur when the 
response to dopaminergic treatment has vanished (i.e. during an OFF-state), when 
FOG is both lengthier and more severe (see also the section on Treatment).329 See 
chapter 3 for an extensive elaboration on the circumstances that provoke FOG.
Characterization
The main characteristic of FOG is a loss of efficient forward movement generation, 
which can manifest itself as three different subtypes. The least severe subtype consists 
of taking very small shuffling steps, with only minimal forward movement. A more 
severe subtype includes trembling of the leg, without any effective forward motion, 
known as ‘trembling in place’. The most severe subtype is a complete akinesia, without 
any observable motion of the legs. The duration of a FOG episode is usually very brief, 
typically ranging from less than a second to up to 10 seconds. Episodes longer than 
10 seconds are very rare and only occur during the OFF-state, when FOG episodes last 
longer compared to the ON-state.329
Diagnosis
The current ‘gold standard’ of diagnosis of FOG is the observation of FOG by an 
experienced examiner. However, FOG is notoriously difficult to elicit in the examination 
room, so the patient’s subjective feeling of periodically being ‘glued to the floor’ 
often serves as surrogate marker to establish the diagnosis. FOG is currently only 
classified as being either ‘present’ or ‘absent’, and reliable gradations of severity are 
not yet available. Assessment of FOG will be discussed in more detail in chapter 3.
FOG should be differentiated from a voluntary stop or hesitation (for example, 
because the patient feels unsafe), overall akinesia, or festination.151 Overall akinesia 
differs from FOG because the episodic character is absent: patients with overall 
akinesia have the feeling of being glued all the time, while patients with FOG 
experience the glued feeling only episodically. Festination should also be differentiated 
from real FOG episodes. During festination, the feeling of being glued to the floor is 
lacking. Festination typically occurs during gait, while FOG mainly occurs during gait 
initiation and turning. Moreover, festination leads to a fastening instead of slowing of 
walking velocity. Finally, FOG should also be differentiated from central nervous 
system overloading that occurs during complex multitasking, as may occur when 
patients undertake a secondary task during walking (e.g. carrying a tray). A classical 
example is the ‘stops walking when talking’ phenomenon, where patients stop 
walking because the task of maintaining a simultaneous conversation is too 
demanding.46;233 Such multitasking can provoke real FOG, but some stops simply 
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reflect a conscious adaptive strategy: it is better to temporarily stop walking when the 
overall task has become too complex. Voluntary stops lack the typical trembling of 
the legs, the preceding sequence effect and the flexed posture seen in FOG.
Pathophysiology
The precise pathophysiology underlying FOG remains unknown, but the following 
hypotheses are commonly heard.
Neuroanatomical substrate
FOG appears to be an independent motor symptom, caused by a pathology different 
from tremor, bradykinesia or rigidity. Dopaminergic cell implants into the putamen of 
PD patients improve bradykinesia and rigidity of the legs, but do not improve FOG,81 
whereas levodopa can decrease FOG in PD patients that do not improve in rigidity or 
bradykinesia.36 Hence, FOG might be related to dopamine deficiency outside the 
putamen. Case reports of freezing after stroke and after misplaced deep brain 
stimulation electrodes suggest a role for the pedunculopontine nucleus and the 
supplementary motor area.37;140;212;363 Furthermore, studies using neuroimaging 
techniques have implicated the caudate nucleus, the orbitofrontal cortex and central 
noradrenergic systems as being possibly involved generating the freezing 
phenomenon.246;298 It is most likely that FOG does not result from localized pathology 
within a specific locus in the brain, but rather reflects dysfunction in an organized 
network that involves the frontal cortex, the basal ganglia (perhaps mainly the 
caudate nucleus) and the connections between these areas. For at least some of the 
patients, non-dopaminergic circuitries (possibly involving noradrenergic pathways) 
may be additionally involved. Chapter 4 sheds some light on the cerebral substrate of 
freezing of gait.
Neurophysiology
Basal ganglia dysfunction in patients with PD leads to a faulty production of adequate 
amplitude and timing of movements. The basal ganglia play two important roles in 
the performance of learned automatic movement sequences.181 The first role is to 
match and maintain the movement amplitude of a cortically selected movement plan 
(motor set), and the second role is to run each component of the plan in a timely 
manner (motor cue production). In patients with FOG, basal ganglia dysfunction leads 
to failure in generating adequate movement amplitudes (reflected by a progressive 
decrease in step length), combined with a disturbed timing of steps, a phenomenon 
known as the ‘sequence effect’.181 Movement timing difficulties in freezers are 
reflected by a disturbed timing of stepping movements during gait. This becomes 
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apparent as an increased variability of gait (even outside overt FOG episodes)164;168 and 
a premature timing of muscle activations immediately prior to FOG episodes.288 More 
recent work specifically pointed to disturbances in the fine regulation of interlimb 
coordination, as reflected by a marked temporal gait asymmetry in patients with 
FOG.306 This indicates an impairment in controlling the simultaneous timing and 
pacing of stepping movements of both legs, rather than an inability to regulate steps 
per se. Finally, a newly emerging concept is that failure to initiate compensatory 
stepping could be due to impairment of anticipatory postural adjustments (a lateral 
weight shift is normally required to allow for a contralateral limb swing).206 Apparently, 
a walking problem (gait akinesia) may be caused by a deficit in the integration of 
balance and gait programs, or by a primary balance deficit, i.e. the inability to shift 
weight. This notion is supported by the finding that PD patients, when provided with 
an assistive (externally imposed) anticipatory postural adjustment, can step faster.250 
Neuropharmacology
Levodopa generally alleviates FOG, both with respect to severity and frequency, 
which implies that dopamine depletion in the striatum is the main neurochemical 
substrate of FOG.49 Methylphenidate  may improve gait and reduce FOG in PD, 
conceivably by increasing the availability of striatal dopamine or by improving 
attention. Furthermore, increasing striatal dopamine using monoamine oxidase type 
B inhibitors (selegiline, rasagiline) is also associated with reduced FOG, although the 
effects in clinical practice are rarely convincing.141
However, FOG is sometimes resistant to dopaminergic therapy. This does not 
necessarily exclude a role for dopamine deficiency in the underlying pathophysiolo-
gy, because the threshold for therapeutic relief may simply be higher for FOG than for 
other symptoms, falsely creating the impression of ‘levodopa-resistance’. More 
puzzling is the observation that dopaminergic therapy can also paradoxically cause 
or aggravate FOG (see Chapter 6.2). This might point to a role for excessive 
dopaminergic stimulation in extra-nigrostriatal circuitries (much like the dopamine 
dysregulation syndrome), or alternatively, to a role for lesions within non-dopaminer-
gic circuitries. The latter assumption is supported by the fact that FOG rarely occurs in 
patients with neuroleptic-induced parkinsonism. Further support could be derived 
from therapeutic trials with non-dopaminergic compounds, such as the noradrenaline 
precursor L-threo DOPS, but this has only been tested in small series and with crude 
outcome measures.278
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Management
Medication 
Most patients have “off” FOG, with more frequent and severe episodes during the 
‘OFF-state’ when the effect of medication has worn off. However, a minority of the 
patients experience FOG in the ‘ON-state’. Paradoxically, dopaminergic medication 
(especially dopamine receptor agonists) can sometimes cause FOG. In patients with 
mainly OFF-state FOG, increasing the dose of antiparkinson medication often leads to 
improvement, while true “on” FOG may be alleviated by tapering the antiparkinson 
medication.  
Selegiline may prevent the development of FOG – possibly by improvement of the 
visuomotor system – but is less effective once the symptoms are fully developed. 
Another MAO-B inhibitor, rasagiline, improved FOG in a double-blind, placebo-con-
trolled study. However, the small improvement seen in this study is unlikely to be 
clinically relevant.
Other pharmacological approaches focus on improving attention and executive 
function, but only small case series have been published. Small open label studies 
suggested methylphenidate may improve ‘OFF-state’ FOG in PD,24;309 but this effect 
was not confirmed in a recent double blind trial.113 L-threo DOPS, an immediate 
precursor of noradrenaline, was effective in Japanese patients with primary 
progressive FOG, but subsequent studies failed to confirm this.141;279 Small studies 
using donezepil, an acetylcholinesterase inhibitor specifically used to enhance 
attention, had beneficial effects in patients with pure FOG. Further placebo-con-
trolled blinded studies with adequate numbers of patients and proper outcome 
measures remain much needed.141 
Physiotherapy
Specific cueing techniques using rhythmic auditory cues can reduce the severity of 
FOG by improving step length and walking speed.284 (see Box 3 in the Introduction). 
Furthermore, physiotherapists can teach patients to avoid or better deal with dual 
tasks, as FOG typically occurs during a shift of attention. Avoiding stress might also be 
beneficial to prevent FOG episodes. Using a wide arc while turning, instead of making 
an axial turn ‘in place’, is also effective in preventing FOG episodes (see chapter 3.2).
Deep brain stimulation
A relatively new method for the treatment of FOG is deep brain stimulation. Currently 
the preferred target for deep brain stimulation in advanced PD is the subthalamic 
nucleus, but the globus pallidus remains a good alternative according to some. There 
is evidence that subthalamic nucleus stimulation improves FOG, but only when it 
occurs in the ‘OFF-state’.86;210 The general rule of thumb is that FOG that fails to improve 
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with dopaminergic treatment will neither respond to deep brain stimulation. 
Moreover, there are concerns about the development of secondary gait worsening or 
postural deficits postoperatively, not immediately after surgery but only after several 
years, even in the face of a persistent beneficial effect on ‘appendicular’ motor 
control.368 Possibly, reducing the frequency of deep brain stimulation (to frequencies 
more typically used to stimulate the pedunculopontine nucleus) can be used to 
optimize deep brain stimulation treatment. 258
A new area of interest is deep brain stimulation of the dorsal mesencephalon where 
the pedunculopontine nucleus is situated, because the pedunculopontine nucleus 
has extensive connections with the basal ganglia, as well as with descending spinal 
pathways.270 Furthermore, the pedunculopontine nucleus has been suggested to play 
an important role in the initiation and maintenance of locomotion.212 Open label 
studies in small groups showed promising results of pedunculopontine nucleus 
stimulation for patients with FOG.351 However, more recent studies were less 
hopeful.31;122 Moreover, the precise localization of the pedunculopontine nucleus for 
deep brain stimulation remains difficult.401
Prognosis
FOG will worsen with advancing disease. Most treatment methods fail to provide a 
lasting effect and may even paradoxically aggravate FOG. Patients with gait disorders 
such as FOG have an increased mortality risk, mainly due to a direct result of falling. In 
addition, the ensuing immobility results in secondary cardiovascular disease and 
cognitive decline. The mobility problems related to FOG are among the most 
distressing symptoms of PD. Hence, there is an urgent need for further understanding 
and management of this intriguing phenomenon.
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Provoking freezing of gait
 3|
Video vignette 1
Freezing is a frustrating phenomenon for patients, family, physicians and researchers, 
as ‘sometimes it’s there, sometimes it isn’t.’ As an example, video vignette 1 shows a 
patient with Parkinson’s disease. He reported to have marked freezing of gait at home, 
interfering with his daily activities. Yet, when he walked through the corridor of the 
outpatients department, no freezing of gait was seen at all. When he turned to come 
back, very slight freezing of gait was elicited. Asking the patient to turn to the other 
direction indeed provoked marked freezing of gait. (Greatly to relieve of his spouse, 
who kept telling us that he really did have marked freezing at home.)

Clinimetrics of freezing of gait
Published as:
Snijders AH, Nijkrake M, Bakker M, Munneke M, Wind C, Bloem BR.  
Clinimetrics of freezing of gait. Movement Disorders. 2008; 23:S468-474.
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Summary
The clinical assessment of freezing of gait (FOG) provides great challenges. Patients 
often do not realise what FOG really is. Assessing FOG is further complicated by the 
episodic, unpredictable and variable presentation, as well as the complex relationship 
with medication. Here, we provide some practical recommendations for a standardised 
clinical approach. During history taking, presence of FOG is best ascertained by asking 
about the characteristic feeling of “being glued to the floor”. Detection of FOG is 
greatly facilitated by demonstrating what FOG actually looks like, not only to the 
patient but also to the spouse or other carer. History taking further focuses on the 
specific circumstances that provoke FOG and on its severity, preferably using 
standardised questionnaires. Physical examination should be done both during the 
ON and OFF-state, to judge the influence of treatment. Evaluation includes a dedicated 
“gait trajectory” that features specific triggers to elicit FOG (gait initiation; a narrow 
passage; dual tasking; and rapid 360 degree axial turns in both directions). Evaluating 
the response to external cues has diagnostic importance, and helps to determine 
possible therapeutic interventions. Because of the tight interplay between FOG and 
mental functions, the evaluation must include cognitive testing (mainly frontal 
executive functions) and judgement of mood. Neuroimaging is required for most 
patients in order to detect underlying pathology, in particular lesions of the frontal 
lobe or their connections to the basal ganglia. Various quantitative gait assessments 
have been proposed, but these methods have not proven value for clinical practice.
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Introduction
Freezing of gait (FOG) is a curious type of gait disorder. It is unusual because of its 
“episodic” character: the gait problem is sometimes there, but often it is not. Patients 
with FOG can experience debilitating episodes during which they are unable to start 
walking or, while walking, suddenly fail to continue moving forward. Because of this 
sudden and unpredictable nature, FOG is an important cause of falls and injuries.49
FOG is a challenge for clinicians. Many patients inadvertently deny having FOG 
because they do not properly know what actual freezing looks like. Even when 
patients report having FOG at home, the phenomenon is notoriously difficult to elicit 
in the clinical setting. Apparently, excitement associated with the doctor’s visit or the 
patient’s extra attention to gait during physical examination can temporarily suppress 
FOG (a form of “kinesia paradoxa”). Another explanation is that FOG, which is typically 
provoked while walking in tight quarters,329 is less likely to occur in a widely spaced 
hospital corridor than at home in a crammed living room. This failure to demonstrate 
the problem that hinders them so much at home is very frustrating for patients and 
carers. It is also inconvenient for doctors who need to base their clinical management 
decisions based on observations in the examination room.
FOG provides equally great challenges for researchers. In a formal testing environment 
(e.g. a gait laboratory), it is even more difficult to elicit FOG.288 This makes it hard to 
evaluate the underlying pathophysiology. Also, because of the aforementioned 
problems, it is not easy to reliably classify a patient as being either a “freezer” or a 
“non-freezer”, yet many research studies are typically focused on a between-group 
comparison of freezers versus no-freezers (e.g. in neuroimaging studies). Just as in 
linkage analyses in the field of genetics, misclassifications can have a great impact on 
the statistical reliability of such studies.
In this review, we will present the available methods to assess FOG, including history 
taking, physical examination, quantitative gait analysis and neuroimaging (Table 1).
History taking
Presence of FOG
It is usually insufficient to simply ask about “freezing”, because not all patients interpret 
this correctly. Instead, ask if patients experience the characteristic feeling of “being 
glued to the floor”. Another helpful suggestion is to ascertain whether patients 
understand what you mean, by demonstrating a typical FOG episode. The examiner 
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Table 1   Several useful “tips and tricks” for the assessment of FOG 
History Ask about being ‘glued to the floor’
Provide demonstration of FOG, including different subtypes:
- Shuffling forward with small steps
- Trembling in place
- Total akinesia
Interview spouse / other carer
Ask patient / carer to maintain a FOG diary
Ask about triggering circumstances: turning, starting, tight quarters, dual 
tasking, reaching destination.
Ask about attenuating circumstances (e.g. external or internal cues)
Differentiate between ON vs. OFF period FOG: 
- ask about FOG immediately after waking up
- ask about recent changes in medication
Falls that point to FOG:
- Forward falls
- Falls during turning
- ‘Spontaneous’ falls
Use the standardised FOG Questionnaire
Physical  
examination
ON and OFF (before first morning dose of medication or at ‘end-of-dose’)
Gait trajectory, including (Figure 2): 
- Gait ignition
- Crossing narrow passage (Doorway / Two chairs)
- (>) 360º axial turns in both directions 
- Voluntary stop 
The trajectory should be repeated as quickly as possible and while performing 
a dual task (mental arithmic task)
Videotape for objective assessment and future comparison
Physiotherapist to make home visit and assess effect of cues
Focus attention by cues:
- Auditory: metronome
- Visual: stripes on the floor
- Mental: counting
Guideline available via http://www.rescueproject.org /
https://www.kngfrichtlijnen.nl/654/KNGF-Guidelines-in-English.htm
Divert attention using dual tasks
Differentiate FOG episode from normal stop
- Preceded by decreased step length and increased cadence
- Trembling / shuffling forward
- Increased flexed posture with fixed flexion hip, knee, ankle
- Ask about concurrent feeling of being ‘glued to the floor’
Simple quantification
- Timed up and Go test 
- Parkinson Activity Scale 
Ancillary 
investigations
Structural neuroimaging to detect underlying pathology
No place yet for functional neuroimaging or elaborate quantitative measures
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may imitate FOG, or show videos of typical FOG episodes. This should be presented 
not just to the patient, but also to the spouse or other immediate carer who provide 
a valuable resource of information because they regularly observe FOG in the 
domestic situation.291 
Sometimes, the presence of falls may point to the presence of FOG.49 Three types of 
falls are particularly associated with FOG: forward falls (which are the inevitable result 
when the feet suddenly become stuck while walking); lateral falls during turning, 
sometimes resulting in hip fractures (which are typically caused by a fall sideways 
onto the trochanter of the hip); and “unexplained” and seemingly spontaneous falls. 
In our experience, when patients with unexplained falls (but subjectively no FOG) are 
carefully examined in both the ON and OFF-state (and using specific tricks to provoke 
FOG – see Physical Examination), FOG can often be identified as the likely cause of the 
falls. Interestingly, even though FOG is an important source of falls in Parkinson’s 
disease (PD), there is no difference in frequency or duration of FOG episodes between 
falling and non-falling freezers.152 Apparently, even a brief FOG episode can be 
sufficient to make people fall, so clinicians should do their utmost to detect even 
these mild forms of FOG.
A phenomenon that is closely related to FOG is “festination”, where patients take 
increasingly rapid and small sequential steps during walking. This festination 
phenomenon is common in severely affected patients. Like FOG, it is an episodic gait 
disturbance, and one may speculate that festination in fact reflects a form of FOG (the 
“shuffling forward” type). Indeed, patients who experience festination are also more 
likely to experience FOG.151 However, an important difference between festination 
and the shuffling type of FOG is that the characteristic “magnetic feeling” under the 
feet is not present in festination. Moreover, festination occurs typically while walking, 
whereas FOG occurs most often while initiating gait or during turning. More research 
is needed to unambiguously differentiate these two types of episodic gait disturbances.
Freezing circumstances
FOG typically occurs during a shift of attention or a circumstantial or directional 
change. Specific questions should be tailored to FOG while starting to walk, turning 
around, moving in tight quarters, when dual tasking (e.g. walking and talking at the 
same time) or when reaching a destination. Turning around appears to be the 
strongest provoking factor (Figure 1).323;329 Stress associated with the need to move 
under time constraints, for example when the telephone or doorbell suddenly rings, 
may also provoke FOG.140;153 Specific environments can either provoke FOG (e.g. a 
busy living room with thick carpets) or help to overcome FOG (e.g. crossing a street at 
a zebra).
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Influence of medication
Most patients – possibly up to 90% of freezers, but this is not precisely known – suffer 
from ‘OFF-state FOG’, with more frequent and severe freezing episodes when 
medication effects have worn off. A minority of patients has more severe FOG during 
the ‘ON-state’, apparently because dopaminergic drugs can sometimes cause 
freezing. In studies comparing dopamine receptor agonists to levodopa, agonists 
were more frequently associated with FOG,153 but this may also be explained by their 
lower therapeutic efficacy on OFF-state FOG. Differentiating between OFF versus 
ON-state FOG has obvious therapeutic implications. When in doubt, a useful trick is to 
ask patients whether they experience any FOG immediately after waking up, before 
Figure 1   Characteristics of FOG episodes
A. Circumstances under which freezing of gait (FOG) occurs. B. Duration of FOG episodes. Data for this 
figure have been distilled from a study of 19 patients with Parkinson’s disease and OFF period FOG.329
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intake of the first morning dose of antiparkinson medication. When FOG is present at 
this time, the patient is likely to have OFF period FOG, and the first morning dose will 
then typically alleviate the complaints. Conversely, when FOG is absent or minimal 
upon awakening, but aggravated by taking antiparkinson medication, ON period FOG 
is most likely. It also helps to ask about recent changes in antiparkinson medication. 
For example, if FOG developed shortly after the start of a new or a higher dose of a 
dopaminergic drug, ON period FOG should be considered.
Differentiating between OFF and ON-state FOG has consequences for drug therapy: 
OFF-state FOG usually improves with higher doses of antiparkinson medication, while 
patients with predominantly ON period FOG may improve with tapering of 
antiparkinson medication. Interestingly, the effect of external cues (as a means to 
improve FOG) is also different between ON and OFF-state FOG.82;207;385 Several cueing 
modalities – visual, auditory, tactile and mental – can improve FOG,25;290;369 but these 
effects appear to be greatest for patients with OFF period FOG.207 
The medication effects may provide information about the underlying aetiology. 
Patients with ON period FOG that do not respond to cues may suffer from frontal 
pathology, rather than idiopathic PD, especially when they have a wide-based gait.207
Severity of FOG
The distress caused by FOG is related to the frequency, intensity and duration of FOG 
episodes.27 Most FOG episodes are actually brief, certainly during the ON-state, 
typically lasting only several seconds and rarely more than 30 seconds.329There are 
three subtypes of FOG: shuffling forward with small steps (the least severe form); 
trembling in place; and total akinesia (the severest form). FOG during the ON-state is 
less severe compared to OFF period FOG, with less frequent and briefer episodes, and 
presenting less often as total akinesia (Figure 1B).329
Standardized questionnaires
Several attempts have been made to develop rating scales for a standardised history 
taking of FOG. The current Unified Parkinson’s Disease Rating Scale (UPDRS) merely 
features a single question concerning the presence of freezing (item 14 of Part II, ADL 
section).216 The scoring system for this question (Table 2) places much emphasis on 
falling as a result of FOG while, as noted earlier, falling is not related to the frequency 
and duration of FOG.152 
A specific set of questions has been bundled into the Freezing of Gait Questionnaire 
(FOGQ).152 The FOGQ can help clinicians screen for the presence of FOG, and also to 
assess the subjective severity. A second version of the FOGQ (NFOGQ), which is 
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accompanied by a video to demonstrate FOG episodes to patients and their carers, 
has been developed to more specifically assess FOG.291 The NFOGQ also incorporates 
the impact of freezing on daily life, for example fear of falling. However, these 
questionnaires only assess FOG during turning and gait ignition, and no other 
circumstances that commonly cause FOG, such as negotiating narrow passages or 
performing a dual task. In addition, they do not document the effect of treatment 
interventions or the environment in which FOG occurs. Finally, the treatment effect 
(ON or OFF-state) in which FOG predominantly occurs is not scored. As patients are 
asked to score the overall presence of FOG during the entire day (including well- 
controlled ON periods), the outcome of the FOGQ may not be strongly related to the 
presence of FOG during the OFF-state.
Physical examination
The next step in the diagnostic process involves the physical examination. Whenever 
possible, patients should be examined during both the ‘OFF-state’ (preferably following 
withdrawal of antiparkinson medication for at least 12 hours) and the subjective “best 
ON” state. Presence of FOG should ideally be examined using a standardised gait 
trajectory that features all possible circumstances that may provoke FOG: gait initiation; 
undisturbed walking in an open space; and walking under challenging situations 
(crossing a door or other narrow space), turning around and while performing a dual 
task (Figure 2). Performance can be videotaped in order to objectively evaluate the 
type of freezing, the duration of each episode and the frequency of FOG.329 
Interestingly, many patients only experience FOG during full turns (360 to 540º) and 
not during partial turns (180º), so a standardised gait trajectory should include such 
full turns.329 We observed that wider turns seem to be easier for patients than turns 
“on the spot”, and slow turns are easier than rapid turns. Also, the examination must 
include turning in both directions because FOG often shows a directional sensitivity, 
being much worse and sometimes even exclusively present for turns in either a 
rightward or leftward direction. Preliminary evidence in our laboratory shows that this 
directional sensitivity has no consistent relationship with the most affected side of 
the body. Others have included obstacles in their trajectory to provoke FOG.288 
Table 2   Scoring of FOG in the ADL section of the UPDRS
0 No freezing when walking
1 Rare freezing when walking; may have start hesitation
2 Occasional freezing when walking
3 Frequent freezing. Occasionally falls from freezing
4 Frequent falls from freezing
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Performance on a gait trajectory can also be timed. An example is the Timed Up and 
Go test, where patients are observed and timed while rising from a chair, walking 
three meters, turning around, walking back and sitting down again.308 Regular FOG 
will obviously increase the timed needed to complete the test, but slowed 
performance can have many other causes as well. A test that also scores the quality of 
gait – in addition to timing – is the Parkinson Activity Scale. This scale also includes a 
Timed up and Go test, but is more specific for FOG because patients have to turn in a 
tight square.287 Apart from the timing, the examiner scores the severity of FOG for 
both gait initiation and while turning (using an ordinal five-point scale). The Parkinson 
Activity Scale has recently been modified and now also includes a cognitive dual task 
(counting backwards) and a motor dual task (carrying a full glass of water) to provoke 
FOG.203 In contrast to the original Parkinson Activity Scale, the modified Parkinson 
Activity Scale has not yet been investigated with respect to its psychometric 
properties. A disadvantage of the Parkinson Activity Scale is that it only includes a 
180-degree turn.
We find it helpful to refer patients to a physiotherapist with expertise in movement 
disorders. Because the physiotherapist can spend more time with patients, they 
become familiarised with the environment, which makes FOG more likely to occur. 
Moreover, the physiotherapist can evaluate the effect of cueing strategies or cognitive 
movement strategies.203 Furthermore, the physiotherapist can give tailored advice, 
Figure 2   Essential elements of a dedicated FOG trajectory
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such as making larger turns to avoid FOG, to increase attention to gait and to avoid 
dual tasking. Finally, the physiotherapist (or occupational therapist) can assess and 
train patients in their own home environment, where FOG occurs most commonly 
and where assessment in the OFF phase is more feasible. 
Patients with FOG should receive a cognitive examination, especially testing the 
frontal executive functions and attention. Frontal executive dysfunction is related to 
gait impairment in Parkinson patients394 and is associated with an increased risk of 
falls.165 Moreover, frontal executive dysfunction and FOG frequently co-occur, but 
there is as yet no proof of a direct causal interrelationship.146 Recklessness, decreased 
ability to learn cues and an increased sensitivity to cognitive overload (for example 
when dual tasking) may explain why patients with frontal executive dysfunction are 
more prone to falls. Moreover, the presence of frontal executive dysfunction may give 
a clue to the underlying aetiology, as it is more prominently present in atypical 
parkinsonism then in idiopathic PD.
Attention has a dual influence on FOG. On the one hand, attention to gait – with or 
without additional external cues – helps to relieve FOG, presumably by switching 
from automatic to more conscious walking. Judging the effect of different types of 
cues (visual, auditory, tactile and mental) should be part of the examination, because 
not all patients improve with the same cueing modality. Moreover, an individual 
tailoring of cueing parameters is critical: when the cueing frequency is too high, 
patients will react with smaller steps that can in fact induce FOG.385 Guidelines are 
available to implement the correct cueing therapy for individual freezers.203
(http://www.kngf.nl/index.html?dossier_id=81&dossiers=1; http://www.rescueproject.org/) 
On the other hand, diverting attention with a secondary task while walking makes 
patients more prone to develop FOG. Note that not all cessations of motor activity 
while performing a dual task should be seen as FOG, because very complex multiple 
tasks can also cause hesitations and motor “blocks” in a substantial proportion of 
healthy subjects controls.52 At least some of these blocks reflect a purposeful 
behavioural adaptation to prioritize certain specific actions in a complex situation, at 
the expense of others that are deemed less important. To differentiate such voluntary 
stops from FOG, the examiner should pay attention to the characteristics of the stop 
itself and the steps preceding the stop. First, a gait stop caused by FOG is accompanied 
by a flexed posture with fixed flexion in the hip, knee and ankle joints.285 Second, the 
FOG stop is often not complete, with some residual trembling in place or forward 
shuffling.329 Third, FOG episodes are often preceded by a progressive decrease in step 
length and increase in cadence.181;288 Finally, it can be useful to ask patients whether 
they experienced the feeling of “being glued to the floor”.
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Other mental functions should also be examined. Depression is possibly associated 
with increased FOG severity.148;227 FOG is also associated with anxiety: 62% of Parkinson 
patients with FOG were found to be moderately to markedly anxious, as compared to 
only 18% of patients without FOG.144 Patients with FOG had more panic attacks (32% 
compared to 9%), with panic attacks often preceding, co-occurring or following an 
episode of FOG.
Neuroimaging
Structural neuroimaging can be important to detect pathology underlying FOG, such 
as frontal atrophy, frontal lesions, hydrocephalus, cerebrovascular lesions or 
abnormalities suggestive of atypical parkinsonian syndromes. Novel MRI techniques 
such as magnetization transfer imaging, diffusion-weighted imaging and magnetic 
resonance volumetry may gain significance in the future, as these are more sensitive 
in detecting abnormal features of atypical parkinsonism.334 Other studies have used 
functional neuroimaging to gain better insights into the underlying pathophysiology 
and neural substrate of FOG.37;114;246 Such techniques are currently only relevant for 
research purposes and are therefore not discussed in more detail here.
Quantitative gait analysis
It would be helpful to have a reliable, objective and quantitative outcome measure for 
FOG, for example to detect FOG episodes in the home setting, or in clinical trials to 
evaluate the effect of new therapeutic interventions. Several approaches are available, 
mainly for research purposes (to clarify the pathophysiology of FOG), but some have 
a potential clinical utility. One example is a device using angular velocity sensors that 
can measure trunk motion in different planes while subjects move about freely.11 This 
has, for example, been used to quantify the “stops walking while talking” test88 and to 
record trunk motion while making axial turns.378 A theoretically interesting application 
would be to detect FOG episodes, although trunk sway measures are only an indirect 
derivative of possible FOG episodes in the legs. A more direct method to detect FOG 
consists of a goniometer and angular velocity sensor attached to the shank of one of 
the legs.256 
Another approach to study FOG more directly is an ambulatory gait analysis system 
with pressure sensitive insoles that continuously record walking in freely moving 
subjects. The results of a study in Parkinson patients showed markedly increased 
stride-to stride variability in freezers compared to non-freezers.329 Another study 
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using this approach showed a marked asymmetry and variability of swing time during 
gait in patients with FOG.306 
More elaborate approaches are also available in specific gait laboratories, their 
advantage being the more detailed and comprehensive set of outcome measures, 
but with several clear disadvantages as well (costs; burden to the patient; and reduced 
likelihood of observing real FOG under these experimental conditions). These 
techniques are discussed in more detail in other contributions in this supplement.
Towards a new definition of “freezers”
As outlined in the Introduction, it is crucial to have a reliable definition of freezers 
versus non-freezers, as misclassification can greatly affect the outcome of research 
studies. Currently, there is no such classification system that can unambiguously 
separate freezers from non-freezers. The main reason is that neither history taking nor 
physical examination is infallible, and gold standard laboratory measures are missing. 
We envision two possible approaches. The first would be an ordinal “black or white” 
classification, where patients would be defined as being a freezer when FOG is present 
according to at least one of the following assessments: (a) subjectively (using a FOG 
questionnaire); (b) according to the carer (using video demonstrations of FOG 
episodes); (c) during physical examination (using a standardized gait trajectory as 
defined in Table 1); (d) “objectively” at home (using ambulatory gait assessment 
techniques); or (e) during formal experimental testing in a laboratory setting (e.g. 
kinematic gait analyses during treadmill walking). An alternative, and perhaps more 
reasonable approach, would acknowledge the inherent difficulties in making an 
absolute distinction between freezers and non-freezers, and rather attempt to classify 
the severity of FOG, ranging from either absent to marked. Such a continuous rating 
scale should accommodate the frequency, severity and specific provoking 
circumstances of FOG, and could be used as a covariate in statistical analyses. Future 
studies are needed to develop and validate such classification systems, as these are an 
essential requirement to gain more insights into this curious gait abnormality.
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Summary
Freezing of gait (FOG) is both common and debilitating in patients with Parkinson’s 
disease (PD). Future pathophysiology studies will depend critically upon adequate 
classification of patients as being either ‘freezers’ or ‘non-freezers’. This classification 
should be based ideally upon objective confirmation by an experienced observer 
during clinical assessment. Given the known difficulties to elicit FOG when examining 
patients, we aimed to investigate which simple clinical test would be the most 
sensitive to provoke FOG objectively. 
We examined 50 patients with PD, including 32 off-state freezers (defined as 
experiencing subjective ‘glueing of the feet to the floor’). Assessment including a 
FOG trajectory (three trials: normal speed, fast speed, and with dual tasking) and 
several turning variants (180° vs. 360° turns; leftward vs. rightward turns; wide vs. 
narrow turning; and slow vs. fast turns). 
Sensitivity of the entire assessment to provoke FOG in subjective freezers was 0.74, 
specificity was 0.94. The most effective test to provoke FOG was rapid 360° turns in 
both directions and, if negative, combined with a gait trajectory with dual tasking. 
Repeated testing improved the diagnostic yield. The least informative tests included 
wide turns, 180° turns or normal speed full turns. Sensitivity to provoke objective FOG 
in subjective freezers was 0.65 for the rapid full turns in both directions and 0.63 for 
the FOG trajectory.
The most efficient way to objectively ascertain FOG is asking patients to repeatedly 
make rapid 360° narrow turns from standstill, on the spot and in both directions.
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Introduction
Freezing of gait (FOG) is an episodic gait disorder characterized by an inability to 
generate effective forward stepping movements.150 FOG is common in Parkinson’s 
disease (PD) and in many forms of atypical parkinsonism.269 It is a distressing 
symptom27;27;255 which, due to the unexpected nature of FOG events, commonly leads 
to falls.201;219 
Both clinical decision making and future research depend critically upon adequate 
classification of patients as being either ‘freezers’ or ‘non-freezers’. Currently, there is 
no gold standard for this classification. Most earlier studies used the subjective 
experience of the patient (‘feet being glued to the floor´), as part of the freezing of 
gait questionnaire (FOGQ).152;291 However, some patients who deny subjective gluing 
may nevertheless demonstrate FOG when being examined in a profound OFF-state 
(at least 12 hours after the last intake of medication).344;348 In such cases, FOG will 
simply remain unnoticed in daily life where dopaminergic treatment suppresses the 
phenomenon.149 Conversely, some patients may misunderstand the question and 
interpret ‘being glued’ as representing their overall akinesia which they can experience 
during a profound OFF-state (but which lacks the typical episodic nature of freezing 
of gait). Demonstrating the phenomenon to patients or showing a video with typical 
examples of FOG may be helpful in such cases.291 
Figure 1 shows an algorithm which combines the subjective experience of patients 
with the objective judgment by an examiner, allowing for a classification of subjects 
as being either a ´non-freezer ,´ a ´probable freezer´ or a ´definite freezer .´235 The need 
to adequately identify and classify freezers as such depends on the setting. In clinical 
practice, no freezers should be missed and, consequently, be withheld from effective 
treatment (e.g. optimizing medication, or offering cueing strategies). In other words, a 
high sensitivity of a test to identify freezers is most important in the clinical setting, 
even if this goes at the expense of specificity. Hence, in the clinic, it is satisfactory to 
define a patient as being a ‘probable freezer’, and for this purpose, use of the FOGQ or 
a question about ‘feeling glued’ suffices.
However, in research studies aiming to study the underlying pathophysiology, it is 
vital to have a high specificity, in order not to include false-positive freezers, especially 
when performing between-group comparisons. Ideally, in a research setting patients 
are classified more strictly as being either ‘definite freezers’ or ‘non-freezers’. For this 
purpose, objective measures (observer-based) are also required. However, objective 
confirmation is challenging, because it is generally difficult to elicit FOG during a 
clinical assessment, and even more so in an experimental environment.286 This would 
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hinder research, because patient inclusion would be more difficult. An objective test 
with a high sensitivity to elicit FOG will make it easier to match patients with and 
without FOG for disease severity, because patients who do not show FOG during 
clinical assessment are usually less severely affected.191 More complex tasks and 
combinations of tests appear to offer a greater diagnostic yield.329 In a recent study, 
full turns in combination with a dual task elicited most FOG episodes, and this 
provoked FOG in 50% of subjective freezers.348 Preferably, more sensitive methods to 
elicit FOG will become available. 
Here, we examined which objective clinical tests are most sensitive to elicit FOG. Our 
aim was to determine which clinical tests are most sensitive to classify ‘definite’ 
freezers. Based on our own clinical experience and on previous research,329;386 we 
hypothesized that several specific factors might influence our ability to classify 
freezers. This included the following specific hypotheses and predictions: turning 
range (narrow versus wide turn, narrow turns expected to be most provocative), 
turning speed (slow versus fast, fast turns expected to be most provocative), turning 
direction (most-affected versus less affected side, turning towards the most affected 
expected to be most provocative) and turn extent (180 versus 360 degree turns, full 
turns expected to be most provocative). To minimize strain on patients and researchers 
Figure 1   Freezer classification algorithm 
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in future practice, we aimed to arrive at the minimum amount of tests needed to get 
a maximum diagnostic yield. Hence, we also hypothesized that rapid axial turns would 
be as sensitive in classifying freezers as a more elaborate and more time-consuming 
FOG trajectory. 
Methods
Patients
We included 50 patients (Table 1) that were recruited by telephone from the total 
database of our large outpatients clinic of the Parkinson Centre Nijmegen. Inclusion 
criteria were idiopathic PD, defined according to the UK PD Brain bank criteria,178 
Hoehn and Yahr stage 2-3, the ability to come to the department for research studies, 
and to perform the experiment in an OFF-state (because these subjects represent the 
patients that are typically used for research studies). To assess patient-rated (subjective) 
FOG, we used the new Freezing of Gait Questionnaire (NFOG-Q).291 We included 
thirty-two subjects with a subjective history of FOG (i.e. they answered ‘yes’ to the 
question: ‘Do you sometimes feel as if your feet are being glued to the floor?’). We 
only included patients whose FOG was most prominent during an OFF-state. In 
addition, we included 18 patients without a history of subjective FOG. Exclusion 
criteria included other causes for gait impairment (such as severe arthrosis or 
neuropathy) and Mini Mental State Examination <25. The study was conducted in 
accordance with the declaration of Helsinki. All subjects gave informed consent, as 
approved by the local medical ethics committee.
We examined 46 patients during a practically defined OFF condition (in the morning, 
>12 hours after intake of the last dose of dopaminergic medication).217 The four 
remaining patients could not withhold their medication for 12 hours and were tested 
Table 1   Clinical characteristics
 N Age  Gender  UPDRS  H&Y  Disease 
duration
 N-FOGQ
 Objective freezers#  25   64  88% male  36.8  2.5  10.7  16.6
 Only subjective freezers*  8   61  63% male  29.9  2.3  6.5  8.1
 Non-freezers  17   62  65% male  26.9  2.1  7  0
 All patients  50   62  76% male  32.3  2.3  8.7  9.6
# Objective freezers: Patients that showed freezing upon examination (definite freezers). * Only subjective 
freezers: Patients that told they were freezing on history, but did not show freezing upon extensive 
examination. H&Y = Hoehn and Yahr Rating Scale; UPDRS = Unified Parkinson’s Disease Rating Scale part 3; 
N-FOGQ = New Freezing of Gait Questionnaire. H&Y and UPDRS values are measured during ‘OFF’ state.
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in the morning during a subjective OFF-state (‘end of dose’ effect of the first morning 
dose), just prior to intake of the second medication dose.
Clinical test battery
To assess the effect of turning range (narrow versus wide turn), turning speed, turning 
direction and turn extent (180 versus 360° turns), patients performed the following 
tests (Figure 2):
•	 	Narrow half turns. Patients arose from a chair, walked 2.5 meters, and then made 
a 180° turn in a narrow quarter. The turning direction was self-selected. This was 
repeated twice, once at preferred speed, and once as rapidly as possible.
•	 	Wide half turns. Same as above, but now using a wide turn around a chair. This 
test was performed by only 33 patients (20 subjective freezers)).
•	 	Normal speed full turns. Patients performed 360° turns from standstill in narrow 
quarters, at self-selected speed, with two leftward turns to and two rightward 
turns, in random order.
•	 	Rapid full turns. Same as above, but now as rapidly as possible.
In addition, to be able to compare the turning with the FOG trajectory, patients 
performed the following trajectories (Figure 2):
•	  Normal speed gait trajectory. Patients performed a 15-meter walking trajectory 
329 at self-selected speed. The trajectory consisted of rising from a chair, walking 
through a narrow passage (created by two chairs placed 50 cm apart), stopping 
and starting again, a full narrow turn (360°) in one self-selected direction, followed 
by one and a half turn (540°) in the opposite direction, and walking straight back to 
the chair. 
•	 	Dual task gait trajectory. Same as above, with a cognitive dual task (subtracting 
serial sevens from 100).
•	 	Rapid speed gait trajectory. Same as above, but now as rapidly as possible. 
The tasks were administered in semi counter balanced fashion. We always started 
with the 180° turns. Half of the patients then first performed the 360° turns and 
subsequently the gait trajectory, the other half performed these tests the other way 
round. During the 360° turns the normal speed turns were always performed first, but 
the direction of turns was counter balanced (randomly). The gait trajectory always 
started at normal speed, was repeated as rapidly as possible, and then with dual task.
Outcome
The entire experiment was videotaped for offline visual analysis. Two independent 
and experienced raters (AS & CH) scored the videos for presence of FOG. The definition 
used to score FOG was an obvious episode with ineffective stepping.150 If the two 
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raters disagreed, consensus was reached in discussion with a third rater (BRB). 
Inter-rater reliability was assessed using Cohen’s kappa, both for all trials separately as 
for the classification as a freezer.
Best way to provoke FOG
To assess our hypothesis that rapid axial turns would be as effective in classifying 
freezers as a more elaborate FOG trajectory, we assessed specificity and sensitivity of 
the rapid turns (4 turns) and the FOG trajectory (normal speed, rapid speed and dual 
tasks combined). For this analysis, as a gold standard we set the answer ‘yes’ to the 
question: ‘Do you sometimes feel as if your feet are being glued to the floor?’ of the 
NFOG-Q. In addition, we evaluated which components of the FOG trajectory provoked 
FOG, to see whether other components then turning were of added value.
Figure 2   Clinical test battery 
A: Half turns. Narrow turns, repeated at normal speed and as rapidly as possible. In addition, performed 
with wide turn around obstacle. B: Axial full turns. From standstill. Two turns to both directions, normal 
speed and as rapidly as possible. Each condition repeated twice: total of 8 turns. C: Gait trajectory. 
Repeated three times: Normal speed, as rapidly as possible and with dual task (100-7).
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Next, we assessed the ability of the separate tests to classify freezers as ‘definite 
freezers’, and investigated which combination of tests would have found all ‘definite 
freezers’ in our sample. 
Provoking factors during turning
We made several specific comparisons to explore the effect of the different provoking 
factors during turning (using Wilcoxon’s signed rank test for related samples). Each 
time, the outcome was a binary classification: the test elicited FOG in a patient (1) or 
not (0). Hence, we did not intend to provide a severity score to assess FOG, as described 
recently.398 We specifically examined the following predefined contrasts:
•	 	Space: wide vs. narrow 180o turns (one turn for each condition).
•	 	Range: 180o vs. 360o turns (one slow and one rapid 180o turn were compared to 
one slow and one rapid 360o turn).
•	 	Speed: rapid versus self-selected speed (two turns each).
•	 	Laterality: turn to the most affected side vs. turn to the least affected side (four 
turns each).
•  Uni- or bilateral: turns into one direction only versus turns into both directions 
(four compared to eight turns).
•	 	Repetition: four vs. eight turns to both sides (four turns were compared to eight 
turns).
SPSS 16.0 was used for statistic testing, with α-value set at 0.0083 to correct for six 
multiple comparisons (Bonferroni). 
Results
Classification of freezers
Clinical assessment revealed objective FOG in 24 of the 32 patients with a subjective 
history of FOG. The patients with definite FOG had a higher NFOG-Q score then the 
patients with only subjective FOG (Table 1). In addition, FOG was elicited during 
clinical assessment in one of the 18 patients without history of freezing. Hence, 25 
subjects with objective ‘definite’ FOG were available to evaluate the diagnostic yield 
of the various tests. The combination of all objective tests thus showed a sensitivity 
for FOG of 0.74 (95% confidence interval (CI) 0.55 – 0.88) and a specificity of 0.94 (CI 
0.73-1.0).
Inter-rater reliability was excellent for the classification as a freezer (agreement 97%, 
Cohen’s kappa 0.93), and very high for all trials rated separately (agreement 96%, 
Cohen’s kappa 0.89).
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Best way to provoke FOG
Taking as a gold standard the NFOG-Q, rapid full turns (four turns) had a sensitivity of 
0.65 (CI 0.45-0.81) and a specificity of 1.00 (CI 0.81-1.0). The gait trajectory (three times) 
had a sensitivity of 0.63 (CI 0.44-0.80) and a specificity of 0.94 (CI 0.73-1.0) (1 patient 
without feeling glued on history was rated to experience FOG during the gait 
trajectory upon gait initiation). 
The elements of the gait trajectory differed in their ability to provoke FOG (Figure 3). 
The element that provoked most FOG was turning, where FOG occurred in all but two 
of the 21 patients that froze during the gait trajectory (90%). These two remaining 
patients only showed FOG upon gait initiation.
A combination of ‘Rapid full turns’, ‘Dual task gait trajectory’ and ‘Normal speed gait 
trajectory’ provoked FOG in all definite freezers (Table 2 shows FOG provocation of 
separate and combined tests). This remained true when the rapid turns were 
performed only into the least affected direction. Performing rapid turns is easier and 
less time-consuming than performing the gait trajectory. Indeed, including only the 
full narrow turns (four at normal speed, and four rapidly) already elicited FOG in 88% 
of the definite freezers.
 
Provoking factors during turning
Comparisons between the different conditions are shown in Figure 4 and Table 2. 
Turning space (wide vs. narrow turn), turning range (full versus half ) and turning 
Figure 3   Provocation of FOG by the different elements of the gait trajectory 
Percentage of definite (objective) freezers that show FOG upon each different element of the gait trajectory.
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speed all influenced the percentage of freezers that showed objective FOG (Figure 
4A-C) with an α-value of <0.05, but these effect was not significant anymore when 
corrected for multiple comparisons. Whether patients turned to their most or least 
affected side did not affect the diagnostic yield (65% of definite freezers showed FOG 
when turning to the most affected side, and 74% to least affected side, Wilcoxon’s Z = 
-0.6, p = 0.53). However, nine patients (43% of definite freezers) exclusively froze when 
turning to one specific side, and not when they turned to the other side. Turning to 
both sides tended to yield more freezers than turning to one side (p = 0.026, figure 
3D). However, this could reflect a repetition effect, because comparing four turns to 
eight turns gave a significant difference (figure 4D).
Discussion
Our goal was to define the most sensitive, simple clinical test to classify ‘definite’ 
freezers. Using various scenarios combined, we found 0.74 sensitivity to elicit definite 
FOG in patients with PD and a subjective history of freezing (‘probable’ FOG). 
Moreover, unambiguous FOG was observed during this assessment in 5% of patients 
who firmly denied the characteristic gluing experience of FOG in daily life. The most 
Table 2   Ability of the different tasks to classify patients as ‘definite freezers’  
(freezing of gait episode(s) seen on examination)
ONE task provoking at least one FOG episode                                        (% of definite freezers)
Task 1 Rapid full turns 84%
Task 2 Dual task gait trajectory 68%
Task 3 Normal speed gait trajectory 60%
Task 4 Normal speed full turns 48%
Task 5 Rapid speed gait trajectory 48%
Task 6 Narrow half turns 40%
Task 7 Wide half turns 0%
TWO tasks provoking at least one FOG episode
Task 1 and 2 Rapid full turns, dual task gait trajectory 96%
Task 1 and 4 Rapid full turns, normal gait trajectory 92%
Task 1 and 3 Rapid full turns, normal speed full turns 88%
Task 2 and 3 Normal gait trajectory, dual task gait trajectory 84%
THREE tasks provoking at least one FOG episode
Task 1, 2, 3 Rapid full turns, dual task gait trajectory, normal gait 
trajectory
100%
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effective test to provoke FOG was rapid 360° turns in both directions and, if negative, 
combined with a gait trajectory with dual tasking. Repeated testing improved the 
diagnostic yield. The least informative tests included wide turns, 180° turns or normal 
speed full turns. Rapid full turns (four turns) were as sensitive to objectively provoke 
FOG in subjective freezers as FOG trajectories (three trajectories, including six turns).
This study confirms the challenge of provoking FOG in patients who complain of 
‘feeling glued to the floor’. It is especially difficult to elicit FOG in patients with less 
severe subjective FOG, as measured by the NFOG-Q. In addition, similar to another 
study,348 we found that one of the 18 subjective ‘non-freezers’ did actually show clear 
FOG during our extensive clinical assessment. Two factors may explain this. First, the 
Figure 4   Provocation of FOG by different testing tests 
Provocation of FOG by different testing tests. Percentage of definite (objective) freezers that show FOG upon the 
different turning tests. Between brackets: number of turns. * = p value between 0.05 and 0.0083. ** = p-value 
< 0.0083 (Bonferroni corrected for performing 6 comparisons). A: Turning range (Wide vs narrow half turn, z = -2, 
p = 0.046) B: Turning extent (Half vs full turn, z = -0.6, p = 0.56) C: Turning speed (Normal vs rapid turns, z = -2.5, p 
= 0.011) D: Side or repetition. Turns to first versus to both sides (Z = -2.2, p = 0.025), one turn each condition (right, 
left, normal, rapid) versus two turns each condition (Z = -2.6, p = 0.008).
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examination took place during a practically defined OFF-state, and this may unveil 
FOG that remains unnoticed in daily life where dopaminergic treatment suppresses 
the phenomenon.141 This is why research studies into FOG should preferably examine 
patients during the OFF-state. Second, our extensive test battery exposed patients to 
situations which they have ‘learned’ – either consciously or subconsciously – to avoid 
in daily life. For example, the spontaneous behavior of many patients is to take wide 
and careful turns, while our present results suggest that rapid turns in tight quarters 
are the best way to provoke FOG. We therefore recommend using such rapid, narrow 
turns as part of the test battery to classify patients as either freezers or non-freezers. 
Our findings confirm that turning is the best way to provoke FOG in PD.329;348;398 We 
also showed that repeated full turns in both direction (four turns) are as effective - and 
more efficient- in provoking FOG as an elaborative gait trajectory (three times, 
including a total of six turns). Indeed, when FOG occurred during the gait trajectory, 
this was usually during turning.
Narrow turns identified more freezers than wide turns. This is probably because a 
narrow turn imposes a greater amount of temporal and spatial asymmetry of steps 
compared to wider turns.307 The step length of particularly the leg on the inner side of 
the turn decreases during a narrow turn, and such a decreasing step length can 
provoke FOG.76 
The observed effect of repetition underscores that examiners should not stop when 
the first test is normal. It may be speculated that the effect of repetition is caused by 
the suppression of FOG by initial anxiety of being examined or the attention given to 
a task when performed for the first time.265 However, a closer look at our data does not 
support this: 10 patients showed FOG in the first turns of the conditions, but not in 
the second, while 6 patients showed FOG in the second turn of the condition, but not 
in the first. Probably the effect of repetition just highlights the episodic quality of 
FOG: sometimes it is there and sometimes it is not. 
A recent study showed that a combination of full turns with dual tasking elicited most 
FOG episodes.348 In this study, 24 turns (of which 12 were full turns) elicited FOG in 
50% of 14 subjective freezers. Using eight full turns, we elicited FOG in 66% of a 
comparable sample of 32 subjective freezers. The ‘full turns’ used in both studies were 
different: Spildooren and colleagues used turns around a small marker after walking 
towards this marker,348 whereas we used turns ‘on the spot’ from standstill. Another 
potentially relevant difference is that we requested subjects to turn ‘as rapidly as 
possible’ during four of the eight turns, and this may explain the slightly higher 
diagnostic yield in our study. Importantly, Spildooren and colleagues found that 
adding a dual task to the turning tasks further improved the diagnostic yield for 
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FOG.348 This dual tasking benefit was less prominent in our study, likely because their 
dual task difficulty was better selected and more challenging (specifically, Spildooren 
and colleagues used a color classification task, for which the load could be varied 
without increasing the level of difficulty). Indeed, more complex multitask conditions 
show great sensitivity to balance deficits in PD and correlate better to falls in daily life 
than simple dual task conditions.46 A small disadvantage to using dual tasks is the risk 
of increasing the false-positive classification rate, because it can be difficult to 
differentiate the akinetic form of FOG from more purposeful stops, as in the ‘stops 
walking when talking’ phenomenon.233
Rapid full turns (four turns) were as sensitive to objectively provoke FOG in subjective 
freezers as FOG trajectories (three trajectories, including six turns). We propose as an 
objective test for the classification of freezers in research studies to perform at least 
eight rapid full turns (four into each direction, ‘on the spot’, each time from standstill). 
If negative, a gait trajectory involving dual tasking may be added. Future work now 
needs to validate this approach. An additional question is whether adding straight 
walking with short steps (25% of step length) adds something to this classification of 
freezers.76;76 Such careful objective testing should be part of future research, thus 
reducing misclassification in pathophysiology studies.
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Summary
Freezing of gait (FOG) is a common and disabling feature of Parkinson’s disease (PD). 
Detailed pathophysiological studies are hampered by the fact that FOG episodes are 
difficult to elicit in a gait laboratory. We evaluated whether the need to avoid sudden 
obstacles could be used to experimentally provoke FOG.
We included 21 PD patients (15 with self-reported ‘OFF-state’ FOG). Patients were 
tested in the OFF-state. FOG during over-ground walking was assessed using a 
standardised gait trajectory and axial 360 degree turns. Subsequently, patients walked 
on a motorised treadmill with suddenly appearing obstacles that necessitated 
compensatory stepping. The available time to respond was varied by dropping the 
obstacle either immediately in front of the patients or at 1 meter distance in front of 
them. Performance was videotaped, and presence of FOG was scored visually by two 
independent raters. 
Thirteen patients showed FOG during over-ground walking. During treadmill walking, 
obstacle avoidance was associated with 13 unequivocal FOG episodes in eight 
patients (all of whom also showed over-ground FOG), whereas only one patient froze 
during undisturbed treadmill walking (Wilcoxon z = -2.0, p = 0.046). FOG episodes 
elicited by obstacle avoidance were brief (typically < 1 s). Almost all episodes were 
provoked when subjects had a longer available response time.
Suddenly appearing obstacles on a treadmill can elicit FOG, permitting detailed 
pathophysiological studies of FOG in a controlled laboratory setting. However, the 
moving treadmill and the obstacle both act as cues that apparently help to 
immediately overcome the provoked FOG episode. This may limit the ecological 
validity of this new approach. 
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Introduction
Freezing of gait (FOG) is a common and disabling feature of Parkinson’s disease (PD).343 
A FOG episode is defined as an episodic inability to generate effective forward 
stepping movements, in the absence of any known cause other than parkinsonism or 
higher cortical deficits.150 It is most commonly experienced during turning and step 
initiation, but also when faced with spatial constraint, stress or distraction. Focused 
attention and external stimuli (cues) can help to overcome the episode.150 Because of 
its sudden and unpredictable nature, FOG often leads to falls and injuries.49 
Several therapies are used to treat FOG, including pharmacotherapy, stereotactic 
deep brain surgery and the use of visual, auditory or mental cueing techniques.124;141;284 
Unfortunately, these therapies generally fail to provide a gratifying and lasting 
improvement in FOG. Improved treatment strategies are needed, tailored to the 
specific underlying pathophysiology. However, the mechanisms leading to FOG remain 
insufficiently understood. 
To further clarify the pathophysiology of FOG, there is a need for detailed gait analyses 
under carefully controlled experimental conditions, for example while patients walk 
on a treadmill in a gait laboratory. However, evaluating FOG proves extremely difficult 
in such a research environment, because even patients with clear FOG typically fail to 
demonstrate the phenomenon during formal experimental testing.288;341 
In this study, we aimed to evaluate a new procedure that would evoke FOG in an 
experimental gait laboratory. Inspired by pilot observations,90 we investigated 
whether suddenly appearing obstacles could be used to provoke FOG in patients 
with PD, walking on a motorised treadmill. In addition, we investigated the effect of 
the available time to negotiate the obstacle. More preparation time may facilitate 
obstacle avoidance, but may also challenge a more complex neural circuitry103 and 
thereby promote FOG episodes.
Methods
Subjects
Twenty-one patients were randomly recruited from the outpatient clinic of Parkinson 
Centre Nijmegen. Inclusion criteria were idiopathic PD (diagnosed according to the 
UK Brain Bank criteria ),178 Hoehn and Yahr stage 2-3 and ability to walk on a treadmill 
during an OFF-state. Exclusion criteria were other neurological disorders, severe 
co-morbidity, other clinically relevant causes of gait impairment or severe cognitive 
impairment (Mini Mental State Examination (MMSE) < 25 or Frontal Assessment 
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Battery (FAB) < 12).104 Fifteen patients were included with subjective FOG (answer ‘yes’ 
to item #3 of the FOG Questionnaire: ‘Do you sometimes feel as if your feet get ‘glued 
to the floor’),152 mainly occurring during OFF periods. We did not include patients with 
mainly ‘On period’ freezing. In addition, six patients without a history of FOG were 
included. Sixteen patients were examined in the morning during a practically defined 
OFF period at least 12 hours after intake of the last dose of antiparkinson medication. 
Because this was impossible for the five remaining patients (all freezers), they were 
measured during an end-of-dose OFF-state. There were no differences in freezing 
outcomes (overground or treadmill FOG, described below) between these five 
patients and the other patients. All subjects gave informed written consent and the 
study was approved by the local ethics committee.
   
Clinical assessment during over-ground walking
Prior to the treadmill experiment, Unified Parkinson’s Disease Rating Scale (UPDRS) 
motor score and Hoehn and Yahr stage (H&Y) were obtained. In addition, cognitive 
status was assessed using the MMSE and the FAB.104 
To grade patient-rated FOG severity, the FOG Questionnaire and the new FOG 
Questionnaire (N-FOGQ) were used.152;291 To examine observer-rated FOG, a 
standardized gait trajectory was used containing specific elements to provoke FOG: 
starting walking, walking through a narrow passage (created by two chairs placed 50 
cm apart), temporarily stop walking and start walking again. Patients also had to turn 
in a tight square of 1 by 1 m. First, they turned 360 degrees in a self-selected direction, 
followed by a 540 degree turn in the opposite direction. Finally, patients walked 7.5 m 
back to the chair. This gait trajectory was repeated three times: at normal speed, as 
rapidly as possible, and while performing a dual task (mental arithmetic). In addition, 
patients were asked to make eight 360 degree axial turns from standstill in both 
directions, and both at normal and at high speed.158;341 
Treadmill experiment
Subjects walked on a motorised treadmill at a speed of 2 km/h. In two subjects 1.5 
km/h was used, as 2 km/h was not feasible. Patients wore a safety harness attached to 
the ceiling to prevent falling, without interfering with natural walking. In addition, one 
of the examiners constantly watched the patient with an emergency brake at hand. 
Patients did not have a handrail.
First, patients were familiarised with treadmill walking for 5 minutes, and practiced 
obstacle avoidance with 5-7 obstacles. Patients were instructed to avoid the obstacle 
and not to step alongside or onto the obstacle. The obstacles were sized 40 cm by 30 
cm with a height of 1.5 cm and were attached by a magnet to a bridge placed over 
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the treadmill, as described earlier (Figure 1).331 Using remote control, the obstacles 
were unexpectedly released in front of one of the legs at random intervals (30-60 
seconds apart). The patients could see the obstacle being attached to the magnet, 
but had no possibility to predict when the obstacle would fall. We manipulated the 
available time to negotiate the obstacle. For this purpose, subjects were positioned at 
either a short distance from the appearing obstacle (10 cm) or a long distance (1 m). 
This was repeated for both the left and right leg. During the Short Distance conditions, 
15 obstacles fell in front of each leg at three different moments in the step cycle (mid 
stance, early swing and mid swing). For the Long Distance conditions, 10 obstacles fell 
in front of each leg. Hence, the whole experiment consisted of 50 obstacles. The order 
of the test conditions (Short Distance – Most affected leg, Short Distance – Less 
affected leg, Long Distance – Most affected leg, Long Distance – Less affected leg), 
was randomly alternated for each subject. 
The period between obstacle release until the obstacle left the treadmill was defined 
as ‘obstacle avoidance’, while the period from the moment the obstacle left the 
treadmill until eight strides later was defined as ‘baseline treadmill walking’. 
Outcome measures
The primary outcome measure was the presence of FOG according to the current 
gold standard: visual assessment of digitally videotaped gait performance.341 
Figure 1   Experimental set-up 
The obstacle is attached by a magnet to a bridge placed over the treadmill.
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Performance during baseline assessment (over-ground walking) and the treadmill 
experiment was digitally videotaped for later objective evaluation. The presence of 
FOG during baseline over-ground assessment was scored by a single rater with 
considerable clinical experience with FOG. To guarantee valid rating of the ‘new’ 
treadmill FOG, the treadmill performance was independently rated by two other 
raters with considerable clinical experience with FOG. Only unequivocal FOG in the 
eyes of both raters was classified as a FOG episode to ensure high specificity. An 
additional third independent rater with extensive knowledge of obstacle avoidance 
ascertained that no variants of normal obstacle avoidance were inadvertently rated as 
FOG episodes. All four raters were not present during the experiments and were 
blinded to the clinical status (prior FOG yes or no) and to the other rater’s score.
For each video fragment with FOG, the circumstances of FOG were determined: 
which leg (most/least affected), which distance to the obstacle (10 or 100 cm), before 
or after crossing the obstacle. Furthermore, the duration of the FOG episode and the 
need to stop the treadmill were determined visually. 
Data analysis
The proportion of subjects that showed at least one unequivocal FOG episode during 
over-ground clinical assessment, baseline treadmill walking and during obstacle 
avoidance on the treadmill was compared using a Friedman test with a significance 
level of p = 0.05. If this test was significant, a Wilcoxon’s signed rank test was used to 
assess differences between these conditions. Patient characteristic differences 
between groups were analysed using a Kruskal-Wallis test. Agreement between raters 
was assessed using Cohen’s Kappa. Data were analysed using SPSS 14.0 for windows, 
using a significance level of p = 0.05.
Results
FOG during over-ground walking
Twelve of the 15 freezers (80%) showed at least one FOG episode during over-ground 
assessment (mean number of FOG episodes 5.6, range 0-16). Only two freezers (13%) 
also showed FOG during straight walking (one freezer during gait initiation, while 
crossing a narrow passage and upon reaching the destination; the other freezer only 
during gait initiation and upon reaching the destination. All other FOG episodes were 
associated with turning).  One subjective ‘non-freezer’ (17%) unexpectedly showed a 
FOG episode during the OFF-state over-ground assessment, although it was very brief 
(<1 s). This patient was therefore classified as a freezer for the remainder of the 
experiment.
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FOG during treadmill walking
Characteristics of the patients and occurrence of FOG are summarized in Table 1. 
During treadmill walking, obstacle avoidance was associated with 13 unequivocal 
FOG episodes in eight patients (all of whom also showed over-ground FOG), whereas 
only one patient (patient 6 in Table 1) froze during undisturbed treadmill walking 
(Friedman Chi square = 16.9, p < 0.001, baseline treadmill walking vs. obstacle 
avoidance Wilcoxon z = -2.0, p = 0.046). The patients with unequivocal FOG episodes 
on the treadmill experienced these with 6% of obstacles that had to be avoided. 
More patients froze during over-ground walking (n = 13) compared to obstacle 
avoidance on the treadmill (n = 8, Wilcoxon z = -2.6, p = 0.008) or baseline treadmill 
walking (n = 1, Wilcoxon z = -3.3, p = 0.001). However, only two patients showed FOG 
episodes during over-ground straight walking, as almost all FOG episodes occurred 
during turning. If only FOG episodes during straight walking were taken into account, 
obstacle avoidance on the treadmill provoked more FOG than overground walking (n 
= 2, Wilcoxon z = -2.4, p = 0.014). There was no difference in age, UPDRS score, Hoehn 
and Yahr stage, or cognitive status between patients with or without FOG on the 
treadmill. In addition, there was no difference in the number of overground FOG 
episodes between freezers with or without FOG on the treadmill. 
Characteristics of FOG episodes on the treadmill
Table 2 states which conditions provoked FOG, and whether FOG occurred before or 
after obstacle crossing. Video 1 shows an example of FOG during the Long Distance 
condition, directly after the obstacle crossing. Video 2 shows an example of FOG 
during the Short Distance condition, between obstacle release and obstacle crossing. 
Video 3 shows one patient (patient 5 in table 1 and 2) where FOG already occurred 
when the obstacle was placed but not yet released, so this was apparently provoked 
by the mere anticipation of the upcoming obstacle. Two patients only showed a clear 
FOG episode during the practice trials. In the other patients the FOG episodes were 
distributed equally over the experiment.
Duration of the FOG episodes during obstacle avoidance was always less than 1 
second, and the treadmill never needed to be stopped because of these episodes. 
The FOG episodes that occurred ‘spontaneously’ during undisturbed treadmill 
walking without the need to actually avoid an obstacle did sometimes force an 
emergency stop (video 3).
Agreement among raters
The rating of separate trials as containing either ‘FOG’ or ‘no FOG’ had an acceptable 
agreement between both clinical raters (Kappa = 0.70, p < 0.001). There was perfect 
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Table 1   Clinical characteristics of all participants in relation to the occurrence of 
freezing of gait (FOG)
Patients Age Gender UPDRS H&Y FOGQ 
score
FOGQ-II 
score
Over-ground 
FOG*
FOG  
during OA  
on treadmill*
1 73 M 31 3 9 18 2 2
2 52 M 45 2.5 7 5 2 1
3 59 M 46 2.5 10 14 16 1
4 61 M 27 2 12 21 2 1
5 62 M 32 2 15 26 9 5
6 64 M 31 2.5 10 13 11 1
7 53 M 22 2 8 14 1 1
8 68 M 24 2 11 19 13 1
9 75 F 46 3 11 17 4 0
10 66 M 45 2.5 13 21 1 0
11 66 M 18 2 16 24 15 0
12 66 M 20 2.5 8 17 8 0
13 65 M 34 2 1 0 1 0
14 55 M 35 2.5 6 7 0 0
15 62 M 29 2.5 16 11 0 0
16 71 M 49 3 9 19 0 0
17 68 M 32 2 2 0 0 0
18 54 F 24 2 3 0 0 0
19 44 F 21 2 1 0 0 0
20 54 M 19 2.5 2 0 0 0
21 69 M 53 2.5 4 0 0 0
Overground 
freezers
64 32 2.3 10 16 100% 67%
Freezers only 
on history
63 38 2.7 10 12 0% 0%
Non-freezers 58 30 2.2 2 0 0% 0%
UPDRS = Unified Parkinson’s Disease Rating Scale. H&Y = Hoehn and Yahr stage. FOGQ-score is FOG 
Questionnaire score152, FOGQ II = new FOG Questionnaire score291. OA = obstacle avoidance 
* = Number of episodes
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inter-rater agreement for the classification of individual patients as ‘treadmill freezer’ 
or ‘treadmill non-freezer’ (Kappa = 1.0, p < 0.001). Also, all trials that were rated as 
‘FOG’ by the clinical raters, were also rated as ‘abnormal’ by the obstacle avoidance 
rater. 
Discussion
Our findings show that suddenly appearing obstacles during treadmill walking can 
provoke unequivocal FOG episodes. This observation opens a new avenue to study 
FOG in a controlled laboratory setting. However, these FOG episodes were less 
common and much briefer compared to episodes during over-ground walking. 
The ability of sudden obstacles to provoke FOG, even while walking in an experimental 
environment, may be interpreted in several ways. A first explanation is that upcoming 
obstacles force subjects to adjust their gait, necessitating a rapid planning and 
execution of adaptive movements. During normal walking, PD patients partially rely 
upon cortical compensation to bypass their defect basal ganglia.181 The need to 
combine consciously controlled walking with a deliberate obstacle avoidance may 
well outweigh the available resources.46;62 In support of this notion, we observed that 
more FOG episodes were provoked when the obstacle fell in front of the most 
Table 2   
Patients Short  
distance 
condition 
Long  
distance 
condition 
Obstacle 
before MA 
leg
Obstacle 
before LA 
leg
FOG before 
obstacle cross
FOG after  
obstacle cross
1 0 1 0 1 0 1
2 NAP 1 0 1 1 0
3 1 0 1 0 1 0
4 0 1 1 0 0 1
5 NAP 1 1 0 1 0
6 1 0 1 0 0 1
7 0 1 0 1 1 0
8 NAP 1 1 0 1 0
Total (%) 40% 75% 63% 38% 63% 38%
0 = No FOG, 1 = at least one unequivocal FOG episode occurred. MA leg = most affected leg,  
LA leg = less affected leg, FOG = Freezing of gait, NAP = Not able to perform due to festination when  
walking close to the obstacle
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affected leg. Probably, movement adaptation with the most affected leg needs more 
resources than adaptation with the least affected leg. In addition, the Long Distance 
condition produced even more FOG episodes than the Short Distance condition, 
even though the task of obstacle avoidance is presumably easier when subjects have 
more time to prepare. We suspect that obstacle avoidance in the Short Distance 
condition engages a fast pathway that runs largely over subcortical structures, 
releasing motor programs stored in the reticular formation.70;313;318;319 Hence, this “cued” 
fast response could bypass the defective basal ganglia and mesencephalic peduncu-
lopontine nucleus. In contrast, the Long Distance condition likely involves a longer 
and more complex circuitry, involving the parietal and motor cortex, the lateral 
cerebellum and pontine gray nuclei, as was demonstrated in the cat.103 This complex 
circuitry may be more susceptible to sudden interference, leading to relatively more 
FOG episodes during the Long Distance condition.
Second, sudden obstacle avoidance calls for a switch in motor tasks, requiring subjects to 
make corrective steps instead of walking straight. PD patients have great difficulties 
switching between motor tasks,14;38;62 and this also applies to gait.46;236 These switching 
difficulties may be related to deficits in frontal executive functions, which are 
increasingly implicated in the pathophysiology of FOG.144;146 
Third, increased anxiety may have contributed to the occurrence of FOG. In everyday 
life, patients report that FOG episodes may be elicited by anxiety and panic.227;316 The 
upcoming obstacle during treadmill walking may well increase anxiety. Indeed, one 
patient froze while merely anticipating the upcoming obstacle and two other patients 
only showed FOG during the practice trials. However, moderate stress, such as visiting 
a doctor, may also suppress FOG, which may partly explain the difficulty to elicit FOG 
in clinical practice.140;341 In this study, fear of falling, being harnessed and being forced 
to keep moving by the treadmill may all have contributed to the state of mind of our 
patients.
Fourth, obstacle avoidance may have caused FOG by interfering with the mechanically 
required motor output. Obstacles interfere with step amplitude, forcing the patient to 
take smaller steps, either to avoid the obstacle, or to regain stability after obstacle 
crossing (when an extra long step with a more forward movement was used to avoid 
the obstacle). A decrease in step length could provoke FOG via the presumed 
‘sequence effect’, where a successive step-to-step amplitude reduction ultimately 
culminates in a motor block.76 In addition, gait rhythm is disturbed by the obstacle. 
Patients with FOG have a disturbed timing of gait, manifesting as an increased stride 
variability and phase fluctuations in between FOG episodes,4;168;306 as well as an 
uncontrolled timing of steps just before a FOG episode.288 Our finding that FOG can 
be provoked by interrupting step length and gait rhythm by a sudden obstacle 
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suggests that these motor deficits might provoke FOG, and represent more than just 
‘coincidental’ features of advanced disease.
A final explanation is supported by interesting recent work, showing that FOG may be 
regarded as a consequence of defective integration between preparatory balance 
adjustments and stepping movements.187;206 Obstacle avoidance likely requires extra 
balance adjustments (including lateral weight shifts) while the subject is forced to 
keep moving. This may particularly explain the FOG episodes occurring immediately 
after obstacle avoidance. 
We should note that while we used sudden obstacles to provoke FOG, a small obstacle 
on the floor (such as an inverted walking stick) is commonly used by patients as an 
external cue to overcome FOG.207;316 One explanation for this apparent contradiction 
is the unpredictability and perceived consequence of the appearing obstacles. 
Unlike therapeutic cues, a sudden and unpredictable event needs more attentional 
resources, and may also lead to increased arousal or stress.
Several limitations of this study need to be mentioned. First, the current ‘gold 
standard’ of  FOG, visual assessment of digitally videotaped gait performance, does 
not accommodate the crucial but subjective feeling of the feet becoming glued to 
the floor. Only the more severe FOG episodes on the treadmill indeed generated the 
feeling of ‘getting glued’. Hence, we cannot be sure whether we really observed FOG, 
or merely episodes that looked to experienced eyes very similar to FOG.
 
Second, we used a fixed speed of the treadmill of 2 km/h. As PD patients display 
abnormalities in the stride length-cadence relationship depending on the velocity,263 
a variable treadmill velocity might have yielded more reliable results. However, to vary 
treadmill velocity depending on the overground individual velocity is not always 
feasible. For example, we noticed that the preferred overground individual velocity is 
often much higher than the preferred treadmill individual velocity. In addition, the 
optimal ‘individual speed’ in relation to preferred speed for eliciting FOG would still 
have to be determined. Introducing more experimental conditions might have caused 
more fatigue, and this could have affected the results. It would be interesting for 
future studies to evaluate which treadmill velocities are best able to provoke FOG in 
individual patients.
Third, the duration of FOG episodes was less on the treadmill compared to over-ground 
walking. This may be expected as the treadmill does not allow a major slowing since 
speed is constant. Obstacles and the treadmill itself could have acted as cues to 
overcome FOG and quickly ‘abort’ the episode.133 This may limit the ecological validity 
of this approach, as FOG is often defined as lasting at least one second.14 However, 
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there is probably a spectrum of ‘ineffective stepping’ before this truly develops into a 
FOG episode that is recognisable for both patients and observers. Future detailed 
electrophysiological assessment of FOG may help to detect such subtle FOG episodes 
that currently escape the clinical eye. 
We showed that the appearance of sudden obstacles can provoke brief FOG episodes 
during treadmill walking. This ability to provoke brief FOG episodes in a standardized 
environment, where it can be combined with e.g. kinematic measures, accelerometry, 
forceplates or electromyography, offers new opportunities to study the pathophysiol-
ogy of FOG. Eventually, this may allow for development of an electrophysiological 
definition of FOG that could support clinicians in diagnosing or evaluating FOG.
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Legend to the video’s
Video 1: A typical FOG episode evoked just after obstacle crossing
Video 2: A typical FOG episode evoked between obstacle release and obstacle cross
Video 3: A more severe FOG episode evoked by the threat of a coming obstacle, 
needing an emergency stop. Hereafter, the patient shows a very subtle FOG episode 
just before obstacle cross.
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Summary
Freezing of gait (FOG) is a clinically defined phenomenon of Parkinson’s disease (PD). 
Recent evidence suggests that subtle FOG episodes can be elicited in a gait laboratory 
using suddenly appearing obstacles during treadmill walking. We evaluated which 
quantitative gait parameters identify such subtle FOG episodes.
We included 10 PD patients with FOG, 10 PD patients without FOG and 10 controls. 
Subjects walked on a motorised treadmill while avoiding unexpectedly appearing 
obstacles. Treadmill walking was videotaped, and FOG episodes were identified by 
two independent experts. Gait was also analysed using detailed kinematics. Knee 
joint signals were processed using time-frequency analysis with combinations of 
sliding Fast Fourier transform and wavelets transform.
Twenty FOG episodes occurred during treadmill walking in five patients (all with 
clinically certified FOG), predominantly in relation to obstacle avoidance. FOG was 
brief when it occurred just before or after obstacle crossing and was characterised by 
short, rapid steps. Frequency analysis showed a typical qualitative pattern: before the 
FOG episode an increase in dominant frequency in the 0-3 Hz band (festination), 
followed by decreased power in 0-3 Hz band and an increased power in the 3-8 Hz 
band during the FOG episode. This pattern led to an increased FOG index as a 
qualitative measure. These approaches detected even very brief FOG with acceptable 
sensitivity (75-83%) and specificity (>95%).
We conclude that time frequency analysis is an appropriate approach to detect brief 
and subtle FOG episodes. Future work will need to decide whether this approach can 
support or even replace expert clinical opinion. 
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Introduction
Freezing of gait (FOG) is defined as an episodic inability to generate effective 
stepping.150 Typically, FOG episodes are brief (1–2 seconds) and are associated with a 
subjective feeling of “the feet being glued to the ground”.153 The ‘shuffling’ phenotype of 
FOG is frequently associated with festinating gait.151;181;329 Festination is often described as 
taking increasingly rapid and small steps during walking, but without the subjective 
feeling of “glueing”.44;61;151 Festination and FOG may represent complementary pheno - 
types along the same pathophysiological spectrum.
Several studies have attempted to characterize FOG. One approach concentrates on 
characterizing FOG using spatiotemporal kinematic parameters of gait. The period 
just before a FOG episode is characterised by an increased cadence, decreased stride 
length, decreased angular excursion of leg joints.285;288;366
Another approach is based on frequency analysis of leg movement. Normal gait is 
characterized by a narrow peak around 1 Hz (which corresponds to the frequency of 
stepping).164 Several studies found an abnormal peak in the 3-6 Hz band during 
FOG.118;164;366 This extra peak could be easily differentiated from increases in cadence 
during or before the FOG episode. In addition, evident FOG episodes of long duration 
show an increase in the 3-8 Hz band, as well a decrease in the 0.5-3 Hz band.256
Despite these promising findings, the question remains which of the previously 
identified factors (increased cadence, decreased step length, high frequency 
oscillations of the legs) are most relevant to detect FOG. A particular challenge is to 
identify very brief FOG episodes. It is often difficult to provoke FOG in either an 
experimental or clinical setting, and when FOG does occur it is often subtle.289;306 
Freezing is a common cause of falls in PD.49;219 Detection of subtle FOG in patients 
would be relevant for daily life, not because the subtle freezing itself would necessarily 
lead to falls, but rather because these laboratory-evoked brief episodes might serve 
as a marker for more severe FOG. We have recently demonstrated that patients with 
clinically certified FOG can experience brief freezing episodes while walking on a 
motorised treadmill when subjects need to avoid suddenly appearing obstacles.345 In 
the present study, we have used this paradigm to provoke FOG. We investigated the 
use of an elaborate set of quantitative outcome measures to optimally detect even 
subtle signs of FOG.
Methods
Patients
We included 10 patients with PD (according to the UK Brain Bank criteria) and an 
unambiguous previous history of FOG (Freezer group, mean age ± SD: 62.5 ± 6.5 
years), 10 PD patients without any clinical evidence of FOG (Non-freezer group, mean 
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age ± SD: 59.5 ± 7.5 years) and 10 healthy age-matched control subjects (Controls, 
mean age ± SD: 60.1 ± 6.0 years). All experiments were done in a practically defined 
‘OFF-state’.217 Patients of the freezer group were defined as having at least subjective 
freezing, according to the FOG questionnaire item #3 (n=10) (median 10, 1st quartile 
(Q1) 8, 3rd quartile (Q3) 14)152; Eight patients also had overt FOG episodes while walking 
on a specific gait trajectory that included all known triggers for FOG.341
Disease severity according to the Hoehn and Yahr stage ranged between 2 and 3 
(median 2.5, Q1 2, Q3 2.5) for freezers, and between 2 and 3 (median 2, Q1 2, Q3 2.4) 
for non-freezers. Median (Q1, Q3) UPDRS motor score in ‘OFF-state’ was 30 (22, 31.75) 
for freezers, 24 (21, 27.5) for non-freezers.
Patients with cognitive impairment (MMSE score <24), other causes for gait disorders, 
major psychiatric disorders or severe co-morbidity were excluded. 
Procedure
Participants walked on a motorised treadmill used in previous experiments187 at a 
fixed speed of 2 km/h. To prevent subjects from falling, they wore a safety harness. A 
bridge with an electromagnet was placed over the front of the treadmill. The 
electromagnet suspended the obstacle (length 40 cm, width 30 cm, height 1.5 cm). 
Participants walked at a fixed and predetermined position on the treadmill, such that 
the most anterior position of the toes had a distance of approximately 100-150 cm 
(depending on the phase of the step cycle) to the obstacle prior to its release. 
Before the experimental procedure, a training phase of 10 min allowed subjects to 
become familiar with treadmill walking and with obstacle avoidance. The experimental 
procedure itself consisted of a maximum of 10-20 obstacle avoidance trials. The 
obstacle was dropped randomly after at least 10 strides. Subjects were specifically 
instructed not to touch the obstacle or step besides the obstacle with the crossing 
foot. A trial consisted of at least 5 strides before obstacle release, obstacle crossing 
and at least 5 strides after obstacle crossing. 
Data analysis
The entire experiment was recorded on videotape. The presence of FOG episodes 
(defined as an episodic inability to generate effective stepping150) was scored off-line 
by two independent experts in FOG (BR Bloem and N Giladi) who were blinded with 
respect to group allocation. Raters were asked to score gait before, during and after 
each obstacle clearance as either “definite FOG”, “possible (very brief) FOG” or “no 
FOG”. If only one expert identified an episode as “definite” FOG but the other expert 
scored this as “possible” FOG, or if both experts identified “possible FOG”, we asked a 
third rater (V Weerdesteyn) with expertise in obstacle avoidance to determine if the 
trial showed normal obstacle avoidance or not. If the trial was also considered as 
abnormal by this third observer, we then scored the event as a FOG episode.
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Detailed gait analyses was performed using 10 reflective markers that were attached 
to the heels, toes, ankles, shoulders, over vertebra T10, and to the obstacle. A 3D 
motion analysis system (VICON® video System, Oxford Metrics, Oxford, England)) 
recorded the marker positions at a sample rate of 100 Hz. In addition, knee angle 
trajectories were recorded using goniometers at a sample rate of 1000 Hz. This joint 
seemed particularly involved in freezing phenomenons.293 The analog signals were 
filtered by a low-pass filter of 10 Hz and differentiated. All measurements were 
determined using a MATLAB® (The Mathworks, Inc.) program.
Spatio-temporal characteristics of gait are influenced by obstacle crossing. Therefore, 
we separated FOG episodes that occurred without obstacle appearance, just before 
obstacle crossing (after release of the obstacle, defined as the pre-cross time window) 
or immediately after obstacle crossing (the first five steps after crossing, defined as 
post-cross time window) for the analysis. 
As kinematic parameters, we calculated the mean and minimum step amplitude and 
step duration for all time windows. We also computed decrease in step duration 
which is the maximum decrease in step duration in %: 100 - (100 * minimum step 
duration / mean step duration). 
Spectral analysis of the knee signal on the side of obstacle release (as both sides 
showed similar results) was first performed using Fast Fourier Transform for both the 
pre-cross and post-cross time windows (Figure 1). From this time frequency analysis 
we calculated the frequency ratio which is the ratio of the maximum power peak in 
the 3-8 Hz band, divided by maximum power peak in 0-3 Hz band, for the time interval 
in question (Figure 1). 
Second, we wanted to describe the temporal course of the changes in frequency, in 
order to better understand the relationship between festination and FOG. In 
secondary qualitative analyses, in order to detect very brief, transient event-related 
spectral perturbations, we used open source software, namely EEGlab.237 For this 
purpose we performed time/frequency analyses using sliding windowed Fast Fourier 
Transform. The window size was 4.1 s at all frequencies between 0 and 8 Hz.92 We also 
performed the sinusoidal wavelet transform in which the data window length 
depends inversely on the frequency in order to obtain a better compromise between 
time changes and frequency changes.333 Indeed, resolution in time to detect changes 
in frequency power was improved with this latter method.
We used visual evaluation on these trials to describe the temporal course of the 
changes in power for the different frequencies that occurred before or after 
obstacle. We compared them to the frequency pattern found in unequivocal FOG 
episodes of longer duration during unobstructed gait on the treadmill. (see Figure 2 
for description).
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Figure 1   Fast Fourier Transform (FFT) in the post-cross time window 
Trial without freezing of gait (FOG) episode. See the main dominant frequency at 1.2 Hz that corresponds to 
the stride frequency. The ratio 3-8 Hz/0-3 Hz corresponds to the ratio of the maximum power peak in 3-8 Hz 
band, divided by the maximum power peak in 0-3 Hz band. Trial with a clear FOG episode. See the decrease 
in power frequencies in the 0-3 Hz band and the increase in the 3-8 Hz band.
Figure 2   Sliding Fast Fourier transform (FFT) and wavelets transform of: 
A. Normal obstacle crossing in a PD patient. OR: obstacle release, cross: moment when the toe marker of the 
crossing leg reaches the obstacle. 1. Increase in power of the very low frequencies due to the crossing. ERSP: 
event-related spectral perturbation, corresponding to event-related shifts in the power spectrum.
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Statistical analyses
The blinded clinical judgement of the videotapes by the two independent raters was 
considered as the gold standard for presence of FOG episodes. 
First, ROC curves were drawn, to differentiate trials with FOG from other trials. We 
then calculated the threshold for each relevant parameter to determine its ability in 
identifying FOG episodes. Correlations between relevant parameters and the FOG 
Questionnaire were also calculated (Spearman test).
In addition, we compared trials with FOG and trials without FOG using ANOVA with 
one factor, accepting p < 0.05 as significance level for all groups. Comparisons 
between four groups were then assessed using Tukey’s test with correction for 
multiple comparisons (p < 0.01). For the detection of the ultimate parameter, we were 
interested in those parameters that showed a difference between FOG trials in 
freezers and all other groups, including trials of freezers that did not show FOG. In 
other words, we wished to identify variables that were capable of detecting strictly 
FOG episodes, and not just the differences in baseline hypokinesia or bradykinesia 
that might be present between freezers, non-freezers and controls. Statistical analyses 
were performed using SPSS 13 (©SPSS Inc.) software.
Figure 2   Sliding Fast Fourier transform (FFT) and wavelets transform of: 
B. FOG episode occurring before obstacle release in a PD patient. The pattern of increased power of the 
dominant frequencies in the 0-3 Hz band (stride and step frequencies) corresponds to festinating gait (1), 
which precedes the increased power in the 3-8 Hz band (2) (associated with the decrease in power in the 0-3 
Hz band (3)) during the actual FOG episode.
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Results
We recorded 90 trials in controls and 96 trials in non-freezers, none of which were 
clinically rated as showing FOG. We recorded 130 trials in PD patients of the freezer 
group. In this group, 20 FOG episodes occurred according to the raters. Eight of the 
episodes occurred in the pre-cross time window, eight immediately after obstacle 
crossing and four during unobstructed gait (in anticipation of obstacle release). The 
duration of the FOG episodes during obstacle avoidance (pre and post OR) was brief, 
less than 1 second and did not necessitate emergency stops. 
The ROC curves revealed that Fast Fourier Transform and decrease in step duration or 
amplitude were good predictors of the occurrence of a FOG with an area under the 
curve (AUC) or 1-AUC > 0.8 (Figure 3; Table 1). A threshold was determined for all 
variables (Table 1, Figure 4).The group results are graphically illustrated in Figure 4 for 
the pre-cross window. There was no difference in outcome of gait parameters 
between FOG episodes rated as ‘possible (very brief)’ or as ‘clear’ FOG by the raters.
Post-hoc analyses showed there was a clear difference between trials with FOG and 
trials without FOG of all three groups (trials of freezers where no FOG occurred, 
non-freezer trials, control trials) for decrease in step duration (% baseline), minimum 
step length and ratio 3-8/0-3 Hz (Table 1). In addition, there were no differences 
between the trials of the freezers where no FOG occurred, the non-freezer trials or 
control trials for these 3 variables. That makes them more interesting than other 
variables in detecting strictly FOG episodes and not differences in baseline hypokinesia 
or bradykinesia between freezers, non-freezers and controls. 
Ratio in the pre cross time window in all trials was weakly correlated with the FOG 
Questionnaire (r = 0.17, p < 0.05) in the freezer group.
Qualitative time-frequency transforms of the knee joint angles
Sliding Fast Fourier Transform and wavelet analysis showed significant changes in 
frequency with an increase in frequency power in the 3-8 Hz band during the four 
clear FOG episodes during unobstructed gait. The FOG phenomenon is associated 
with a typical Frequency pattern, with initially an increased main frequency in the 0-3 
Hz band, corresponding to an increase in stepping frequency (what would be called 
festinating gait), and subsequently with a decreased power in the 0-3 Hz band (the 
motor block) with an increase in frequencies in the 3-8 Hz band (probably reflecting 
the attempt to overcome the block) (Figure 2). Festination could occur either in 
isolation or in association with FOG (as defined by the clinical observers). This is 
illustrated in Figure 5. We next examined whether this typical Frequency pattern 
would help in identifying less obvious FOG periods (duration < 1 second) just before 
or after obstacle avoidance. The pattern was seen in all trials with FOG episodes. 
However, this pattern was also present in 5.4% of trials of freezers where no FOG 
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episode occurred, although only in patients who did present clear FOG episodes 
during other trials of the experiment. It was present in none of the trials of non-freezers, 
but in one trial of the control subjects. 
Table 1   Validity of the parameters
PRE CROSS variabels
Mean SD AUC Cut-off Sens Spec ANOVA: 
F, p
Post-Hoc 
Tukey, p
Decrease in step duration (%)
Freezer-FOG  55.4  31.8 0.87 48 0.75 0.95 11.8*** 1≠2***,3***,4***
Freezer-no FOG  16.2  25.1  
 
 
2≠1***
Non-freezer  10.0  16.6 3≠1***
Controls  11.1  20.2 4≠1***
Ratio 3-8/0-3 Hz
Freezer-FOG 0.77 0.84 0.96 0.21 0.88 0.97 35.3*** 1≠2***,3***,4***
Freezer-no FOG 0.12 0.24 2≠1***
Non-freezer 0.04 0.04 3≠1***
Controls 0.04 0.04 4≠1***
Mean step duration (cs) before OR (at least 5 unperturbed strides)
Freezer-FOG 45 16 0.07 65 0.79 0.87 50.7*** 1≠2***,3***,4***
Freezer-no FOG 66 13 (1-AUC=0,93)
 
 
2≠1***,3***,4***
Non-freezer 72 10 3≠1***,2***,4***
Controls 82 6 4≠1***,2***,3***
Mean step duration (cs) between OR and OC
Freezer-FOG 39 15 0.05 65 0.75 0.87 35.1*** 1≠2***,3***,4***
Freezer-no FOG 66 16 (1-AUC=0,95) 
 
 
2≠1***,3*,4***
Non-freezer 72 11 3≠1***,2*,4***
Controls 80 10 4≠1***,2***,3***
Minimum step duration (cs) between OR and OC
Freezer-FOG 24 20 0.08 42 0.9 0.87 24.7*** 1≠2***,3***,4***
Freezer-no FOG 58 19 (1-AUC=0.92) 
 
 
2≠1***,3*,4***
Non-freezer 65 16 3≠1***,2*,4*
Controls 73 17 4≠1***,2***,3*
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Table 1   Continued
PRE CROSS variabels
Mean SD AUC Cut-off Sens Spec ANOVA: 
F, p
Post-Hoc 
Tukey, p
Mean step distance (mm) before OR
Freezer-FOG 230 106 0.09 357 0.75 0.87 50.6*** 1≠2***,3***,4***
Freezer-no FOG 352 78 (1-AUC=0.91)
 
 
2≠1***,3***,4***
Non-freezer 395 54 3≠1***,2***,4***
Controls 443 34 4≠1***,2***,3***
Mean step distance (mm) between OR and OC
Freezer-FOG 187 70 0.03 276 0.9 1 27.1*** 1≠2***,3***,4***
Freezer-no FOG 358 94 (1-AUC=0,97) 2≠1***,4***
Non-freezer 384 84 3≠1***,4***
Controls 435 74 4≠1***,2***,3**
Minimum step distance (mm) between OR and OC (at least five unperturbed strides)
Freezer-FOG 12 125 0.09 141 0.82 0.87 7.5*** 1≠2**,3**,4***
Freezer-no FOG 266 153 (1-AUC=0.91) 
 
 
2≠1**
Non-freezer 283 172 3≠1**
Controls 325 223 4≠1***
POST CROSS variables
Decrease in step duration (%)
Freezer-FOG  51.5  22.9 0.86 43 0.83 0.95 9.1*** 1≠2***,3***,4***
Freezer-no FOG  9.1  25.2  2≠1***
Non-freezer  12.4  11.8 3≠1***
Controls  10.9  19.7 4≠1***
Ratio 3-8/0-3 Hz
Freezer-FOG 1.15 1.97 0.98 0.39 0.83 0.98 26.8*** 1≠2***,3***,4***
Freezer-no FOG 0.12 0.17  
 
2≠1***
Non-freezer 0.05 0.04 3≠1***
Controls 0.05 0.03 4≠1***
Minimum step duration (cs) 5 steps after OC
Freezer-FOG 15 12 0.02 40 0.95 1 42.5*** 1≠2***,3***,4***
Freezer-no FOG 58 15 (1-AUC=0.98)
 
 
2≠1***,4***
Non-freezer 62 10 3≠1***,4***
Controls 72 14 4≠1***,2***,3***
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Table 1   Continued
POST CROSS variables
Mean SD AUC Cut-off Sens Spec ANOVA: 
F, p
Post-Hoc 
Tukey, p
Minimum step distance (mm) 5 steps after OC
Freezer-FOG -86 141 0.05 120 0.89 1 7.0*** 1≠2**,3**,4***
Freezer-no FOG 249 107 (1-AUC=0.95) 
 
2≠1**
Non-freezer 236 156 3≠1**
Controls 289 286 4≠1***
OR: obstacle release; OC: obstacle cross. * <0.05, **<0.01, ***<0.001. SD = Standard deviation; AUC = area 
under the curve. Sens = Sensitivity; Spec = Specificity; Freezer-FOG = Freezer group, trials with FOG;  
Freezer-no FOG = Freezer group, trials without FOG.
Figure 3   ROC curve representing the sensitivity and 1-specificity in detecting 
FOG episodes for decrease in step time (% baseline), ratio 3-8/0-3 Hz, 
mean and minimum value of step duration and distance between 
obstacle release (OR) and obstacle cross (OC), mean value of step 
duration and distance before OR in the pre-cross window (similar 
results in the post-cross time window). 
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Figure 4   Decrease in step duration (% of baseline) and ratio 3-8 Hz/0-3 Hz in the 
four populations (8 trials with FOG in the Freezer group; 122 trials 
without FOG in the Freezer group, 96 trials of Non freezer group; and 
90 trials of controls) in the pre-cross time window (results similar in the 
post-cross time-window) 
Top Figure, right: for decrease in step duration, rate of false positives in the ‘Freezer group, trials without FOG 
group’ was 5.7%; rate of false positives in the ‘Non freezer group’ was 2.1%, rate of false positives in the 
‘Controls’ group was 3.3%. Top Figure, left: for Ratio 3-8/0-3 Hz, rate of false positives in the ‘Freezer group, 
trials without FOG group’ was 5.7%; rate of false positives in the ‘Non freezer group’ was 0%, rate of false 
positives in the ‘Controls’ group was 0%.
Bottom Figure, Y axis: Mean ± 1.96 standard error. See the more important decrease in step duration and 
increase in frequency ratio in case of trials with FOG.
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Discussion
We have demonstrated that the occurrence of high frequencies in a biomechanical 
gait signal or a marked reduction in step duration and amplitude can detect even 
very brief FOG episodes, with acceptable sensitivity (75-88%) and specificity (>95%). 
The link between a decrease in step length and FOG is in keeping with recent work.76 
Qualitative frequency analysis showed a decreased power in the 0-3 Hz band and an 
increased power in the 3-8 Hz band (representing the actual FOG episode with the 
motor block and the attempt to overcome the block). 
We were able to predict more than 83% of all subtle FOG periods using knee 
goniometer data. A study using accelerometer data, had a similar prediction 
percentage of 78.256 These patients experienced long, severe FOG episodes (mean 
around 20 seconds),256 while our study focused on much subtler episodes of < 1 
second duration. This difference is likely explained by the fact that the PD patients in 
Figure 5   Sliding FFT and wavelets transform of a FOG episode. A pattern of 
increase in the dominant frequency in the 0-3 Hz band (at 6 s) 
corresponding to festinating gait (FSG) precedes another similar 
pattern (at 9 s) that leads to a FOG episode  
It is difficult to differentiate the first pattern of changes in frequency corresponding to festination alone with 
the second (festination + FOG episode).
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our study were less severely impaired compared to previous studies.164;256;288 In 
addition, the treadmill and the obstacles may have acted as cues to overcome the 
episode.133 
The detection of a FOG episode was quite specific. None of the controls or PD patients 
without FOG history had a ratio up to the threshold for neither time interval. The first 
question that arises is whether the current methods detected FOG episodes or merely 
festinating steps. We found the occurrence of abnormal frequencies in the 3-8 Hz 
band to be highly sensitive and specific for detection FOG. However, such high 
frequencies are not completely specific because these may also occur during 
festinating gait without FOG.256 Moore et al differentiated festination from FOG, noting 
a clear decrease in frequencies < 3 Hz before a FOG episode that was not present 
during festination without FOG. Our data suggest that it is possible to visualize 
festination, both with and without FOG (Figure 5). However, it is often difficult to 
distinguish festinating steps that occur before FOG from pure festination without 
subsequent FOG. For example, Nieuwboer and colleagues288 found no differences in 
spatiotemporal parameters of pre-freezing and festinating steps. We should note that 
some of our non-freezers present a clear decrease in step duration (false positives) 
without any change in frequency ratio. This may correspond to isolated festination. 
Iansek and colleagues181 have postulated that FOG is the consequence of a “sequence 
effect” (inability to maintain a predefined movement amplitude and movement 
timing) that is superimposed on gait hypokinesia, and consequently that FOG will not 
occur in the absence of festination. 
Our current qualitative analyses using sliding Fast Fourier Transform and wavelet 
analysis clearly describe a characteristic frequency pattern. These findings would 
suggest that festination and FOG phenomenon are linked phenomena. Indeed, our 
Frequency Pattern was observed in both festination that does not lead to a 
recognisable FOG episode and in FOG. Possibly, these high frequencies in freezers 
without an overt FOG episode do reflect pathology and perhaps even herald FOG 
that currently escapes both the clinical eye and the sensation of the patient. A 
spectrum may exist from festination leading to FOG, all characterised by the same 
characteristic Frequency Pattern. Sometimes, the patient will be able to overcome the 
FOG episode before it even becomes recognisable.
Our findings support the hypothesis that FOG is not an isolated phenomenon that 
appears randomly.181 Indeed, the appearance of an obstacle induces a need to adjust 
the step in order to facilitate an optimal crossing,381 and in case of PD patients, this 
process of step adjustment may culminate in festination or even overt FOG. This is in 
agreement with a recent study76 that provoked FOG by asking the patients to walk 
with increasingly shorter steps. Moreover, FOG can also be elicited when patients are 
placed under considerable strain like extreme imposed step duration by a 
metronome.257 It would also fit with another hypothesis,187 that it is the inability to 
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generate correct anticipatory postural adjustments prior to the step that is responsible 
for provocation of FOG. Another explanation could be withdrawing of attention 
because of the noise of the obstacle. However, this cannot explain the FOG episodes 
that occur just after the crossing of the obstacle.
A limitation of this study is that we did not study “real life” FOG, but instead focused 
on an admittedly artificial form of “freezing” that occurred while subjects were 
walking on a motorised treadmill with a similar speed for all subjects. However, 
controls still showed a regular gait pattern and were still able to use big steps, in 
comparison to the small steps seen in PD. We should point out that treadmill walking 
also presents obvious advantages (better control of speed; possibility to introduce 
FOG-eliciting methods; and availability of detailed electrophysiological gait analysis). 
The phenotype on the treadmill looked remarkably like “real” FOG. and there was a 
high rate of agreement.344 In addition, the longer FOG episodes that occurred during 
unobstructed gait on the treadmill  showed the same Frequency Pattern. Hence, we 
assume that the subtle episodes we provoked are indeed similar to subtle episodes 
that frequently occur in daily life. 
Future perspectives
This study provides ‘proof of concept’ that even subtle FOG episodes can be detected 
using frequency analysis, and thereby opens several new perspectives. More work is 
now needed in larger groups of ambulatory patients to determine if this approach 
can be used as a screening test for “real life” FOG and for risk of falls.. Future work will 
also need to establish whether these new methods are a valuable addition to clinical 
screening. Indeed, the ‘gold standard’ of clinical rating is possibly not sensitive 
enough, as very brief and subtle FOG episodes may well escape even an experienced 
clinical eye, particularly in a clinical setting when FOG is often paradoxically 
suppressed. 
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Video vignette 2
Based on animal studies and open label studies, the pedunculopontine nucleus has 
been proposed as a promising new target for deep brain stimulation, specifically 
directed at improving gait.299 However, double blind studies have failed to live up to 
these expectations.122;261 Video vignette 2A and 2B show two patients with Parkinson’s 
disease who received pedunculopontine nucleus stimulation (4 years after subthalamic 
nucleus stimulation).122 In video vignette 2A, surgery did not have any effect on FOG 
(woman, age 68 years, disease duration 18 years, location contact relative to ponto-
mesencephalic line: 6.7, 9.5, 0.8). In contrast, video vignette 2B shows a patient with a 
remarkable response of his FOG on pedunculopontine nucleus stimulation (man, age 
68 years, disease duration 13 years, location contact 5.3, 8.7, 1.5). Interestingly, the 
electrodes of both patients were located posterior to the pedunculopontine nucleus.122 
I’m thankful to Muriel Ferraye and Bettina Debu for the use these videos.
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Summary
Freezing of gait is a common, debilitating feature of Parkinson’s disease. We have 
studied gait planning in patients with freezing of gait, using motor imagery of walking 
in combination with fMRI. This approach exploits the large neural overlap that exists 
between planning and imagining a movement. In addition, it avoids the confounds 
introduced by brain responses to altered motor performance and somatosensory 
feedback during actual freezing episodes. 
We included 24 patients with Parkinson’s disease [12 patients with freezing of gait 
(‘freezers’), 12 matched patients without freezing of gait (‘non-freezers’)] and 21 
matched healthy controls. Subjects performed two previously validated tasks: motor 
imagery of gait, and a visual imagery control task. During fMRI scanning, we quantified 
imagery performance by measuring the time required to imagine walking on paths of 
different width and length. In addition, we used voxel-based morphometry to test 
whether between-group differences in imagery-related activity were related to 
structural differences. 
Imagery times indicated that freezers, non-freezers, and controls engaged in motor 
imagery of gait, with matched task performance. During motor imagery of gait, 
freezers showed more activity than non-freezers in the mesencephalic locomotor 
region. Freezers also tended to have decreased responses in mesial frontal and 
posterior parietal regions. Furthermore, freezers had grey matter atrophy in a small 
portion of the mesencephalic locomotor region. The gait-related hyperactivity of the 
mesencephalic locomotor region correlated with clinical parameters (freezing of gait 
severity and disease duration), but not with the degree of atrophy.  
These results indicate that Parkinson’s disease patients with freezing of gait have 
structural and functional alterations in the mesencephalic locomotor region. We 
suggest that freezing of gait might emerge when altered cortical control of gait is 
combined with a limited ability of the mesencephalic locomotor region to react to 
that alteration. These limitations might become particularly evident during 
challenging events that require precise regulation of step length and gait timing, such 
as turning or initiating walking, which are known triggers for freezing of gait.
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Introduction
Freezing of gait (FOG) is an episodic gait disorder during which the feet appear ‘glued 
to the floor’.49 The pathophysiology underlying FOG remains largely unknown. 
Behavioural studies have identified several gait alterations in Parkinson’s disease (PD) 
patients with FOG (“freezers”), even when the patient is not experiencing an actual 
FOG episode. Alterations include premature timing of muscle activations,289 increased 
variability of gait,168 increased temporal gait asymmetry,307 and faulty generation of 
postural adjustments before step initiation.186 A recent paper suggested that FOG may 
be caused by a failure to generate adequate amplitudes for the intended movement. 
This will lead to a progressive reduction of step size that may culminate into a FOG 
event.76 This so-called sequence effect could result from defective stride length 
amplitude setting by the supplementary motor area and its maintenance by the basal 
ganglia, leading to a mismatch between intention and automation.76 However, 
empirical tests of this hypothesis are difficult, because most non-invasive 
neuroimaging methods are not suitable for assessing gait.30
Some experimental approaches can bypass these difficulties, allowing researchers to 
study the cerebral correlates of FOG.37;114;213;246 One possibility is to focus on the 
planning phase of walking movements, rather than the manifestation of actual FOG 
episodes. Motor imagery (asking subjects to imagine a particular movement) exploits 
the large functional and neural overlap between motor planning and imagery of a 
movement.77;193;251 Imagining a movement is sensitive to motor control variables,138 it is 
contingent on the current physical configuration of the subject,89;282 and it relies on 
neural processes similar to those evoked during performance and planning of the 
same movement.213;352  We have recently shown that motor imagery of gait follows 
similar motor constraints as actual walking.29 Accordingly, motor imagery of gait has 
been used repeatedly to study human walking using fMRI28;213 or PET.239
Although motor imagery of gait is likely to engage only a portion of the cerebral 
circuits controlling walking, it has several advantages for investigating FOG. First, 
motor imagery provides opportunities for studying alterations in the planning of gait, 
which may be a crucial element in FOG pathophysiology.76;187 Second, meaningful 
cerebral comparisons between patients and controls require matched behavioural 
performance.311 This condition can be met with motor imagery of gait, whereas real 
motor performance will often differ between patients and controls. Third, motor 
imagery of gait allows us to isolate cerebral responses related to walking, distinct from 
alterations in motor performance and somatosensory feedback produced by actual 
FOG episodes.12 
Accordingly, we used motor imagery of gait in combination with fMRI to study the 
cerebral correlates of gait planning in patients with and without FOG. Stimulated by 
current hypotheses concerning FOG pathophysiology – which mainly deal with 
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deficits in regulating step length and gait timing76;307 – we also included a behavioural 
control experiment where actual gait was electrophysiologically quantified. Finally, 
we used voxel-based morphometry to assess whether between-group differences in 
imagery-related activity were related to structural differences.
Methods 
Subjects
We included 25 patients with PD, 13 freezers and 12 non-freezers who were matched 
for disease severity and duration (Table 1 – one freezer was excluded from the 
analyses due to his inability to engage in imagery, see below). Patients were diagnosed 
according to the UK Brain Bank criteria.178 All patients except one used dopaminergic 
medication (levodopa or dopamine-agonists). Patients were examined in the morning, 
at least 12 hours after intake of the last dose of antiparkinson medication. Disease 
severity was assessed using the Hoehn & Yahr stages and Unified Parkinson’s Disease 
Rating Scale (UPDRS). Patients with marked resting tremor were excluded. In the 
remaining patients, we carefully controlled for tremor influences on scanning results 
by recording electromyography (see below). Twenty-one healthy volunteers, matched 
for age and gender, served as controls (Table 1).
Freezers were identified based on three criteria: (1) convincing subjective reports of 
FOG, based on consistent and characteristic accounts of the phenomenon (including 
the typical feeling of the feet being glued to the floor); (2) patient’s recognition of 
typical phenotype when this was demonstrated to them by an experienced clinician, 
or using the New Freezing of Gait Questionnaire (NFOG-Q) video.291 In addition, a 
standardized and videotaped gait trajectory was performed containing specific 
elements known to provoke FOG.341 These videos were rated off-line for the presence 
of FOG by two different experts. Nine of the 12 freezers (75%) also showed FOG during 
physical examination. None of the non-freezers experienced subjective freezing, 
recognized the phenotype when this was demonstrated to them, or manifested 
freezing during physical examination. The median NFOG-Q score291 for freezers was 
12.4, range 5-27. The score for non-freezers was 0.
All subjects were right-handed according to the Edinburg Handedness Inventory, had 
no cognitive dysfunction (Mini-Mental State Examination > 24, Frontal Assessment 
Battery > 13), and no vestibular, orthopaedic, neurological or psychiatric diseases. 
Before participation, subjects received the (unrevised) Vividness of Motor Imagery 
Questionnaire (VIMQ)183 to screen for ability to perform motor imagery. When a 
subject was unable to perform motor imagery (VIMQ score >200), the subject was 
excluded (one freezer with a score of 240). Patients and controls were equally able to 
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perform motor imagery (one-way ANOVA, effect of group: F(2,41) = 1.4, p = 0.24), with 
scores comparable to age-matched healthy subjects.268 The study was approved by 
the local ethics committee, and written informed consent was obtained from all 
subjects prior to the experiment according to the Declaration of Helsinki.
Tasks
We used a behaviourally validated protocol29 used in a previous fMRI study in young 
healthy subjects.28 Briefly, subjects performed two tasks: motor imagery of gait (MI), 
during which they had to imagine walking along a path, and a matched visual imagery 
control task (VI), during which they imagined seeing a disc moving along the path 
(Figure 1). Subjects were presented with a picture of a path with a target placed on it. 
They were asked to either imagine themselves walking towards the target (MI), or to 
imagine a disc moving towards the target (VI). During both tasks, the motion-relevant 
portion of the path could have two different widths (narrow, broad) and five different 
distances (2, 4, 6, 8, and 10 m). These manipulations allowed us to monitor the subject’s 
ability to perform motor imagery in the scanner.28 Specifically, imagery times for both 
MI and VI should vary with alterations in path length. Furthermore, only MI times 
should be susceptible to path width alterations, because a narrow path requires 
precision gait. Conversely, the VI task (a moving disc) should not be influenced by 
path width.28 The MI and VI tasks were performed in two successive sessions of 25 
Table 1   Clinical characteristics
Parameter Group N Mean SD P-value
Gender Patients
Controls
24
21
9F / 15M 
9F / 12M
0.18
Freezers
Non-Freezers
12 
12
4F / 8M 
5F / 7M
0.22
Age (years) Patients 
Controls
24 
21
60.2
57.0
8.9
9.1
0.25
Freezers
Non-Freezers
12 
12
58.7 
62.6
9.0 
7.1
0.20
Disease duration Freezers 
Non-Freezers
12 
12
9.8 
7.1
4.6 
3.0
0.10
UPDRS III Freezers 
Non-Freezers
12 
12
34.6 
28.6
9.6 
12.2
0.20
FAB Freezers 
Non-Freezers
12 
12
16.5
17.1
1.4
0.8
0.22
H&Y = Hoehn and Yahr Rating Scale; UPDRS III = Unified Parkinson’s Disease Rating Scale part 3; FAB = Frontal 
Assessment Battery; M = Male; F = Female. Statistical inferences are based on independent samples t-test 
(Chi-squared test for Gender).
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minutes each, separated by a break outside the scanner. The order of the sessions was 
counterbalanced across subjects. To control for actual movements related to tremor 
or overt leg movements, muscle activity from the forearm and lower leg was measured 
during the fMRI experiment. For further details, see the supplementary material 
directly after this chapter.
After the imagery sessions, we tested subjects’ actual walking along the same paths 
as displayed during the imagery session. Performance on each of the 10 experimental 
conditions (2 different path widths over 5 different distances) was sampled once, 
recording the actual walking time with a stopwatch. These measurements served to 
confirm the relationship between imagined and actual walking performance.29
Figure 1   Task setup 
A) Examples of photographs of walking trajectories presented to the subjects during motor imagery (MI), and 
visual imagery (VI) experiments. The photographs show a corridor with a white path in the middle and a green 
pillar positioned on the path. During MI trials, a green square is present at the beginning of the path. During VI 
trials, a black disc is present at the beginning of the path. During both tasks, the path width can be either broad, 
or narrow. In addition, the green pillar can be positioned at 2, 4, 6, 8 or 10 m from the start marker (2 m is 
presented in the photos of this figure). B) Time course of motor imagery trials. During each trial, after a short 
inspection of the photo on display, the subjects closed their eyes and imagined standing on the left side of the 
path, next to the green square. The subjects were asked to press a button with the index finger of their left or 
right hand to signal that they had started imagining stepping onto the path and walking along the path. The 
subjects were also asked to press the button again when they imagined having reached the end of the walking 
trajectory. Following the second button press, a fixation cross was presented on the screen and the subjects 
could open their eyes. The duration of the inter-trial interval (ITI) was 4-12 s.
Motor ImageryVisual Imagery
Imagine walking
trial n+1trial n
ITI (4-12 s)Imagery time 
1) Inspect picture
2) Close eyes
3) Imagine standing
Stimulus
Time
Task
Open eyes
A
B
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Behavioural analysis
We objectively monitored task performance by testing whether imagery times were 
modulated by the width and length of the path presented to the subjects. For each 
trial, imagery time was defined as the time between the button presses indicating the 
onset and offset of imagery. Trials in which subjects failed to press the button (either 
at the onset or offset of the imagery phase) were excluded from analyses (freezers 
mean [range]: 1.1 [0 to 4] trials; non-freezers: 0.5 [0 to 3] trials; controls: 0.5 [0 to 5] 
trials). Afterwards, the standard deviation (SD) of the mean picture inspection duration 
and imagery time was computed. Trials outside the mean ± 3 SD range were 
considered outliers and removed (freezers mean [range]: 1.2 [0 to 3] trials; non-freezers: 
0.6 [0 to 2] trials; controls: 0.8 [0 to 2] trials).
We considered the effect of “Group” (analysis 1: patients versus controls; analysis 2: 
freezers versus non-freezers), “Task” (MI, VI), “Path Width” (narrow, broad) and “Path 
Length” (2, 4, 6, 8, 10 m) on imagery time. The significance of the experimental factors 
was tested within the framework of the General Linear Model using two 2x2x2x5 
mixed-effects ANOVAs. When interactions were significant, the simple main effects 
were investigated by additional ANOVA’s. The alpha-level of all behavioural analyses 
was set at p < 0.05. In a separate analysis, we used Spearman’s correlation to assess the 
relationship between actual walking times and mean imagery times across the 
different experimental conditions for patients and controls.
Pre-processing of imaging data
Functional data were pre-processed and analyzed with SPM5 (Statistical Parametric 
Mapping, www.fil.ion.ucl.ac.uk/spm).  Details on MR images pre-processing can be 
found in the supplementary material directly after this chapter.
Statistical analysis of imaging data – first level
The ensuing pre-processed fMRI time series were analyzed on a subject-by-subject 
basis using an event-related approach in the context of the General Linear Model.136 
The model was aimed at finding regions in which the cerebral response changed as a 
function of “Task” (MI, VI) and/or “Path Width”. “Path Length” was also considered in 
the analysis, which gave rise to a model with twenty different regressors of interest. 
The model also included separate regressors of no interest, modelling BOLD activity 
evoked by picture inspection, button presses, and incorrect trials, separately for each 
session. Further details can be found in the supplementary material.
Statistical analysis of imaging data – second level
We report the results of a random effects analysis. The statistical significance of the 
estimated evoked haemodynamic response was assessed using t-statistics in the 
context of the General Linear Model. For each subject, four contrast images (MI-broad, 
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MI-narrow, VI-broad and VI-narrow) were calculated and entered into a second level 
random effects analysis. Analogously to the analysis of the behavioural data, we 
considered two analyses: Analysis 1 compared controls (c) with patients (p); analysis 2 
compared freezers (f ) with non-freezers (nf).
First, we identified the cerebral correlates of motor imagery of gait within each group, 
searching for brain responses that were larger for MI than for VI [analysis 1: cMI>cVI, 
pMI>pVI; analysis 2: nfMI>nfVI, fMI>fVI ].  Second, we identified regions where 
task-related activity differed between groups, assessing the “Group*Task” interaction 
[analysis 1: (cMI>cVI) > (pMI>pVI), (pMI>pVI) > (cMI>cVI); analysis 2: (fMI>fVI) > 
(nfMI>nfVI) , (nfMI>nfVI) > (fMI>fVI)]. Third, we looked for the shared effects (across 
groups) of environmental constraints (i.e. “Path Width”) on MI-related activity, 
searching for brain responses that were larger during imagined walking on a narrow 
path than during imagined walking on a broad path [analysis 1: cMI-narrow>cMI-
broad, pMI-narrow>pMI-broad; analysis 2: nfMI-narrow>nfMI-broad, fMI-narrow>fMI-
broad]. Fourth, we assessed differential effects of “Path Width” between groups, 
looking at the “Group*Path Width” interaction. 
Statistical inference (p < 0.05) was performed at the cluster-level, correcting for 
multiple comparisons over the search volume (i.e. the whole brain) using family-wise 
error, given an intensity threshold of t > 3.4.135
Region of interest analysis 
Besides whole brain analyses, statistical inference was also performed on regions of 
interest that were based on our previous study in healthy controls28 (see supplementary 
material for nomenclature and stereotactic coordinates of regions of interest). More 
precisely, we considered the local maxima of the clusters that were previously found 
to be significantly activated in the following contrasts: 1) “MI>VI” for the analyses 
considering the effects of “Task” and “Group” described above; and 2) “MI-narrow>MI-
broad” for the analyses considering the effects of “Path Width” and “Group”. More 
specifically, we drew spherical region of interests centred at these coordinates with a 
radius of 8 mm. Statistical inference was performed at the voxel-level, with a 
family-wise error correction for multiple comparisons (p < 0.05).
Gait assessment
In a separate behavioural experiment, gait characteristics were measured with an 
electronic pressure-sensitive walkway (GAITRite, CIR Systems Inc, USA). This system 
consists of a 4.6 m long walkway, containing six sensor pads encapsulated in a roll-up 
carpet to produce an active area 61 cm wide and 366 cm long. This system captures 
the geometry and relative arrangement of each footfall as a function of time, and can 
detect gait alterations that are typical for PD.12 Subjects were asked to walk at their 
normal speed. This procedure was repeated three times. We compared normalized 
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step length (step length/leg length) and gait asymmetry (natural logarithm (LN) of 
the difference in the swing time of the slowest and swing time of fastest foot) 
between freezers, non-freezers and controls using univariate ANOVA and post-hoc 
independent sample t-tests.
Brain-disease, brain-behaviour, and structural-functional relationships
We tested whether the activity related to motor imagery of gait was correlated with 
clinical characteristics (disease severity, disease duration, and freezing severity). We 
considered the significant between-groups effects obtained in the second level 
analysis of the imaging data, and correlated subject-specific beta values (relative to 
the contrast motor imagery minus visual imagery) with the UPDRS score, disease 
duration, and NFOG-Q score, using Pearson’s correlation with an alpha-level set at 
p<0.05. We took part 2 of the NFOG-Q score, looking at severity of FOG.  
We also examined whether the activity in motor-imagery related areas was correlated 
to the kinematic characteristics of gait movements, and whether this effect was 
different between the three groups. We only considered effects that were robust to 
the removal of potential outliers (Z-score above/below 2.5 units). We considered the 
significant between-groups effects obtained in the second level analysis of the 
imaging data, and we used a generalized linear model with subject-specific beta 
values (relative to the contrast motor imagery minus visual imagery) as a dependent 
variable, fixed factor of ‘group’ and the gait parameters as covariates. The generalized 
linear model uses the Wald statistic with chi-square distribution, to be able to compute 
the individual contribution of predictors.125 If a significant effect (p < 0.05) was found, 
post hoc univariate ANOVA was performed on the different groups with the gait 
parameter as a covariate.
In addition, we evaluated whether the between-group differences in imagery-related 
activity was associated with structural differences, performing a voxel-based morpho metry 
analysis.22 We tested whether there were  between-groups differences in grey matter, 
white matter, or cerebral spinal fluid volume (CSF) (analysis 1: Controls versus patients; 
analysis 2: Freezers versus non-freezers). We assessed regional differences, as well as 
differences over regions of interest based on the results of the whole brain fMRI analyses 
(mesencephalic locomotor region, Table 3), testing for the relevance of structural 
differences by correlating them to the magnitude of the functional differences (i.e., beta 
weigths for the MI vs VI contrast). Statistical inference was performed at the voxel level, 
with a family-wise error correction for multiple comparisons (p < 0.05). For further details 
on the voxel-based morphometry analysis, see the supplementary material.
Anatomical inference 
Anatomical details of significant signal changes were obtained by superimposing the 
statistical parametric maps (SPMs) on the anatomical sections of a representative 
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subject of the MNI series. The atlas of Duvernoy was used to identify relevant 
anatomical landmarks.106 The SPM Anatomy Toolbox was used for regions where cyto-
architectonic maps were available.108;330 We used the WFU PickAtlas Tool version 2.4 to 
translate MNI into Talairach coordinates (where necessary for relating our findings to 
existing literature). To define coordinates of mesencephalic locomotor regions, we 
used maps and coordinates.109;200;402 The functional labelling of premotor cortical areas 
was based on Mayka et al 2006247 and Picard et al 1996.304
Results 
During electrophysiological gait testing patients had a smaller step length and an 
increased temporal gait asymmetry compared to controls (Table 2). 
Behavioural results
Imagery times are shown in Figure 2; statistical values in Table 3. During the motor 
imagery experiment, none of the freezers experienced ‘imagined’ FOG. Although 
non-freezers were numerically slower than freezers (and controls) across both imagery 
tasks, imagery times for VI and MI were not statistically different between groups (no 
effect of “Group”, Table 3, Figure 2). In addition, there was no difference between MI 
and VI (no effect of “Task”, Table 3). The effect of task on imagery times did not differ 
between groups (no “Task*Group”  interaction, Table 3, figure 2B) and showed that all 
groups performed the imagery adequately. First, there was an effect of increasing 
path length in both tasks, and this effect was not different between groups (significant 
effect “Path Length” and no interaction “Group*Path Length”, Table 3, Figure 2A). 
Table 2   Gait data
Parameter Group Mean SD P-value
Normalized  
step-length
Patients
Controls
0.71
0.78
0.08
0.08
0.009
Freezers
Non-Freezers
0.66
0.73
0.15
0.07
0.17
Gait asymmetry Patients
Controls
0.036
0.015
0.027
0.011
0.003
Freezers
Non-Freezers
0.040
0.033
0.027
0.029
0.5
Normalized step length: Step length / leg length
Gait asymmetry: Natural logarithm (ln) of the difference in swingtime between the feet  
Statistical test: independent samples t-tests.
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Second, the effect of path width on imagery times differed for the different tasks, 
which was not different between groups (significant “Task*Path Width” interaction, 
no interaction “Task*Path Width*Group, Table 3, Figure 2B). A smaller path width 
resulted in longer imagery times in the MI task (F(1,42) = 17.7, p < 0.001), but had no 
effect on imagery times in the VI task (F(1,42) = 0.4, p = 0.52). Actual and imagined 
walking times were significantly correlated, both in controls (Spearman’s rho = 0.78, p 
< 0.001) and in patients (rho = 0.54, p<0.001). The correlation was also significant for 
the freezer and non-freezers subtype separately (freezers: rho = 0.77, p < 0.001, 
non-freezers: rho = 0.53, p < 0.001).  
Electromyography
There were no differences in EMG activity between VI and MI (effect “Task” F(1,43) = 
1.7, p = 0.20). Patients showed more EMG activity than controls (effect “Group” F (1,43) 
= 5.4, p = 0.03). Crucially, there were no differences in EMG activity between the two 
groups (controls, patients) across tasks (analysis 1: “Task*Group” interaction: F(1,43) = 
1.3, p = 0.26), nor between freezers and non-freezers across task (analysis 2: 
“Task*Group” interaction: F(1,22) < 1, p = 0.50). Hence, differences in actual movements 
(related to tremor or overt leg movements during motor imagery of gait) did not 
account for changes in differential (MI compared to VI) cerebral activity between 
groups.
Cerebral activity during motor imagery of gait for each group
Controls and patients (analysis 1)
We could confirm the presence of significant motor imagery effects in controls 
(cMI>cVI) in those areas previously reported in young healthy controls28 [cMI>cVI; 
Table 3   Behavioural performance (between-groups comparisons on imagery times)
Effect: Patients versus Controls Freezers versus Non-freezers
F (df) p-value F (df) p-value
Group < 1 (1,43) 0.35 3.7 (1,22) 0.07
Task (MI vs VI) 1.3 (1,43) 0.26 2.5 (1,22) 0.13
Task*Group 2.3 (1,43) 0.13 < 1 (1,22) 0.44
Path length 69.8 (4,172) < 0.001 62.1 (4,88) < 0.001
Path length * Group 1.5 (4,172) 0.23 2.8 (4,88) 0.61
Task*Path width 17.5 (1,43) < 0.001 8.8 (1,22) 0.007
Task*Path width*Group < 1 (1,43) 0.734 < 1 (1,22) 0.80
MI = motor imagery; VI = visual imagery
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region of interest analysis; left and right supplementary motor area, left and right 
superior parietal lobule, right anterior cingulate lobule, left putamen; for statistical 
data see supplementary material]. In the patient group, there was a significant effect 
of motor imagery in the right supplementary motor area [pMI>pVI; region of interest 
analysis, see supplementary material – Table 1]. Furthermore, a post-hoc analysis 
assessing the cerebral effects evoked during MI of walking (as compared to the 
baseline provided by the inter-trial epochs) revealed clear responses in other portions 
of the known locomotor network,188 in particular cerebellar and striatal regions, in 
both patients and controls (Supplementary material - section 8, Table 2, Figure 2).
Non-freezers and freezers (analysis 2)
In non-freezers, activity in both the right and the left supplementary motor area was 
larger during motor imagery than during visual imagery [nfMI>nfVI; region of interest 
Figure 2   Behavioural performance during scanning 
Average imagery times (±SEM) measured in freezers, non-freezers and controls. MI = motor imagery, 
VI = visual imagery. A) Imagery times for trials with different path lengths [2, 4, 6, 8, and 10 m] and B) for trials 
with different path widths [broad, narrow].
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analysis; see supplementary material]. In freezers, none of the areas previously 
reported were significantly activated during motor imagery [fMI>fVI; region of interest 
analysis], but whole-brain analysis revealed a strong effect in the posterior mid-mes-
encephalon (mesencephalic locomotor region, local maximum [2 -30 -18], cluster-size 
= 330, Z = 5.2, p (cluster-level corrected) = 0.004).
Differential cerebral activity during motor imagery of gait across groups
Controls and patients (analysis 1)
ROI analysis of the differential motor imagery-related activity of controls compared to 
patients [(cMI>cVI) > (pMI>pVI)], revealed a reduced activity in patients compared to 
controls in the superior parietal lobule (Brodmann areas 5L and 7) and in the anterior 
cingulate cortex (caudal cingulate motor area, Brodmann area 24) (Figure 3; Table 4).304;330
Non-freezers and freezers (analysis 2)
Comparing non-freezers to freezers [(nfMI>nfVI) > (fMI>fVI); region of interest analysis], 
there was no above-threshold between-group difference, although there was a 
statistical trend towards increased activity in non-freezers compared to freezers in the 
left supplementary motor area (Brodmann area 6) and the right superior parietal 
lobule (Figure 3 and 4; Table 4).
Comparing freezers to non-freezers [(fMI>fVI) > (nfMI>nfVI); whole brain analysis], 
there was increased imagery-related activity in the posterior mid-mesencephalon of 
freezers (Figure 4; Table 4).
The maximum of the cluster was located dorsomedial to the pedunculopontine 
nucleus, just including the pedunculopontine nucleus.402 The cuneiform nucleus and 
the periaqueductal grey were included in the cluster.109;200 The locus coeruleus is 
located on the lower-dorsal border of our cluster.200 The mesencephalic locomotor 
region is a neurophysiologically defined region which includes the pedunculopon-
tine nucleus, cuneiform nucleus, periaqueductal grey and locus coeruleus.194 The 
activity we found most likely includes several nuclei of the mesencephalic locomotor 
region, especially the cuneiform nucleus and the periaqueductal grey.
Specific effects of environmental constraints on cerebral activity during motor imagery
We found no significant differential activity for motor imagery of gait along a narrow 
compared to a broad path, nor was there a “Group*Task” interaction for Path width.
Brain-disease, brain-behaviour, and structural-functional relationships
Differential mesencephalic locomotor region activity in freezers (MI minus VI) 
correlated to FOG severity as measured by part 2 of the NFOG-Q (Figure 5A, r = 0.60, 
p = 0.041). Mesencephalic locomotor region activity correlated to disease duration, 
only significantly when taking both patient groups into account (Figure 5B, freezers r 
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= 0.53, p = 0.08, all patients r = 0.58, p = 0.003). Motor imagery-related activity (MI>VI) 
in the supplementary motor area was associated with greater step length (General 
linear model effect STEP LENGTH Wald χ2 = 41.0, p < 0.001, Post-hoc ANOVA showed a 
significant relation between supplementary motor area activity and step length in 
controls (F(1,14) = 9.6, r2 = 0.38, p = 0.01) but not in freezers (F(1,8) < 1, r2 = 0.10, p = 0.71 
after removal of outlier) or non-freezers (F(1,9) = 2.9, r2 = 0.26, p = 0.12. Motor imagery-
related activity (MI>VI) in the mesencephalic locomotor region, superior parietal 
lobule or cingulate motor area was not associated with step length or gait asymmetry. 
There were no differences in global grey matter (GM), white matter (WM), or CSF 
Figure 3   Imagery-related brain activity 
Brain areas in which the relative increase in activity for motor imagery (MI) versus visual imagery (VI) was 
greater in controls than patients (region of interest analysis, p < 0.05 corrected for multiple comparisons 
using family-wise inference on voxel level). A) Statistical parametric maps of increased activity in the 
right superior parietal lobule and right anterior cingulate cortex (cingulated motor area), superimposed 
on a sagittal brain section (top: cingulate motor area, bottom: superior parietal lobule) B) Beta weights 
of the contrast between motor imagery and visual imagery (mean ± SEM) from right caudal cingulate 
motor area cluster (top) and the right superior parietal lobule cluster (bottom) in controls, non-freezers 
and freezers. PD = Parkinson’s disease; F = freezers; NF = non-freezers; * = p < 0.05.
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volume between groups (patients versus controls; freezers versus non-freezers) (VBM 
Analysis 1: GM: F(1,41) = 0.753, p = 0.391; WM: F(1,41) = 0.215, p = 0.645; CSF: F(1,41) = 
0.329, p = 0.569;  Analysis 2: GM: F(1,20) = 0.401, p = 0.534; WM: F(1,20) = 0.321, p = 
0.577; CSF: F(1,20) = 0.406, p = 0.531). The analysis of regional volume differences 
between groups did not show any differences in local grey matter, white matter or 
CSF between groups at a whole-brain corrected threshold of p < 0.05. When focusing 
on the mesencephalic locomotor region cluster found in the comparison between 
Figure 4   Imagery-related brain activity 
Brain areas in which the relative increase in activity for motor imagery (MI) versus visual imagery (VI) 
differed between freezers and non-freezers (Supplementary motor area: region of interest analysis, p = 
0.06 corrected for multiple comparisons using family-wise inference on voxel level; Mesencephalic 
locomotor region: whole brain search, p < 0.05 corrected for multiple comparisons using family-wise 
error (cluster-level).  A) Statistical parametric map of decreased activity in the supplementary motor area 
and increased activity in the mesencephalic locomotor region, superimposed on a sagittal brain section 
(top-left: supplementary motor area, middle-left: mesencephalic locomotor region) and a transversal 
brain section (top-right: supplementary motor area, middle-left: mesencephalic locomotor region). The 
bottom brain sections include the small cluster with significant difference in grey matter between 
freezers and non-freezers in the mesencephalic locomotor region B) Beta weights of the contrast 
between motor imagery and visual imagery (mean ± SEM) from the supplementary motor area cluster 
(top panel) and the mesencephalic locomotor region cluster (bottom panel) in controls, non-freezers 
(NF) and freezers (F). 
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freezers and non-freezers [(fMI>fVI)>(nfMI>nfVI)], there was a significantly larger grey 
matter volume in the latter group [2, -33, -18; Z = 2.89, p (voxel-level corrected) = 
0.028, Figure 4, Figure 1 Supplementary Material]. The magnitude of this structural 
difference did not correlate to FOG severity (r = 0.28, p = 0.37). Crucially, the gait-related 
difference found in the mesencephalic locomotor region did not correlate to the 
proportion of grey matter in this same region (MI vs VI; r = 0.17, p = 0.60, Figure 5C). 
This indicates that differential brain atrophy between the freezers and non-freezers 
groups cannot account for the gait-related differences we observed in this region.
Table 4   Stereotactic coordinates of local maxima with differential cerebral activity 
during motor imagery of gait across groups
Contrast Search 
volume
Anatomical 
label
Functional 
label
Cluster 
size
Hemi-
sphere
Z-value p-value x y z
Analysis 1: Controls versus Patients
(cMI>cVI )  
>  
(pMI>pVI) ROI
Superior parietal 
lobule
Area 5L 144 R 3.1 0.019 14 -58 66
Ant. cingulate 
cortex
Area 24 65 R 3.0 0.025 2 2 40
Analysis 2: Non-freezers versus Freezers
(nfMI>nfVI) 
 >  
(fMI>fVI) ROI
Superior parietal 
lobule
Area 5L 93 R 2.6 0.074 22 -50 72
Superior frontal 
gyrus
SMA 64 L 2.6 0.061 -10 -16 72
(fMI>fVI) 
 >  
(nfMI>nfVI)
Whole-
brain
Posterior  
mid-
mesencephalon
Mes-
encephalic 
locomotor 
region
170 4.5 0.049 0 -28 -20
Results of whole-brain analysis are corrected for multiple comparisons for search over the whole brain 
using cluster-level family-wise inference (p<0.05). 
Results of ROI analysis are corrected for multiple comparisons over the ROI volume using voxel-level 
family-wise inference (p<0.05). 
Stereotactic coordinates are reported in Montreal Neurological Institute (MNI) space. Details on the 
anatomical and functional labelling can be found in the Methods and Results sections.
 c = controls; f = freezers; nf = non-freezers; MI = motor imagery; VI = visual imagery; R = right; L = left; SMA 
= supplementary motor area
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Figure 5   Brain-disease and structural-functional relationships 
Relation between differential cerebral activity and clinical/structural parameters in freezers. A) Scatterplot 
of beta weights of the contrast between motor imagery (MI) and visual imagery (VI) from the mesencephalic 
locomotor region (MLR) cluster (y-axis) against score on the New Freezing of Gait Questionnaire part 2 
(N-FOGQ; x-axis; Pearson’s correlation r = 0.60, p = 0.04) B) Scatterplot of beta weights of the contrast 
between motor imagery and visual imagery from the mesencephalic locomotor region cluster (y-axis) 
against disease duration (in years; x-axis; r = 0.53, p = 0.08) C) Scatterplot of beta weights of the contrast 
between motor imagery and visual imagery from the mesencephalic locomotor region cluster (y-axis) 
against grey matter volume (in millilitre) of the same cluster (x-axis; r = -0.17, p = 0.44).
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Discussion 
We used motor imagery to investigate alterations in cerebral activity related to 
planning of walking in PD patients with or without FOG. We showed that the 
mesencephalic locomotor region, just dorsomedial to the pedunculopontine nucleus, 
contributed to motor imagery of gait in freezers but not in non-freezers or controls. 
This altered cerebral activity was not confounded by the effects of altered motor 
execution, somatosensory processing, task performance or brain atrophy, and it was 
related to subjective FOG severity. In addition, controls and non-freezers recruited the 
supplementary motor area during motor imagery of gait, while freezers did not. 
Freezers and non-freezers, taken together, showed less motor imagery-related activity 
in the superior parietal lobule (Brodmann areas 5L and 7) and in the anterior cingulate 
cortex (Brodmann area 24) than controls.
Increased gait-related activity
Mesencephalic locomotor region
PD patients with FOG solved the motor imagery task by evoking additional activity in 
the posterior mid-mesencephalon. This region includes several components of the 
mesencephalic locomotor region, namely the pedunculopontine nucleus, the 
cuneiform nucleus and the periaqueductal grey. The pedunculopontine nucleus has 
been implied in the pathophysiology of akinesia and gait disorders in PD, based on 
several observations. In animal experiments and human case studies, lesions of the 
pedunculopontine nucleus yield akinesia, while stimulation or disinhibition of the pe-
dunculopontine nucleus alleviates akinesia.243;299;305;351 Direct electrical stimulation of 
the pedunculopontine nucleus in humans has so-far resulted in only modest and 
non-significant effects on gait.122 Analysis of electrode positions among the few 
patients that received the greatest benefit from pedunculopontine nucleus 
stimulation suggested that a more posterior stimulation may afford greater beneficial 
effects on gait.122;310 In another study, this more posterior part of the mesencephalon 
was activated by mimicked gait in PD patients.303 Those findings suggest that either 
the pedunculopontine nucleus lies more posterior than previously suspected, or that 
the subcuneiform/cuneiform nucleus was stimulated. The cluster found in the present 
study included the pedunculopontine nucleus, with the local maximum located in 
the cuneiform nucleus, and reaching the periaqueductal grey, a structure severely 
affected by PD.57;404 We also found grey matter atrophy in the mesencephalic 
locomotor region in freezers compared to non-freezers, although this did not account 
for the differences in gait-related mesencephalic locomotor region activity. Taken 
together, these observations suggest that the mesencephalic locomotor region, and 
in particular the cuneiform nucleus and the periaqueductal grey, may be involved in 
FOG.
141
4
GAIT-RELATED CEREBRAL CHANGES IN FREEZING OF GAIT
Compensation or pathology?
The mesencephalic locomotor region is recruited during actual gait in humans.161 
Output from this structure is likely inhibited during motor imagery of gait, to prevent 
the mesencephalic locomotor region from driving the actual walking generators.196 
Accordingly, the increased gait-related mesencephalic locomotor region activity we 
observed in PD patients with FOG may be pathological, reflecting a decreased 
inhibition from the basal ganglia. Other findings support this interpretation. First, 
increased mesencephalic locomotor region activity was associated with higher 
subjective FOG severity scores. Second, the magnitude of mesencephalic locomotor 
region activity evoked during motor imagery of gait was correlated to disease 
duration. This finding fits with the observation that longer disease duration increases 
the likelihood of developing FOG,234 with the mesencephalic locomotor region 
becoming more affected as PD progresses.57 Third, ischemic lesions in the dorsomedial 
mesencephalic locomotor region cause gait ataxia, but not a hypokinetic-rigid gait.163 
However, if gait-related activity in the mesencephalic locomotor region of freezers were 
exclusively pathological in nature, then how could freezers have solved the task as 
adequately as non-freezers and controls, despite their altered cortical responses during 
imagery of gait? This could point to a possible compensatory role of the mesencephalic 
locomotor region. This possibility is supported by recent findings, showing increased 
mesencephalic locomotor region activity when healthy controls perform motor imagery 
of gait involving frequently repeated periods of gait initiation and termination, but less 
prominent activation during stable gait.213 The latter finding fits with the absence of 
gait-related mesencephalic locomotor region activity in our controls, who also imagined 
a stable gait. Crucially, we showed that patients with FOG deviate from this pattern, 
showing strong mesencephalic locomotor region activity even during imagery of stable 
gait. This observation also fits with the increased mesencephalic locomotor region elec-
trophysiological activity observed in freezers during mimicked stepping movements.303 
Taken together, these findings suggest that the mesencephalic locomotor region might 
play both a compensatory and a pathological role, dependent on the computational 
demands imposed on this structure and on disease progression. We speculate that early 
in the disease, possibly even at a pre-symptomatic stage,63 medial frontal areas 
(supplementary motor area) of prospective freezers fail to regulate step length. At 
such early stages, increased mesencephalic locomotor region activity could play a 
compensatory role, supporting gait planning and execution. However, the mesencephalic 
locomotor region ability to control gait may be limited, especially when the structure 
becomes more severely affected with disease progression. Additional requirements to 
finely adapt gait parameters to time-varying demands, as during turning and step 
initiation, might then lead to a collapse of this compensatory system. This scenario would 
reconcile a compensatory role of the mesencephalic locomotor region during stable gait, 
with a pathological contribution under more demanding circumstances. 
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Decreased gait-related cortical activity
Cingulate and supplementary motor areas
Gait-related activity in the caudal cingulate motor area was decreased in PD patients 
compared to controls.  The caudal cingulate motor area is involved in updating and 
switching action plans.170;324 We suggest that alteration of gait-related cingulate motor 
area activity might create a pre-condition for the manifestation of FOG, limiting the 
ability of PD patients to switch between motor programs. This is especially required 
by situations that require rapid gait adjustments like turning and step initiation.
Failures in additional gait-related cerebral structures may be necessary to actually 
evoke FOG. One example is the supplementary motor area. Differently from controls 
and non-freezers, PD patients with FOG solved the motor imagery task without 
evoking additional activity in the supplementary motor area, as compared to a visual 
imagery control task. The observed cluster falls within the portion of the supplementary 
motor area concerned with leg movements.128 Hypoactivity in the supplementary 
motor area is associated with hypokinesia in PD,271;325 and movement amplitude in PD 
patients improves when supplementary motor area activity is normalized (e.g. after 
medication, motor cortex stimulation, or deep brain stimulation).31;120;271;358 Furthermore, 
decreased supplementary motor area activity is related to higher cadence and 
decreased step length in PD patients.161 Accordingly, in this study we show a relation 
between brain activity in the supplementary motor area (during motor imagery) and 
step length (during actual walking outside the scanner). These findings suggest that 
the decreased supplementary motor area activity observed in freezers may be related 
to altered regulation of step amplitude. The emphasis here is on abnormal regulation, 
since freezers could produce step amplitudes largely overlapping with those of 
non-freezers and controls. As such, this finding qualifies the hypothesis that a failure 
to generate steps of adequate amplitude could lead to a progressive decrease in step 
amplitude, and ultimately produce FOG.76
Superior parietal lobule 
During motor imagery of gait, cerebral activity in the right superior parietal lobule 
was reduced in patients compared to controls. This confirms previous SPECT findings 
related to gait execution in PD.161 We suggest that the reduced activity in the superior 
parietal lobule of PD patients during imagery of gait underlies their difficulty in 
predicting the somatosensory consequences of a motor plan.42;390 This interpretation 
fits with the known impairments of PD patients in integrating proprioceptive 
information into a motor plan.12;198;225
Interpretational issues
Patients were classified as ‘freezers’ when there was an evident history of FOG. All 
freezers reported the characteristic gluing of the feet, and recognised the typical 
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phenotype when this was demonstrated to them. Most patients also showed FOG 
during neurological examination. We included patients with relatively mild FOG, as 
this facilitated a proper match between freezers and non-freezers with respect to 
disease severity and duration. This may explain why three patients with mild freezing 
did not demonstrate FOG during clinical examination, despite convincing subjective 
accounts of FOG. Post-hoc exploratory analyses suggested that the mesencephalic 
locomotor region activation in these patients without objective FOG was intermediate 
between fully overt freezers and non-freezers, perhaps reflecting a spectrum of 
severity (data not shown).
All three groups performed the task proficiently, without overall differences in 
imagery times between groups. Non-freezers showed a trend towards slower imagery 
times, but this included both the motor imagery and visual imagery task. Hence, this 
tendency for different imagery times cannot explain the differential (MI>VI) functional 
brain activity. Moreover, in all groups imagery times were equally sensitive to the 
length and width of the path and correlated to actual walking times. These findings 
indicate that both patients and controls were equally effective in solving the motor 
imagery task. This excludes task difficulty as an explanation for between-group 
cerebral differences during motor imagery. 
The basal ganglia are affected in PD, and are involved in motor imagery of gait in 
young healthy subjects.28 Moreover, other studies have suggested that failure of the 
caudate nucleus may contribute to FOG.37 However, we found no differences in 
cerebral activity in the basal ganglia between patients and controls.  This is likely a 
sign of the extreme selectivity of our functional comparison (MI vs. VI), rather than a 
lack of sensitivity (see Supplementary Table 2, Figure 2).
Conclusions
We have shown that PD patients with FOG performing motor imagery of gait use 
different cerebral structures than matched PD patients without FOG or healthy 
controls. These cerebral differences were observed in the context of matched 
behavioural performance across groups, and could not be explained by brain atrophy. 
During imagined walking, patients with FOG showed increased activity in the 
mesencephalic locomotor region, which was related to subjective FOG severity. In 
addition, patients with FOG tended to have reduced activity in mesial frontal and 
posterior parietal regions. These findings provide new insights into the pathophysiol-
ogy of FOG: the cause of FOG may be altered cortical regulation of movement 
execution, together with a progressively impaired ability of mesencephalic structures 
to flexibly compensate for that alteration. This may explain the manifestation of FOG 
during changes in motor behaviour, such as turning or initiating walking. These gait 
adaptations not only require a switch of motor program, but also more precise 
regulation of step length and gait timing.
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1. Tasks
Subjects performed two tasks: motor imagery of gait, and a matched visual imagery 
control task. Both tasks started with the presentation of a photograph showing a 
corridor with a path in the middle (Fig. 1). During the motor imagery task (MI), subjects 
were asked to imagine walking along this path. During the visual imagery task (VI), 
subjects were asked to imagine seeing a disc moving along the path. A MI trial started 
with the presentation of a photograph with a green square as a start marker (Fig. 1a). 
Subjects were asked to briefly inspect the picture, close their eyes, imagine walking 
along the path (starting from the green square and stopping at the green pillar) and 
open their eyes when they imagined having reached the green pillar (see Fig. 1b for 
trial time course). Subjects were instructed to vividly imagine the walking movement, 
in a first person perspective, as if their legs were moving, but without making any 
actual movements. A VI trial started with the presentation of a photograph with a 
black disc as start marker (Fig. 1a). Subjects were asked to briefly inspect the picture, 
close their eyes, imagine standing on the left side of the beginning of the path and 
seeing the disc moving towards the green pillar, and to open their eyes when they 
imagined the disc reaching the green pillar. During both tasks, the path could have 
two different widths (narrow, broad). In addition, the green pillar could be placed at 
five different distances from the green square or the black disc (2, 4, 6, 8, and 10 m). 
During each trial, subjects signalled that they had started and stopped the imagery 
by pressing a button. Patients pressed the button with their least affected hand (17 
left, 8 right). Controls were matched to the patients: i.e. 14 controls pressed the button 
with their left hand and 7 with their right hand. Also the freezer and non-freezer 
groups were matched (freezers: 9 left, 4 right ; non-freezers: 8 left, 4 right). We explicitly 
instructed subjects not to count during the imagery tasks.
2. Experimental procedure 
During the experiment, subjects were lying supine in the MR scanner. Visual stimuli 
were presented by means of a PC running Presentation software (Neurobehavioural 
systems, Albany, USA), and were projected onto a screen at the back of the scanner. 
Subjects could see the screen via a mirror above their heads. 
The MI and VI tasks were performed in two successive sessions of 25 minutes each, 
separated by a break outside the scanner. Task order was counter-balanced across 
subjects. For each session, the trial order was pseudo-randomized across the 
experimental factors (i.e. path width (2 levels) and path length (5 levels)). We used two 
fixed pseudo-randomized orders that were counterbalanced across the two tasks. In 
between trials a fixation cross was presented (inter-trial interval, ITI: 4-12 sec).
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Before each session, subjects were given written and verbal instruction about the task 
they were going to perform, followed by training in the relevant task outside the 
scanner (15 trials) and inside the MR-scanner (first session only, 7 trials). Prior to the MI 
task, subjects were asked to walk along short versions (three meters) of the same 
broad and narrow paths used in the MI task (3 times for each path width), at a 
comfortable pace, avoiding to place their feet outside the path. We instructed 
subjects to pay attention to the feeling of walking along the different path widths, 
and to imagine walking in a similar way along the two different paths during the 
imagery trials. To familiarize subjects with the movement of the disc, prior to the VI 
task, they saw a video of the disc moving through the same corridor as in the 
photographs. The disc moved for 6 m, in a straight line, at a uniform speed of about 
0.8 m/s. We instructed subjects to imagine seeing the disc moving in a similar way 
along the two different paths during the imagery trials. 
3. Data collection
Button presses were recorded with an MR-compatible keypad (MRI Devices, Waukesha, 
WI) positioned on the subjects’ abdomen. 
MR images were acquired on a Siemens 3T Trio system (Siemens, Erlangen, Germany), 
using an 8 channel head coil for signal reception and a body coil for radio-frequency 
transmission. Blood oxygenation level-dependent (BOLD) sensitive functional images 
were acquired using a single shot gradient EPI sequence (TR/TE = 2380 ms/30 ms; 50 
ms gap between successive volumes; 35 transversal slices; ascending acquisition; 
voxel size 3.5 x 3.5 x 3 mm; FOV = 224 mm). High-resolution anatomical images were 
acquired using an MP-RAGE sequence (TR/TE = 2300/2.92 ms, 192 sagittal slices, voxel 
size 1.0 x 1.0 x 1.0 mm, FOV = 256 mm). 
Eye movements were measured with a video-based infrared eyetracker (Sensomotoric 
Instruments, Berlin, Germany). These measures allowed us to have online visual 
inspection of task performance.
4. EMG recordings, preprocessing and subsequent analyses
A concern that arises when comparing cerebral activity during motor imagery of gait 
in patients versus controls is that differences in actual movements (related to tremor 
or overt leg movements during motor imagery of gait) might result in changes in 
cerebral activity between patients and controls. To control for these factors, muscle 
activity from the forearm and lower leg was measured during the fMRI experiment. 
Muscle activity was recorded with an MR compatible EMG (electromyography) system 
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(Brain Products GmBH, Gilching, Germany). Silver/silver-chloride electrodes were 
placed three cm apart on the tibialis anterior and extensor carpi radialis in a belly 
tendon montage. Ground electrodes were placed on the lateral malleolus and on the 
head of the radius. For patients this was done at the side which displayed the most 
severe tremor (13 right, 6 left). The side of recording in control subjects was matched 
to the patients (14 right, 7 left).
Offline MR artefact correction followed the method described earlier10;370 including 
low-pass filtering (400 Hz), and down-sampling (1000 Hz). Subsequently, we applied 
high-pass filtering (25 Hz, to remove possible movement artefacts) and rectification. 
We used the EMG recordings from the leg muscle to control for overt leg muscle 
movements. We considered the root mean square (rms) of the EMG signals measured 
during the imagery time (imagery epoch) and during the ITI (inter trial epoch) for 
each trial of the imagery experiment. For each subject, the average rms value of the 
EMG measured during the imagery time epoch was normalized to the average rms 
value of the ITI epoch, testing for an effect of GROUP (PD, controls) and TASK (MI, VI) 
with a repeated measures ANOVA. 
We used the EMG recording of the forearm muscle to correct for tremor related 
cerebral activity in the fMRI data. First, the whole EMG time series was segmented 
(one segment for each EPI volume). Subsequently a time frequency analysis was 
performed. That is, we calculated (for each segment) EMG power between 0 – 20 Hz. 
The peak frequency between 4 and 6 Hz. (i.e. the frequency corresponding to the rest 
tremor) was determined for each individual subject after visual inspection of the 
average power spectrum. Subsequently, the EMG power at this frequency was 
extracted in Matlab (MathWorks, Natick, MA) using the FieldTrip toolbox for EEG/MEG 
analysis (www.ru.nl/neuroimaging/fieldtrip). We also calculated the EMG amplitude 
and we log-transformed the EMG power to minimize outliers, leading to three 
tremor-related EMG regressors (power, amplitude and log of power). Last, we applied 
a z-transformation to each of these three regressors and convolved them with the 
hemodynamic response function (hrf ), before adding them to our statistical model. 
5. Preprocessing of imaging data
Functional data were pre-processed and analyzed with SPM5 (Statistical Parametric 
Mapping, www.fil.ion.ucl.ac.uk/spm).  The first four volumes of each patient’s data set 
were discarded to allow for T1 equilibration. The remaining functional volumes were 
spatially realigned using a least squares approach and a 6 parameter (rigid body) 
spatial transformation.136 Subsequently, the time-series for each voxel was temporally 
realigned to the acquisition of the first slice. Images were normalized to a standard EPI 
template centered in MNI (Montreal Neurological Institute) space 21 and resampled at 
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an isotropic voxel size of 2 mm. The normalized images were smoothed with an 
isotropic 10 mm full-width-at-half-maximum Gaussian kernel. 
Anatomical images were spatially coregistered to the mean of the functional images,21 
spatially normalized by using the same transformation matrix applied to the functional 
images and finally segmented into grey matter, white matter, CSF and other nonbrain 
partitions.23
6. First level statistical analysis of imaging data 
The ensuing pre-processed fMRI time series were analyzed on a subject-by-subject 
basis using an event-related approach in the context of the General Linear Model.136 
The model was aimed at finding regions in which the cerebral response changed as a 
function of TASK (MI, VI) and/or PATH WIDTH. PATH LENGTH was also considered in the 
analysis, which gave rise to a model with twenty different regressors of interest. The 
model also included separate regressors of no interest, modelling BOLD activity 
evoked by picture inspection, button presses, and incorrect trials, separately for each 
session. Each effect was modelled on a trial by trial basis as a concatenation of 
square-wave functions convolved with a canonical haemodynamic response function, 
down sampled at each scan, generating a total of 26 task-related regressors.134 For the 
regressors of interest, onsets of the square-wave functions were time-locked to the 
button press marking the onset of imagery, and durations corresponded to the 
imagery time of each separate trial (eg. time between the two button presses). For 
the picture inspection regressors, onsets were time locked to the onset of picture 
presentation, and offsets were time-locked to the button press marking the onset of 
imagery. For the button press regressor, onsets were time locked to the button press 
marking the offset of imagery, and duration was set to zero. For the incorrect trials 
regressor, onsets were time locked to the onset of picture presentation, and offsets 
were time-locked to the button press marking the offset of imagery. The potential 
confounding effects of residual head movement-related effects were modelled using 
the time series of the estimated head movements during scanning. We included the 
original time series, the squared, the first-order derivatives of the originals and the 
first-order derivatives of the squared.232 The intensity changes attributable to the 
tremor-related movements through the magnetic field were accounted for by using 
the time series of the mean signal from the white matter, cerebral spinal fluid and out 
of brain voxels.377 Finally, the three EMG regressors of the arm muscle (power, 
amplitude and log transformation of the power) were modelled,171 and the data was 
high-pass filtered (cut-off 128 s) to remove low-frequency confounds such as scanner 
drifts. 
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7. Details on region of interest analysis
Besides the whole brain analysis, statistical inference was also performed on regions 
of interest that were based on our previous study in healthy controls.28 More precisely, 
we considered the maximum coordinates of the clusters that were previously found 
to be significantly activated in the following contrasts: 1) MI>VI; and 2) MI-narrow>MI-
broad, masked with (MI-narrow>MI-broad) > (VI-narrow>VI-broad). 
This concerned the following coordinates [x y z]:
1) MI>VI:    
 i. Superior frontal gyrus left:   [-12 -10  68]
 ii. Superior frontal gyrus right; [16  -12  74]
 iii. Anterior cingulated gyrus: [6  0  46]
 iv. Superior parietal lobule left [-16 -58 60]
 v. Superior parietal lobule right [20 -56 68]
 vi. Putamen [-24 -4 8]
2) MI-narrow>MI-broad
 i. Superior parietal lobule left [-16  -50 64]
 ii. Superior parietal lobule right [16 -54 64]
 iii. Middle occipital gyrus [56 -70 -12]
The set of coordinates obtained from contrast 1) were used for the analyses considering 
the effects of TASK and GROUP, the set of coordinates obtained from contrast 2) were 
used for the analyses considering the effects of PATH WIDTH and GROUP. More 
specifically, we drew spherical ROIs centred at these coordinates with a radius of 8 
mm, using WFU Pickatlas. Statistical inference was performed at the voxel level, with 
a family-wise error correction for multiple comparisons (p < 0.05).
8.  Details on a post-hoc analysis assessing the cerebral 
effects evoked during MI of walking as compared to  
the baseline
The whole-brain and ROI analysis on differential imagery-related effects did not reveal 
activation of the whole known locomotor network in either patients or controls. 
However, this network was not defined using a comparison similar to that used in this 
study (i.e. MI vs. VI). Accordingly, we performed a new analysis more closely matched 
to that used in the studies defining the locomotor network.189;213 More precisely, in 
order to better approximate the comparison between imagining to walk and 
imagining to lie in a horizontal position (as used in previous papers defining the 
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locomotor network ,189;213 we considered the cerebral effects evoked during motor 
imagery of walking as compared to the inter-trial epochs. Whole-brain statistical 
inference was based on the same threshold used in the rest of the paper (FWE 0.05 
cluster-level, on the basis of a >3.4 intensity). When using this approach we could 
clearly observe significant cerebellar and striatal activity in both controls and patients. 
We have added this information to the main text (Results section) and to the 
Supplementary material (Table 2, Figure 2).
9. Details on voxel-based morphometry
Voxel-based morphometry (VBM) analyses were done in SPM8. We segmented the 
anatomical MRI scan of each subject into grey matter, white matter, cerebrospinal 
fluid (CSF), and extra-cerebral compartments (e.g. out-of-brain, skull, skin). We used 
the DARTEL toolbox20 to create a group-specific anatomical template and register all 
individual images to this template. All images were subsequently normalized to MNI 
space, while correcting for volume changes induced by normalization (ie. modulation). 
Last, we smoothed all images using a kernel of 8 mm FWHM. 
Global (differences) in grey matter volume and white matter volume were quantified 
by integrating the tissue probabilities over all voxels. In order to avoid possible edge 
effects around the border between grey and white matter, we used an absolute grey 
and white matter threshold of p < 0.15.
Global differences in volume between groups were assessed using a two-tailed 
multivariate linear regression analysis that considered age as a covariate. Regional (i.e. 
voxel-by-voxel) differences in volume between groups were assessed with t-tests 
using the general linear model. We considered age and gender as confounding 
covariates in addition to total grey matter, white matter or CSF volume for the different 
test respectively.154;301 The results were corrected for search volume by using 
family-wise error (FWE) correction (p < 0.05).  We also considered the fMRI cluster in 
the mesencephalic locomotor region (MLR, see main results and Table 4) as a region 
of interests for additional analysis.
152
CHAPTER 4
Supplementary Table 1   
Stereotactic coordinates of the local maxima showing cerebral activity during motor 
imagery of gait for each group
Contrast Anatomical label Cluster 
size
Hemi-
sphere
Z-value p-value x y z
cMI>cVI Superior frontal gyrus 236 L 4.0 0.001 -8 -16 70
Superior frontal gyrus 83 R 3.5 0.006 10 -16 72
Superior parietal lobule 163 L 3.7 0.003 -10 -56 64
Superior parietal lobule 159 R 4.3 < 0.001 12 -56 68
Anterior cingulate gyrus 175 R 3.4 0.008 4 -4 40
Putamen 193 L 3.0 0.023 -16 -4 8
pMI>pVI Superior frontal gyrus 184 R 3.3 0.011 12 -18 74
nfMI>nfVI Superior frontal gyrus 241 R 3.6 0.005 10 -16 72
Superior frontal gyrus 150 L 3.5 0.005 -8 -16 68
fMI>fVI * Posterior  
mid-mesencephalon
330 R 5.2 0.004 2 -30 -18
The results are based on ROI coordinates derived from 28, using voxel-level family-wise inference (p < 0.05).  
* This result is based on whole-brain analysis, using cluster-level family-wise inference.
Stereotactic coordinates are reported in Montreal Neurological Institute (MNI) space. 
c = controls; p = patients; nf = non-freezers; f = freezers; MI = motor imagery; VI = visual imagery; 
R = right; L = left
Supplementary Table 2   
Stereotactic coordinates of the local maxima showing cerebral activity during motor 
imagery of gait versus baseline for controls and patients
Contrast Anatomical label Cluster 
size
Hemi-
sphere
Z-value p-value x y z
cMI > 
baseline
Superior frontal gyrus
Inferior parietal lobule
Supra marginal gyrus
Inferior frontal gyrus
Putamen
Inferior frontal gyrus
Cerebellum (VI, Cr1)
6982
5301
1306
2333
1927
1177
L
L
R
L
L
L
R
R
L
L
L
R
R
R
R
Inf
7.74
7.04
Inf
7.51
7.25
7.81
3.36
7.68
5.99
5.82
6.62
6.38
5.55
6.31
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0
-24
30
-12
-44
-50
48
58
-52
-52
-28
54
58
30
34
0
-8
-6
-70
-46
-38
-36
-42
10
6
18
10
10
22
-54
60
54
60
60
54
50
44
40
2
34
8
10
20
6
-32
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Supplementary Table 2   Continued
Contrast Anatomical label Cluster 
size
Hemi-
sphere
Z-value p-value x y z
Middle frontal gyrus
Middle frontal gyrus
Cerebellum (VI, Cr1)
591
220
232
R
R
L
R
L
5.84
5.85
6.29
4.90
4.65
<0.001
0.029
0.024
46
34
-36
38
-34
60
-50
36
40
-54
-30
-30
32
32
-34
pMI > 
baseline
Superior frontal gyrus
Cerebellum (V1, Cr1, VIIIA)
Cerebellum (VI, CR1, VIIIA)
27984
1097
1098
L
R
L
L
L
L
R
R
R
Inf
Inf
Inf
6.57
4.57
4.32
5.14
5.08
4.96
<0.001
<0.001
<0.001
-2
4
-4
-48
-34
-36
44
32
32
4
-2
-4
-60
-56
-50
-62
-60
-34
58
66
68
-28
-34
-50
-30
-30
-50
The results are based on whole-brain analysis, using cluster-level family-wise inference (p < 0.05). 
Stereotactic coordinates are reported in Montreal Neurological Institute (MNI) space. 
 c = controls; p = patients; MI = motor imagery; R = right; L = left
Supplementary Figure 1   Average tissue type volume within MLR  
Average volume (± SEM) of different tissue classes within the MLR activation blob, determined for freezers 
and non-freezers. 
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Supplementary Figure 2   Motor imagery related brain activity  
SPM(t) maps of increase in activity for motor imagery (MI) versus baseline for patients and controls separately. 
The results are based on whole-brain analysis, using cluster-level family-wise inference (p < 0.05).
MI > baseline
Controls
Patients
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Cycling and freezing of gait
 5|
Video vignette 3
A 58-year old man with a 10-year history of idiopathic Parkinson’s disease presented 
with an incapacitating freezing of gait (video vignette 3). The patient had severe 
difficulties initiating gait and was merely able to take a few shuffling steps when 
provided with a visual cue (the examiner’s foot placed in front of the patient). Attempts 
to walk evolved rapidly into forward festination, and a fall towards the ground. Axial 
turning was impossible. However, his ability to ride a bicycle was remarkably preserved 
(video vignette 3). Gait freezing re-occurred instantaneously after dismounting the 
bicycle. This striking ‘kinesia paradoxica’ may be explained by the rotating pedals that 
possibly acted as an external pacing cue. Alternatively, the motor control mechanisms 
involved in gait and cycling could be affected differentially in Parkinson’s disease. 
Regardless of the explanation, cycling offers a useful approach for rehabilitation and 
exercise training in Parkinson patients grounded by severe freezing of gait.
Published as: 
Snijders AH, Bloem BR. Images in clinical medicine: Cycling for freezing of gait. 
NEJM. 2010; 362(13):e46.

Cycling breaks the ice for freezing of gait 
Published as:
Snijders AH, Toni I, Ruzicka E, Bloem BR. Bicycling breaks the ice for freezers of gait. 
Movement Disorders 2011; 26(3):367-71.
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Summary
Patients with freezing of gait have episodic problems with generating adequate 
steps. This phenomenon is both common and debilitating in patients with Parkinson’s 
disease or atypical parkinsonism. We recently presented a video case of a patient with 
longstanding Parkinson’s disease and severe freezing of gait, who showed a 
remarkably preserved ability to ride a bicycle. Here, we comment on the scientific and 
clinical implications of this single case observation, and show the video of a similar 
case. We first consider several pathophysiological explanations for this striking 
discrepancy between walking and cycling in Parkinson’s disease. We then discuss the 
merits and shortcomings of cycling as a potential new avenue for rehabilitation and 
exercise training in patients grounded by freezing of gait. Finally, we provide some 
directions for future research stimulated by this fascinating observation.
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Background
Patients with freezing of gait (FOG) have episodic problems with generating adequate 
steps.150 FOG is common in patients with Parkinson’s disease (PD) and in the various 
forms of atypical parkinsonism.153;269 The presence of FOG often has great clinical 
implications, with a marked impact on the quality of life.49 Affected patients lose their 
mobility, leading to loss of independence, and also to reduced fitness. In addition, 
FOG frequently leads to falls and injuries,219 because the feet become suddenly and 
unpredictably “glued” to the floor while the trunk continues to move forward. Falls are 
particularly common as patients cannot anticipate the impending falls because of the 
unpredictable nature of the freezing events.
There are several therapeutic options, but generally treating FOG remains difficult for 
most patients (for recent reviews, see:141;235. The mechanisms leading to FOG remain 
poorly understood, and this hampers development of improved treatment strategies.
Case report
Single case observations provide the lowest class of scientific evidence. Yet, a remarkable 
observation in a single patient can sometimes help to advance the field, by generating 
new ideas for further research.373 We recently published a case report of a 58-year old 
man with longstanding PD who was grounded by severe freezing of gait.338 To our 
surprise, this patient manifested a strikingly preserved ability to ride his bicycle, as was 
demonstrated on a video that accompanied our publication. This phenomenon could 
aptly be referred to as “abasia sine abicyclia” (inability to walk, without inability to cycle).
Our observation has since attracted widespread media attention, because of the 
potential implications for research, for delivering exercise therapy to patients who are 
physically inactive because of walking difficulties, and perhaps also because of the 
hope it offers to patients. 
In the video accompanying this chapter, we present another patient with a similarly 
preserved ability to ride a bicycle, despite marked freezing of gait. It concerns a 
57-year-old man who had been treated with bilateral subthalamic nucleus stimulation 
for severe motor fluctuations, 12 years after onset of PD. The home video shows the 
patient’s severe gait disorder, mainly caused by freezing of gait. However, he can 
immediately generate smooth cycling movements as soon as he mounts his bicycle.
Here, we comment in more detail on the possible implications of these intriguing 
case observations.
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Pathophysiological implications
The preserved cycling ability is perhaps a trivial mechanical consequence of the 
regularly rotating pedals: the patient’s legs are passively pushed forward, irrespective 
of the ability to actively initiate each pedalling movement. It is also possible that the 
forces transferred from the rotating pedals to the patient’s feet might provide tactile 
cues that triggered appropriate rhythmic cycling movements. In this perspective, 
cycling could provide external pacing cues that are less prominent during gait. It is 
well-known that external sensory cues are effective in overcoming the defective 
basal ganglia circuitry of PD patients, perhaps by activating the motor cortex via 
alternative circuitries.25;203;284 An example that is famous even to the layman’s audience 
is that of auditory cueing in patients with postencephalitic parkinsonism who were 
unable to move, but could dance ‘out of the frame’ when music was played.326 Visual 
and auditory cues are best known, but tactile cues are also effective.369 More precisely, 
the afferent feedback provided by the symmetrically moving pedals may regulate the 
timing and amplitude of limb movements during cycling. This way, the pedals could 
restore two mechanisms that have been implied in the pathophysiology of FOG: the 
inability of PD patients to generate and maintain appropriate movement amplitudes;76;181 
and the abnormal temporal coordination between both legs.4;307 In contrast to gait, 
cycling provides the patient with a mechanical constraint that keeps “step” length 
constant. In addition, it corrects the coupling between central commands and the 
biomechanical constraints of the legs.214
We recently speculated that the cause of FOG might relate to an altered cortical 
regulation of movement execution, together with a progressively impaired ability of 
mesencephalic structures to flexibly compensate for that alteration.340 The fixed 
amplitude and timing of leg movements during cycling may decrease the regulatory 
load on the defective cortical areas. Hence, the mesencephalic locomotor region may 
retain its ability to support a central rhythm generator during cycling, resulting in 
adequate cyclic movements. This hypothesis could also explain why sudden gait 
adaptations (such as turning while walking) that provide greater challenges to these 
cortical areas may elicit FOG more frequently than simple straight walking.329
Yet, these mechanisms do not explain how patients can self-initiate pedalling movements 
without problems, but not walking movements. Moreover, one study reported that 
some PD patients could experience sudden cessations of pedalling while cycling on a 
stationary ergometer, and this actually correlated with freezing episodes during 
walking.4 We therefore need to consider alternative possibilities. One further 
explanation is that FOG involves a pathological alteration of motor control mechanisms 
specifically dedicated to gait movements, while sparing other complex motor acts. It 
may be even hypothesized that FOG involves the most common gait routines and 
spares more complex walking programs, e.g. walking upstairs that is often preserved 
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in patients with FOG.  Analogous phenomena can be observed in task-specific 
dystonia, where movement impairments are bound to performing a particular action, 
rather than the use of a specific muscle or “effector”.160 In this perspective, it is 
conceivable that an action different from walking (i.e., cycling) but involving the same 
“effector” (i.e., the legs) could be spared. Indeed, there are similar anecdotes of 
disabled patients with PD who are still able to ice-skate, ski, or play badminton.
It is necessary to also examine specific differences between walking and cycling. Both 
acts evoke similar modulations of cutaneous reflexes,396 but compared to walking, 
cycling may require much less unloading of the weight-bearing leg. Indeed, unlike 
cycling, walking requires a delicate integration between gait commands (generating 
a forward stepping movement) and anticipatory postural adjustments (lateral weight 
shifts, in order to shift the body’s centre of mass laterally towards the weight-bearing 
leg, allowing the contralateral leg to initiate the swing phase.245 PD patients with FOG 
have specific difficulties in generating these preparatory lateral weight shifts, and this 
impairs their step initiation.187;320 Such an integration of anticipatory adjustments with 
rhythmic leg movements would seem less critical for cycling.
Dynamic balance control is also different during cycling and walking. Specifically, 
cycling mainly requires lateral weight shifts, while gait mainly requires dynamic 
balance control in the forward-backward direction. Various studies have shown that 
balance deficits in PD are directionally dependent, being greatest in the backward 
direction, and much less so in the medio-lateral direction.72;177 This relatively preserved 
medio-lateral stability could also explain why PD patients typically walk with a 
narrow-based gait,75;273 and why tandem gait is preserved in most patients.3
Effects of the rapidly changing visual scene during cycling should also be considered. In 
this respect, it is relevant to discuss two recent studies that studied why FOG commonly 
occurs when Parkinson patients walk through narrow doorways. Both studies showed 
that step length decreases to a greater extent in PD patients than healthy controls when 
they try to walk through a door. This phenomenon worsens as the size of the doorway 
decreases.13;80 Almeida and colleagues suggested that visual perceptive deficits could 
explain the propensity for FOG to occur while crossing a narrow doorway. However, 
these authors provided no direct perceptual evidence for this.13 This issue was addressed 
by Cowie and colleagues, who demonstrated that explicit perception of door width was 
no different in freezers than in healthy controls.80 Instead, they raised the interesting 
suggestion that freezers might over-react to visual information, which is normally 
needed to inform the next motor actions. For example, the visual information from 
doors indicates that subjects should slow down, and Parkinson patients do so extremely. 
Similarly, PD patients over-react to optic flow for maintaining balance.59 These findings 
may have direct relevance for our observations, because during cycling subjects receive 
a lot of optic flow information which might act as a powerful cue to motion. 
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Other incidental factors could underlie the discrepancy between walking and cycling 
abilities, but they appear unlikely. For example, it could be argued that cycling – 
having a faster rhythm and greater ground speed than walking – might better capture 
the patient’s attention, for example via the rapidly changing features in the 
environment. Moreover,  the task-focused nature of cycling will lead to a more 
consistently goal directed behaviour.226 Indeed, voluntary attention to the task at 
hand can improve motor performance in PD.84
Emotional factors could theoretically play a role. Strong emotions may produce 
kinesia paradoxa in PD,81 and emotions and motor control are regulated in tight 
conjunction by the subthalamic nucleus.238 Yet, it seems unlikely that emotional 
factors could account for such a sustained kinesia paradoxa (several patients were 
able to make 10 km bicycle rides, without any problems). Hence, the preservation of 
cycling is probably more related to cueing than to kinesia paradoxa. Anxiety may also 
play a role, as this is one of the triggers for FOG. Many patients with PD are afraid to 
fall while walking.5;45 Cycling cannot cause trips or slips, and some of our patients 
anecdotally reported having greater confidence during cycling, which may in turn 
lead to fewer freezing episodes.
Implications for rehabilitation
Our findings may have therapeutic importance. FOG commonly leads to a decreased 
mobility and loss of independence.49 The resultant reduction in physical activities can 
lead to secondary cardiovascular disease, osteoporosis, depression, cognitive decline, 
obesity and a heightened mortality.2;274;382 Promoting physical activity might alleviate 
or prevent these complications, and also offer PD-specific merits. For example, 
increasing the level of physical activity could have a positive influence on sleep 
disturbances and constipation, which are common symptoms in PD. Finally, animal 
work in rodents with experimental parkinsonism suggests that aerobic exercise 
may arrest neurodegeneration by inducing adaptive changes in dopaminergic 
transmission.129;302;361 Such findings raise the fascinating possibility that physical 
activity might slow down disease progression in PD. However, to date no study has 
examined whether exercise can induce structural or functional brain alterations in PD, 
and how such neuroplasticity might occur. We are currently taking this to the test in 
the ParkFit study, a large randomised clinical trial currently involving 580 patients, 
where we use behavioural change strategies to induce a sustained increase in physical 
activity levels.371
Another implication of our observation may be the possibility of using the preserved 
cycling behaviour for devising alternative walking procedures that are less affected by 
FOG. An example could be the use of insoles that give tactile cues to the posterior 
165
5
CYCLING BREAKS THE ICE FOR FREEZING OF GAIT
stance leg when the swing leg touches the ground (mimicking the mechanical 
coupling and cueing of pedals).
The greatest challenge is to find safe and palatable ways to exercise patients with PD 
for sustained periods of time. Cycling is certainly an interesting option, even for 
patients with marked FOG, but safety issues need to be considered. Our patients felt 
secure while cycling, but reported difficulties – and occasionally falls – during 
mounting or dismounting the bicycle, particularly when this was unexpected (for 
example, while approaching a traffic light turning suddenly red). Cycling on a normal 
bicycle is therefore not ideal for all patients, but a tricycle can be a good alternative. 
Additional concerns relate to busy traffic and the need for dual tasking, which is 
problematic in PD.46;321 The safety of driving a car is also challenged when PD patients 
are distracted.365 Other aspects that merit attention include recklessness and 
impulsivity (which could increase the risk of accidents) or dementia (patients getting 
lost). For such patients, a stationary bicycle at home could provide an effective way to 
remain mobile. A final concern relates to the cardiovascular complications of exercise, 
which may be increased in PD.274 Patients should therefore be recommended to 
undergo a health fitness check before embarking upon any exercise program.
Directions for future research
Two lines of research may follow from this observation. The first approach involves 
fundamental work, trying to understand why cycling in PD is preserved better than 
walking. We will illustrate several possibilities. It would be interesting to quantitatively 
assess foot kinetics during cycling in PD patients, to test whether their apparently 
fluent performance contains subtle alterations related to FOG. This could be done 
using ergometers – with or without phase lock4 – and combined with electrophysio-
logical or kinematic assessment. Equally relevant would be to take the idea of hyper-
reactivity to visual information80 to the test, for example by having participants cycle 
in natural conditions (lots of visual flow) or on an exercise bicycle facing a wall or with 
eyes closed (no forwards flow  or lateral flow).
Another attractive research approach would involve mimicked cycling movements 
(for example, while lying recumbent), to assess the consequences of removing the 
tactile cues from the rotating pedals. This might further clarify whether the motor 
control program is really different for gait and cycling.  Alternatively, subjects can be 
asked to mentally imagine making the cycling movements, as this creates the 
possibility to scan subjects using functional magnetic resonance imaging.190;340 A 
disadvantage is that mental imagery is only relevant for the preparatory phase of 
movements. This shortcoming can now be circumvented by asking subjects to make 
repetitive hand movements while being scanned, as this may elicit upper limb 
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freezing that bears remarkable similarity to leg freezing and that is correlated to 
FOG.272;292 Functional imaging while making bilateral hand movements can reveal the 
cerebral substrate underlying freezing, and perhaps unveil why external influences 
such as rotating pedals may alleviate this. Finally, it may also be relevant to examine 
cycling in patients with a wider spectrum of freezing behaviours, for example subjects 
with unilateral freezing149 as this may offer new insights into the bilateral coordination 
of leg movements in PD. 
The second approach is more clinically oriented, aiming to evaluate strategies to 
implement cycling into clinical practice in a safe and enjoyable way, thus offering 
patients new possibilities to increase their physical activity levels.
Legend to the video
This home video shows the patient’s severe gait disorder, caused mainly by freezing 
of gait of the akinetic type, although some leg trembling is occasionally seen. The 
patient is only able to move forward by letting himself fall forward on his knees. 
However, he is able to generate smooth cycling movements with the legs as soon as 
he mounts his bicycle.
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Cycling is less affected then walking  
in freezers of gait  
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We recently described two patients with Parkinson’s disease (PD) who presented with 
severe freezing of gait (FOG), but who also manifested a remarkably preserved ability 
to ride a bicycle.338;342 Following these publications, we have been approached by 
many patients who reported a similar discrepancy between severe gait difficulties 
and an often striking ability to ride their bicycle.
Stimulated by these anecdotes, we performed a structured interview in 53 consecutive 
outpatients with PD (diagnosed according the UK Brain Bank Criteria). This structured 
interview consisted of predefined multiple choice questions about FOG, the ability to 
cycle, and any subjective experience of ‘freezing’ during cycling (operationally 
defined as intermittent blockades of one or both legs during cycling). The precise 
question was ‘Have you ever experienced the feeling of being glued, or experienced 
freezing or blocks of the legs, while you were riding your bicycle?’ This question was 
asked by an interviewer with considerable experience with FOG, and more clarification 
was given if necessary. Also, when a subject answered positively, additional detailed 
questions were asked to decide with more certainty that this was truly freezing. We 
excluded eight patients who had never cycled or stopped cycling years earlier for 
reasons unrelated to PD. Data of 45 remaining patients are shown in Table 1. We 
classified patients as having FOG when they expressed the characteristic feeling of 
the feet being glued to the floor.152 Twenty-five patients indicated having FOG. 
Twenty-one patients had more FOG during the OFF-state compared to the ON-state, 
although 19 patients also experienced less severe FOG during the ON-state. Four 
patients were unable to answer which state was worse, but they had only mild FOG. 
None of the 25 freezers reported that freezing was more evident during the ON-state. 
Four patients (all freezers) had cognitive impairment.
Only one patient (a woman in her seventies, disease duration of 14 years, without 
dyskinesias or cognitive impairment) experienced comparable episodes of ‘freezing’ 
while cycling. She specified this as episodic blocking of her legs, which briefly kept 
her from actively pushing onto the pedals. These freezing episodes on the bicycle 
were much less frequent and less severe than her freezing episodes during walking. 
She experienced the freezing during cycling as a phenomenon comparable to her 
FOG. We therefore interpreted this as freezing episodes during cycling. We considered 
asterixis or negative myoclonus as an alternative explanation,224 but neurological 
examination revealed no asterixis or negative myoclonus. Eight other patients with 
FOG (i.e. 32% of the 25 freezers, without cognitive impairment) reported that the feet 
sometimes exerted an irregular pressure on the pedals, but without overt blockades. 
We considered it unlikely that choreiform dyskinesias could explain this phenomenon, 
as only one of these eight patients had manifest dyskinesias. Fourteen freezers (61%) 
cycled without any difficulties, including a normal ability to start the cycling motion. 
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In addition to these subjective accounts, we observed cycling in three patients with 
marked FOG, and did not observe any freezing during cycling on a real or stationary 
bicycle. None of the 20 patients without FOG ever experienced freezing or blockades 
of the legs while cycling, nor any irregular pressure on the pedals.
This questionnaire provides new evidence that preservation of cycling abilities is not 
a rare phenomenon in PD. Many patients can ride a bicycle without difficulties, even 
when walking has become problematic. Indeed, when cycling becomes impossible 
early in the course of a parkinsonian syndrome, the patient is unlikely to have PD, but 
rather has a form of atypical parkinsonism.6 And if freezing does occur during cycling 
in a patient with PD, the episodes seem less frequent and less severe compared to the 
freezing episodes during walking. The precise mechanisms underlying the preserved 
cycling ability remain to be determined, but several explanations can be considered 
(reviewed in chapter 5.1342). Specifically, the moving pedals could generate external 
tactile cues, maintaining the legs within a fixed amplitude and phase. The angular 
momentum of the pedals, gear and chain would carry the feet along, even if muscular 
Table 1   Results of the structured interview in 45 consecutive patients with Parkinson’s 
disease who had been regularly riding a bicycle
FREEZERS NON-FREEZERS
Number of patients 25 20 
Still cycling 19 18
Gender (men) 19 (76%) 9 (45%)
Age (years) 62.6 (SD 11.3) 62.4 (SD 6.6)
Hoehn and Yahr (On medication)
   Stage 1
   Stage 1.5 
   Stage 2
   Stage 2.5
   Stage 3
   Stage 4
0
1
14
3
5
2
2
2
10
4
2
0
Disease duration (years) 8.7 (SD 5.3) 4.2 (SD 3.3)
Difficulty cycling
   Freezing (blockades) of the legs 
   Irregular pressure on the pedals
   Unable to mount a bicycle
   Unable to maintain balance
   Fitness
   Other (e.g. muscle cramp, deviation)     
18
1
8
3
6
3
5
7
0
0
0
2
3
4
Data are expressed as absolute numbers (percentage between brackets), or as means and standard 
deviations.
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effort was momentarily interrupted. This does not explain why patients can start 
cycling without initiation failure. Therefore, cycling may involve a different, better 
retained motor program compared to walking. In addition, as both feet are 
mechanically coupled, the less affected side may help the more affected side to 
move. Another explanation is that compared to walking, cycling does not require 
postural adjustments (lateral weight shift) to unload the swing leg to initiate a step. 
Compared to walking, cycling may also involve greater amounts of visual input, or 
place different attentional demands. In addition, compared to cycling, walking is 
more likely to be performed during an OFF-state, although only two of our patients 
experienced exclusive OFF-state FOG. Indeed, various patients explicitly indicated 
that cycling was normal even during a profound OFF-state, when gait was severely 
impaired. Finally, preserved cycling abilities may be regarded as a form of kinesia 
paradoxica. However, kinesia paradoxica classically refers to movements that are 
markedly affected most of the time, but which can be performed sporadically in an 
almost normal manner (e.g. when elicited by strong emotions). In contrast, cycling is 
always retained, not only during specific moments, and it is not elicited by strong 
emotions. Future research will have to take these different hypotheses to the test. 
 
The observed discrepancy between cycling and walking may also have implications 
for clinical practice, and in particular for rehabilitation. Cycling may offer an attractive 
way to promote physical activity in PD, as long as postural stability is intact. Safety is 
obviously an issue, because patients can have difficulty mounting or dismounting 
their bicycle. We recommend patients to cycle on an ordinary bicycle in daily life only 
when they can safely mount and dismount, and otherwise to use a tricycle or 
stationary bicycle at home. For various reasons (including motor impairment, 
cognitive decline, depression, apathy, and fatigue), PD patients are heavily inclined to 
lead a sedentary lifestyle. Our results suggest that cycling can be offered to the 
majority of these patients to prevent the many complications of immobility. 
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Treating freezing of gait
 6|
Video vignette 4
The most common form of FOG occurs most frequently during the ‘OFF-state’ (“off” 
freezing). Hence, freezing is often alleviated by taking an adequate dose of 
dopaminergic medication. An illustration is seen in video vignette 4A and 4B. These 
videos show a woman with Parkinson’s disease while walking and turning. On video 
vignette 4A she has not taken her morning medication of levodopa, leading to severe 
freezing of gait. After taking 200 mg levodopa/50 mg benserazide, she is able to walk 
and turn without freezing of gait (video vignette 4B).
I’m thankful to Martin Amarell, Michael Barbe and Lars Timmermann for the use of these 
videos.
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a need for 3D cues?  
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CHAPTER 6
Summary
Visual cues can ameliorate freezing of gait, an incapacitating symptom frequently 
seen in patients with parkinsonism. Here, we describe a patient with severe freezing 
of gait who responded well to three-dimensional cues, but not to two-dimensional 
visual cues. We discuss the potential implications of this phenomenon.
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Introduction
Freezing of gait (FOG) is an incapacitating symptom frequently seen in patients with 
parkinsonism. Visual cues are well known to improve walking in parkinsonism.312 Here, 
we describe a patient with severe FOG who responded well to three-dimensional (3D) 
cues, but not to two-dimensional (2D) visual cues. We also discuss the potential 
implications of this interesting phenomenon.
Case report
An 82-year-old retired engineer presented with a 8-year history of rapidly progressive 
and symmetrical parkinsonism, without response to levodopa, and with early urinary 
incontinence and brisk tendon reflexes. Cognition was normal. Cerebral MRI was 
normal except minor aspecific white matter lesions (Fazekas I). IBZM-SPECT showed 
bilateral D2 receptor loss. Blood pressure was 160/80 mmHg supine, 140/70 mmHg 
after 5 minutes standing. Our diagnosis was probable multiple system atrophy. His 
main problem was severe FOG (video 1). To overcome his FOG episodes, he initially 
used auditory cues, such as whistling. With disease progression, these auditory cueing 
lost their efficacy, but being an engineer, he self-developed two treatment devices. 
First, he adjusted his walking tripod by attaching a foam obstacle, allowing him to 
deliberately step over it (video 2). Second, to reach the pond in his spacious garden, 
he created a ‘walking ladder’ consisting of parallel bars attached to the grass (video 3). 
Interestingly, he said not to improve with flat stripes taped to the floor, but only to 3D 
cues. This created difficulties at home, as his wife would frequently stumble over the 
bars he had attached in the hallway. In addition, he showed marked improvement 
when climbing stairs, which he did several times each day to remain active (video 4). 
To document this selective reaction to 3D cues, we videotaped him in the hospital. 3D 
bars improved his FOG considerably (video 5), but he did not react at all to 2D visual 
cueing (video 6).
Discussion
This patient selectively improved with 3D visual cues, but not with 2D cues. This 3D 
improvement was the case for the visual cues on the floor, which only alleviated FOG 
when these had a certain height, and to a large extent also for the modified tripod 
and for the retained ability to climb stairs. The observation that flat stripes on the 
floor were ineffective, while 3D obstacles were, has not been described earlier. The 
modified tripod used by our patient resembles the inverted walking stick, which 
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occasionally improves gait in a subset of Parkinson patients with FOG.99;207 The kinesia 
paradoxa when climbing stairs was noted already in 1921 by Souques, who described 
a patient with PD who was unable to walk on an even surface, but who could run 
upstairs with two flights at a time.346 Indeed, 43% of PD patients with FOG indicate 
that going upstairs improved their walking.316 
Why did our patient show a differential response to 2D and 3D visual cues? First, this 
observation suggests that the effect of visual cues is not mediated solely by focusing 
attention to the stepping process or by the requirement of generating larger stepping 
amplitudes.25 A second explanation may be enhanced visual feedback of the 3D cues 
on the floor.25 Decreased spatial contrast sensitivity is associated with a propensity to 
develop FOG, even when corrected for disease duration, perhaps because such 
patients are deprived from visual compensation for their compromised basal ganglia-
supplementary motor area axis.85 The addition of an extra (third) dimension to the 
visual cue could enhance visual feedback, resulting in more powerful activation of 
visual cortical areas. With disease progression, this improvement with visual cues may 
eventually become lost when cortical areas become involved in the disease process. 
We did not test contrast sensitivity in our patient. 
Third, the differential effect of 3D cues may be discussed in light of current theories 
about the pathophysiology of FOG. When crossing 3D obstacles (and also when 
climbing stairs), the feet need to be lifted higher, with more marked knee flexion. This 
type of walking could represent a different motor program compared to normal 
‘automatic’ walking. Parkinson patients can have a remarkable preservation of specific 
motor programs involving repetitive leg movements, such as cycling,338 even in the 
face of severe FOG. Perhaps the exaggerated and more conscious ‘cock walk’ - with 
bent knees and the feet lifted higher - is better preserved in parkinsonism than 
ordinary walking.
Fourth, walking with lifted feet and flexed knees demands larger lateral weight shifts 
compared to crossing flat stripes on the floor. Defects in these automatic postural 
adjustments before a step have been suggested to contribute to development of 
FOG, because inability to make a lateral weight shift will lead to clearance problems at 
the onset of the swing phase, resulting in the foot being ‘glued to the floor’.187 Our 
current observation would therefore appear to argue against this hypothesis, because 
the need to make larger lateral weight shifts when negotiating 3D obstacles should 
lead to greater gait difficulties. However, we cannot exclude that the larger lateral 
weight shifts need to be performed more consciously, and thereby help to overcome 
the clearance problem of the swing leg. 
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A final hypothesis relates to the so-called action relevance of objects (also referred to 
as ‘affordances’). The affordance of an object points to the “action possibilities” that 
are implied by an object. For example, a cord affords pulling and a ball affords throwing. 
This affordance is dependent on the actor and his capability: thus, a bicycle will not 
afford the act of cycling if the actor is a crawling infant. Parkinson patients seem to 
have an exaggerated response to affordances.80 3D cues may have another action 
relevance than 2D cues, because an increased step height is required to step over 
them. Indeed, 3D cues can be regarded as obstacles that need to be negotiated, in 
order to avoid stumbling and even falling. Regularly appearing obstacles may act as 
cues and thus improve walking, but a suddenly appearing obstacle can actually 
induce FOG.344 The sudden appearance of a single obstacle introduces time pressure, 
which makes patients more prone to develop FOG. The perceived consequence of 
the appearing obstacle may then influence the outcome: for patients expecting 3D 
cues to be helpful, the 3D object will serve as a cue to improve gait. For other patients 
the 3D object may be perceived as an obstacle that threatens gait and leads to FOG. 
This case report is also a tribute to the inventiveness of patients in developing ‘self 
made’ cues. Clinicians can learn from this experience, and in turn extend this 
knowledge about beneficial inventions to other patients. Finally, this report 
underscores the need for an individually tailored approach in each patient with FOG, 
considering their specific domestic circumstances, any self-invented cues, safety, and 
every patient’s individual response to specific cueing modalities. If 2D visual cues 
prove insufficient, adding an extra dimension may be successful for some patients.
Legend to the videos 
Video 1: Severe freezing of gait (FOG) in the absence of cues (videotaped at home), 
during straight walking and when making turns.
Video 2: Marked improvement with a self-modified walking tripod (videotaped at 
home), during straight walking and when making turns.
Video 3: Marked improvement when stepping over 3D bars attached at regular 
distances on the grass. Note the reoccurrence of FOG when the patient tries to 
negotiate the turn; apparently, the turning cycle is too tight. Walking immediately 
improves once the turn has been completed.
Video 4: Marked improvement when walking up and down stairs.
Video 5: Severe FOG in the absence of cues, but marked improvement with 3D bars 
placed on the floor (videotaped in the hospital). 
Video 6: Severe FOG, with hardly any improvement with 2D cues, namely stripes 
taped to the floor (videotaped in the hospital).

‘ON-state’ freezing of gait in  
Parkinson’s disease: A paradoxical 
levodopa-induced complication
Published as: 
“On” state freezing of gait in Parkinson’s disease: A paradoxical levodopa-induced 
complication. Espay AJ, Fasano A, van Nuenen BFL, Payne MM, Snijders AH, Bloem BR. 
Neurology 2012; 78:454-7.
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Summary
Our objective is to describe the phenotype of levodopa-induced “on” freezing of gait 
(FOG) in Parkinson’s disease (PD).
We present a diagnostic approach to separate “on” FOG (deterioration during the 
‘ON-state’) from other FOG forms. Four PD patients with suspected “on” FOG were 
examined in the ‘OFF-state’ (>12 hours after last medication intake), ‘ON-state’ (peak 
effect of usual medication) and ‘supra-ON-state’ (after intake of at least twice the 
usual dose). 
Patients showed clear “on” FOG, which worsened in a dose-dependent fashion from 
the ‘ON-‘ to the ‘supra-ON-state’. Two patients also demonstrated FOG during the 
‘OFF-state’, of lesser magnitude than during ‘ON-state’. In addition, levodopa produced 
motor blocks in hand and feet movements, while other parkinsonian features 
improved. None of the patients had cognitive impairment or a predating “off” FOG.
True “on” FOG exists as a rare phenotype in PD, unassociated with cognitive 
impairment or a predating “off” FOG. Distinguishing the different FOG subtypes 
requires a comprehensive motor assessment in at least three medication states. 
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Introduction
Freezing of gait (FOG) is common in Parkinson’s disease (PD). FOG refers to sudden, 
relatively brief episodes of gait arrest, experienced subjectively by patients as their 
feet being “glued to the floor”.329 The relationship between FOG and dopaminergic 
medication is complex. Most common is “off” FOG, which is relieved by dopaminergic 
medication.329 Less well recognized types include “unresponsive FOG”, which is 
indifferent to changes in dopaminergic medication;49;276 “pseudo-on” FOG, seen 
during a seemingly optimal ‘ON-state’, but which nevertheless improves with stronger 
dopaminergic stimulation; and “on” FOG, induced by dopaminergic medication.16 
Here, we describe the phenotype of “on” FOG, illustrated by four patients with PD. We 
also present a diagnostic approach to separate the various FOG subtypes, as a basis 
for understanding pathophysiology and for tailored therapeutic intervention. 
Methods
Four patients (ages 59-82, disease duration 6-20 years) with a history of deteriorating 
FOG during “on” are described in the Supplementary Material at the end of this 
chapter. Subjects were tested in three states: (1) ‘practically defined OFF-state’, after 12 
hours without medication;217 (2) ‘ON-state’, 45-60 minutes after intake of regular 
levodopa doses; and (3) ‘supra-ON-state’, after at least twice the regular dose. 
Institutional Review Board approved the study protocol and written informed consent 
was obtained. These tests were done on one day, in a fixed order, without blinding. 
Subject 3 was also tested one month later in the “supra-off” state, after 72 hours 
without any medication. Motor evaluations included the UPDRS-III subscale 
(supplementary table 1) and timed gait tasks (gait initiation, straight walking with two 
180-degree turns, and one 360-degree turn in each direction). Determination of FOG 
appearance was based on patient and investigator judgment. 
Standard Protocol Approvals and Patient Consents: Subjects provided informed consent 
to participate in this Institutional Review Board-approved study protocol, according 
to the recommendations of the Declaration of Helsinki.
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Results
Effect of levodopa
All subjects had gait worsening in the ‘ON-state’, which deteriorated further in the 
‘supra-ON-state (Figure 1). Overall motor UPDRS scores either did not improve or 
worsen in three of four patients due to the appearance of severe FOG and associated 
postural impairment , in the absence of substantial improvements in bradykinesia or 
rigidity to compensate for such deterioration. In the ‘OFF-state’, only subject 1 and 3 
showed FOG, although substantially less compared to the ‘ON-state’. The other 
subjects exhibited mainly hypokinetic gait, with small steps and shuffling, but no 
FOG. Timed gait tests are available in supplementary table 2. After 3 days without 
medication subject 3 experienced gait ignition problems, but without associated 
trembling or subjective gluing, which were typical for his FOG in the ‘ON-state’. 
Probably, this represented profound general akinesia, instead of episodic FOG. In the 
‘ON-state’, all subjects developed FOG. In the ‘supra-ON-state’, subjects showed 
severely disabling FOG, being almost completely unable to walk. Consequently, timed 
tasks took longer to complete from ‘OFF’ to ‘ON’ to ‘supra-ON-state’. Video 
documentation of gait for Subject 2  and 3 is shown in the videos, described at the 
end of this chapter in the ‘supplementary material’.
Other levodopa side-effects
Subject 2 and 3 showed peak-dose dyskinesias. Subjects 2 and 4 experienced nausea, 
yawning and orthostatic hypotension during the ‘supra-ON-state’. None of these side 
effects interfered with gait. 
Phenotype of ‘ON’ FOG
Periods of FOG were sudden and never preceded by “festination” (rapid increase in 
cadence at the expense of shortening stride length), and were more common during 
gait ignition and turns. Subject 1, 3 and 4 also displayed marked FOG during straight 
walking. FOG was almost as severe during straight walking as during 180-degree 
turns in all subjects, and during 360-degree turns in subject 4 (Figure 1). Most episodes 
had the trembling-in-place phenotype, although there were some akinetic episodes, 
especially in the supra-on phase. During the “on” phase, FOG sometimes led to 
near-falls (subjects 1, 3 and 4). 
Concurrently with progressive FOG in the ‘ON-’ and ‘supra-ON-states’, there was 
corresponding deterioration of rapid alternating pro- and supination of the hands 
resembling freezing. These movements were relatively fast, with low amplitude. In 
contrast, other parkinsonian features (speech, handwriting, rigidity) improved with 
levodopa. 
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Discussion
This paper addresses two issues. First, we propose a test protocol to unveil the 
complex relationship between medication effects and FOG, using both suprathera-
peutic medication doses and a practically defined OFF-state. Second, we preselected 
four PD patients with self-reported levodopa-induced worsening of gait, to report the 
phenotype of “on” FOG. Several common characteristics emerged: 1) a trembling FOG 
type which worsened with increasing levodopa doses; 2) debut of “on” FOG without 
predating “off” FOG, after a short disease duration and brief dopaminergic treatment; 
3) concurrent worsening (freezing) of repetitive alternating hand movements in the 
‘ON-state’; 4) good levodopa-responsiveness of other parkinsonian features; and 5) 
preserved cognition, unlike the frontal cognitive impairment associated with “off” 
FOG during the ‘ON-state’.17 In three patients FOG affected open space walking as 
much as turning and gait initiation, unlike classical “off” FOG, where turning is much 
Figure 1   The 360-degree turn task  
Subjects performed a 360-degree turn into each direction in each medication state. The figure shows the 
time normalized with respect to baseline performance (OFF). For each subject, only the worst performance 
(with regard to the right/left direction) is displayed; Case 1 was unable to complete the 360-degree-turn task 
and therefore the straight walking task is shown (the same subject was unable to complete the task in the 
supra-ON condition). 
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more affected compared to straight walking.329 These features point to a different 
pathophysiology underlying “on” and “off” FOG, and suggest that “on” FOG does not 
result from an effect of dopaminergic drugs on alertness, from orthostatic hypotension 
or from isolated D2 agonism in the absence of D1 stimulation. Perhaps “on” FOG is 
related to dopaminergic disruption in rhythm generation of alternating hand and feet 
movements.292 Alternatively, dopamine regulation or non-dopaminergic neurotrans-
mitter systems may be changed by levodopa use, as occurs in levodopa-induced 
dyskinesias.67 
Based on prior evidence and the observations reported here, four FOG types can be 
recognized (Figure 2): (1) the most common, “off” FOG, which diminishes or disappears 
in the ‘ON-state’; (2) “pseudo-on” FOG, due to insufficient dopaminergic stimulation 
(probably representing “off” FOG); (3) “unresponsive” FOG, where FOG is present in 
Figure 2   Types of freezing of gait  
The theoretical ‘threshold’ (or rather, the dose range) for motor improvement (and also the threshold for 
improvement of “off” FOG) may be lower for appendicular manifestations of Parkinson’s disease (PD) (A) 
versus freezing of gait (B). “Off” FOG occurs below the threshold for motor benefits. In this case a dose 
increase above such threshold is expected to eliminate the FOG. “Pseudo-on” FOG is an intermediate 
FOG level, occurring at doses where patients appear to otherwise respond well to medication. Although 
counterintuitive, a tolerable increase in the dose of antiparkinsonian medication in these patients is also 
expected to eliminate the FOG. Finally, “on” FOG reported here may develop or worsen with higher 
Levodopa doses. For these patients, gait only improves after Levodopa dose reduction (adapted from 
Grimbergen et al156).
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‘OFF-‘ and ‘ON-states’, and which is not influenced by medication; and (4) “on” FOG, 
reported here, where FOG is absent during ‘OFF-state’ (e.g. immediately after waking 
up) and emerges after the first medication dose. 
Appropriate distinction between “on” and “off” FOG may be difficult during routine 
clinical visits, where patients typically present in their usual “wearing off” or 
“subjectively good on” state (Table 1). To identify the FOG subtypes with more 
certainty, we recommend testing patients after supra-therapeutic doses of 
dopaminergic agents and, in selected cases, after medication withdrawal for >12 
hours (“practically defined off” state). Using these two extreme medication conditions, 
we showed that our patients worsened in a dose-dependent fashion, from ‘OFF-’ to 
‘ON-‘ to ‘supra-ON-state’. This protocol thus eliminated the possibility of “pseudo-on” 
FOG and “off” FOG.
Most FOG during the ‘ON-state’ may actually represent patients who are relatively 
undertreated, because the ‘threshold’ (dose range) to improve FOG is higher than the 
threshold to improve appendicular motor signs.156 The term “on” FOG should be 
reserved for FOG that is truly levodopa-induced, as in our cases. They did not have 
“unresponsive” (or non-dopaminergic) FOG, because their gait improved and FOG 
disappeared when levodopa doses were reduced, and did not even return during a 
profound OFF-state.
“On” FOG was first observed at the time when levodopa was introduced.16 Symptoms 
disappeared when levodopa dosage was reduced. Further studies will be needed to 
determine whether supra-therapeutic levodopa doses have similarly deleterious 
effects in patients without overt “on” freezing.  Also, the prevalence of true “on” FOG 
with the current medication regime remains to be determined.  
Table 1   OFF and ON FOG behavior according to medication state
Medication State “off” period FOG “on” period FOG
Supra-OFF +++ -
OFF ++ +/-
ON + ++
Supra-ON - +++
FOG: Freezing of gait; OFF: after an overnight withdrawal, with testing about 12 hours after the last dose 
of dopaminergic medication; ON: approximately 45 minutes after a dose of Levodopa, once a subject 
recognizes his/her best response; supra-OFF: after more than 70 hours without any medication; 
supra-ON: 45 to 60 minutes after intake of 200% of the regular or “therapeutic” Levodopa dose. 
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“On” FOG presents a serious therapeutic dilemma. Dopaminergic treatment should 
be reduced to alleviate FOG, but this may lead to unacceptable worsening of other 
parkinsonian features. Subthalamic deep brain stimulation is not a good option, 
because this is generally reserved for levodopa-responsive features, and not for med-
ication-resistant features. However, its dopa-sparing effect may alleviate “on” FOG. 
Finally, external cueing may be considered, which was indeed effective in three of our 
subjects. However, others have reported less favorable results of visual cueing for PD 
patients with “on” FOG.207 
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Supplementary material for chapter 6.2: Case Reports
Case 1. A 77-year-old man developed slowly progressive asymmetric hypokinesia and 
bradykinesia (disease duration 20 years, left-dominant). His brain MRI showed no 
vascular lesions or other abnormalities. His cognitive function was preserved (MMSE 
= 28/30; Frontal Assessment Battery = 16/18). A comprehensive neuropsychological 
evaluation showed only mild executive impairment but no other difficulties. After a 
disease duration of 5 years, he started walking with short steps but without FOG. 
Levodopa improved his speech and handwriting, but worsened his gait. Initially, FOG 
episodes were restricted to turning and crossing doorframes. Subsequently, FOG 
began to affect straight walking. From the outset, his FOG only improved with visual 
cueing or when levodopa was discontinued (which led to self-imposed drug 
‘holidays’). He used a laser-cued walker or a motorized scooter for longer ambulation. 
His FOG was mainly the ‘trembling in place’ phenotype. His Freezing of Gait 
Questionnaire (FOGQ) score was 24/24.
Throughout the disease, he only used a dose of 150 mg of levodopa in the morning. 
Any dose increases elicited severe FOG. He did not improve after therapeutic trials 
with pramipexole, ropinirole, and rotigotine. He reported improvement in gait with 
methylphenidate 5 mg three times daily, but developed seizures after three months, 
prompting discontinuation. 
Case 2. This 82-year-old woman presented with an asymmetric hypokinetic-rigid 
syndrome with marked hypophonia (disease duration 9 years, left-dominant). 
Cognition was normal (MMSE = 30/30; Frontal Assessment Battery = 18/18; Montreal 
Cognitive Assessment = 30/30).  Although there was marked improvement in speech 
and handwriting with levodopa, she experienced FOG, falls, and gait disturbance 
when “on” after 4 years of disease duration, with progressive worsening in severity 
and frequency. In addition, levodopa caused postural lightheadedness and mild leg 
chorea, interpreted as diphasic dyskinesia. Several earlier trials of levodopa increase 
led to severe peak-dose dyskinesias and FOG worsening, which only improved upon 
dose reductions.
Her currently preferred dose of levodopa was 150 mg five times each day. However, 
severe FOG (FOGQ score 24/24) prevented her from playing tennis or even driving, as she 
would freeze trying to get out of the car, greatly limiting her socially. She demonstrated 
FOG when turning and while crossing a doorframe, which was overcome with visual 
cueing.
Legend to the videos
Turns of case 2: 
Video 1: ‘OFF-state’ gait (task completion = 32 seconds) shows no freezing. 
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Video 2: ‘ON-state’ gait, after 150 mg of levodopa (task completion = 47 seconds) 
shows moderate FOG. 
Video 3: ‘Supra-ON-state’, after 300 mg of levodopa (task completion = 94 seconds) 
shows severe FOG with motor blocks during turns.
Case 3. This 59-year-old man without cognitive complains developed dopa-responsive 
rest tremor, hypokinesia, bradykinesia, and rigidity in the right arm, 17 years prior to 
this assessment. The left side slowly became involved over several years. Five years 
after disease onset, he developed gait initiation problems and FOG episodes, which 
were initially restricted to turning and crossing narrow passages, resulting in falls. 
Moving over longer distances could only be accomplished by sitting on a wheeled 
walker, pushing himself backwards. However, he was able to walk from his bed to the 
toilet in the early morning (before intake of any medication) with virtually no FOG, 
although he experienced severe FOG without any fluctuations during the rest of the 
day (FOGQ 20/24). There was no improvement of FOG with increasing levodopa 
dosages, although tremor, rigidity and speech did improve. Visual or auditory cues 
were not successful. Current treatment consisted of levodopa 125 mg 12 to 14 times 
each day and 1 mg pergolide each day. 
Legend to the videos: 
Case 3:
Video 4: Walking while in ‘OFF-state’ shows a hypokinetic gait with small steps and 
shuffling, but no real FOG episodes. 
Video 5: Walking in the ‘ON-state’ shows moderately severe freezing. 
Video 6: Severe freezing with almost complete inability to walk during ‘supra-ON-
state’ (after 1250 mg of levodopa in 3 hours).
Case 4. This 74-year-old man suffered from an asymmetric hypokinetic-rigid syndrome 
(left-dominant, disease duration 6 years) with postural impairment. Cognitive function 
was normal (MMSE = 28/30; Frontal Assessment Battery = 18/18; comprehensive neu-
ropsychological evaluation revealed only mild short-term memory difficulties). His 
symptoms were dopa-responsive, although he did notice left foot dyskinesias as well 
as sweating and hypotension one hour after each levodopa dose. He experienced 
slowness of walking since disease onset, but suddenly developed FOG 5 years after 
disease onset. This led to frequent falls (3-4 monthly) and a FOGQ of 22/24. He suffered 
from FOG when initiating gait, during turning and when walking in open space. FOG 
could be overcome by using a cane. His current medication was levodopa 125 mg 
plus entacapone 200 mg q.i.d.
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‘ON-STATE’ FREEZING OF GAIT IN PARKINSON’S DISEASE: A PARADOXICAL LEVODOPA-INDUCED COMPLICATION
Supplementary Table 1   Motor UPDRS and levodopa doses per state
Subject UPDRS ‘off’ 
/108)
UPDRS ‘on’ 
(/108)
UPDRS 
‘supra- on’ (/108)
Levodopa  
‘on’ (mg)
Levodopa
‘supra-on’ (mg)
1 34.5 36 36.5 200 400 (600 in 2 hr)
2 42.5 42 45 150 300 (450 in 2 hr)
3* 61 43 40 375 1250
4 32 31 30 200 300 (500 in 2 hr)
* Subject 3 ‘supra-OFF-state’ UPDRS = 59. Overall motor UPDRS scores either did not improve or worsen 
in three of four patients due to the appearance of severe FOG and associated postural impairment , in the 
absence of substantial improvements in bradykinesia or rigidity to compensate for such deterioration 
(Hoehn & Yahr scores were 3 when ‘off ’ and 4 when ‘on’ and ‘supra-on’).
Supplementary Table 2   Timed gait per task
Subject / Task OFF (sec) ON (sec) Supra-ON (sec)
1 / Initiation 32 33 51
1 / Walking 143 242 Unable 
1*/ 360° turns Unable to complete
2 / Initiation 18 50 84
2 / Walking 32 47 94
2 / 360° turns R 11 101 64
2 / 360° turns L 20 38 100
3 / Initiation 1 2 8
3 / Walking 8 32 51
3/ 360° turns R 7 11 13
3/ 360° turns L 11 17 Not tested
4 / Initiation 1 9 9
4 / Walking 22 128 125
4 / 360° turns R 4 12 14
4 / 360° turns L 4 9 11
* Subject 1 was unable to complete the 360°-turn task.

Summary & discussion
 7|
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SUMMARY & DISCUSSION
This work presented in this thesis aimed to tackle various complementary elements of 
freezing of gait (FOG) in patients with Parkinson’s disease (PD). The first two sections 
offer an outline of this thesis and a review of the available literature on gait disorders 
and freezing of gait. The remaining sections describe our original work, specifically 
tuning into the following issues: 
1. A diagnostic question: what is the best way to provoke the episodic phenomenon 
of FOG? First, how can we provoke it in clinic, as a basis for use in clinical practice, 
as well as for optimal inclusion in further research studies. Second, can FOG be 
provoked in the controlled environment of treadmill walking, to aid further patho-
physiological studies (Section 3).
2. A neuroanatomical question: what is the cerebral correlate of gait planning in 
patients with FOG (Section 4).
3. A pathophysiological question, aiming to clarify the remarkable ‘kinesia paradoxa’ 
that allows patients with severe FOG to engage seemingly normal in cycling 
activities, despite marked gait difficulties (Section 5).
4. A treatment question, specifically the effect of cueing on FOG and the complex 
relationship between levodopa and FOG (Section 6).
Here, we will discuss the main findings of this thesis, and argue directions for future 
research for each of these issues. In addition, a short review of ‘state-of-the-art 
treatment’ of FOG in PD will be presented. 
Provocation of FOG
FOG is an episodic phenomenon, its sudden appearance causing discomfort and 
falls.201;219 However, when assessing patients with FOG in clinic or in the gait laboratory, 
it appears to be very difficult to elicit a freezing episode.288;341 In clinic, a simple test to 
elicit FOG would be useful. In a research setting, it is mandatory to have a test to 
classify ‘definite’ freezers, where unambiguous FOG is observed by an experienced 
observer (see Figure 1, which is elaborated upon in Chapter 3.2). The goal of Chapter 
3.2 was to define the most sensitive, simple clinical test to classify ‘definite’ freezers. 
We evaluated various turning scenarios, including wide and axial 180° turns and axial 
360° turns (slow and rapid, in both directions). In addition, we tested a gait trajectory 
that included turns, a voluntary stop and a narrow passage. This trajectory was 
repeated three times: at normal speed, as rapidly as possible, and with dual tasking. 
The combination of all tests offered a sensitivity of 74% to elicit definite FOG in PD 
patients with a subjective history of freezing (‘probable’ FOG). Moreover, unambiguous 
FOG was observed using this assessment in 5% of patients who firmly denied the 
characteristic gluing experience of FOG in daily life. The most effective individual test 
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to provoke FOG was rapid 360° turns in both directions. If this turning test was 
negative, it could be combined with a gait trajectory that included dual tasking. 
Repeated testing improved the diagnostic yield. The least informative tests included 
wide turns, 180° turns or normal speed full turns. We showed that repeated rapid full 
turns in both direction were equally effective – and more efficient – in provoking FOG 
compared to the elaborative gait trajectory. Interestingly, when FOG occurred during 
the more elaborative gait trajectory, this was usually during turning, again highlighting 
the importance of this particular test as the diagnostic procedure of first choice for 
the work-up of possible FOG. Other researchers also found that turning is a particularly 
difficult procedure for patients with FOG.316;329;348;350;398 This is probably because a turn 
imposes increased asymmetry as well as a decreased amplitude of steps.180 Both 
increased asymmetry and decreasing step length are known to provoke FOG.76;307 
Based on these findings, we propose a practical diagnostic paradigm to assess FOG, 
both in a clinical setting and in a research environment (see Appendix 1: FOG Scoring 
Form). In this paradigm, we use not only the full rapid turns, but also the instruction 
to walk with small steps, based on the study by Chee et al.76 In this latter study, 
Figure 1   Flowchart to define ‘definite’ freezers (based on the flowchart in 
Chapter 3.2) 
Does the patient feel intermittently glued to the oor?
Has the caregiver seen the patient freezing?
Freezing certied by an 
experienced examiner?
Markers of freezing present during 
quantitative gait analysis?
+ –
–
–
Probable 
FOG
Denite 
FOG
+
Use freezing of gait 
questionnaire
Educate caregiver about freezing, e.g. 
videodemonstration
Use repeated rapid full narrow turns 
and, if negative, FOG trajectory  with dual 
tasking or walking with small steps
Use quantitative analysis, 
showing e.g. an increased Freezing Index 
(power 3-8Hz/power 0-3 Hz)
+
Assessment of freezing of gait
future perspective
Freezing certied by an 
experienced examiner?
+–
No
FOG
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subjects were instructed to walk with smaller than usual steps, and this proved to 
elicit FOG in 11 out of 16 assessed patients (69%). This specific test was motivated by 
pathophysiological considerations, specifically the hypothesis that the basal ganglia 
in PD are unable to maintain a preset stride length.181 Forcing patients to walk with 
extra small steps should then worsen this problem and provoke FOG, which indeed 
proved to be the case. This study aimed to clarify the pathophysiology of FOG and 
was not designed as a diagnostic study, so this “small step paradigm” is not yet 
validated for use as a diagnostic test. However, our own unpublished clinical 
experience supports the observations made by Chee and colleagues: we observed a 
high proportion of FOG events when subjects with subjective FOG are forced to walk 
with small steps, especially when asked to walk as rapidly as possible. An advantage is 
that this test takes little time to complete. A disadvantage is that the phenomenon of 
FOG may be difficult to see with the naked clinical eye, because the purposeful small 
steps conceal the underlying freezing event. This can be solved by asking patients 
about the subjective experience of gluing during this test procedure. Therefore, we 
feel inclusion of this test may further improve the diagnostic yield of FOG provocation. 
Future work now needs to validate this combined approach. Pending such further 
evidence, we recommend the use of these objective tests as part of the inclusion 
procedure of test subjects for future research, to reduce misclassification in patho-
physiology studies.
A further unmet need is the lack of a continuous rating scale to grade the severity of 
FOG, taking various factors into account such as the frequency, severity and specific 
provoking circumstances of FOG. A recent study showed that the current scores on 
Freezing of Gait Questionnaires do not correlate with the duration and frequency of 
FOG during extensive objective assessment.336 This makes the development of such a 
continuous severity scale even more important. 
We showed in Chapter 3.3 that the sudden appearance of obstacles during treadmill 
walking can provoke brief FOG episodes. We discussed various possible explanations 
Box 1  Take home message FOG provocation 
- To provoke FOG, ask patients to make full (360°) turns from standstill, both leftward 
and rightward, instructing them to turn as rapidly as possible. Repeat the test 
once or twice if needed.
- In addition, instruct patients to walk rapidly with small steps, and ask about the 
subjective experience of glueing during this test procedure.
- Appendix 1 proposes a provocation protocol for use in research studies.
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why obstacles can induce FOG, even though the treadmill itself may have acted as an 
external cue to facilitate gait. First, obstacle avoidance forces subjects to suddenly 
adjust their gait, necessitating rapid planning and execution of adaptive movements.62;181 
Second, it calls for a switch in motor tasks, requiring subjects to make corrective 
steps.170;236 Third, the knowledge of an upcoming obstacle may increase anxiety.227;316 
In addition, the obstacle may force the patient to take smaller steps to avoid stepping 
on it, the smaller steps in turn provoking FOG.76 Lastly, extra balance adjustments are 
needed to step over the obstacle, and patients with FOG are known to have difficulties 
integrating postural weight shifts with their stepping commands.187;206(See also Box 3)
However, the FOG episodes that were provoked on the treadmill were less common 
and certainly much briefer compared to the typical FOG episodes evoked during 
normal over-ground walking, presumably because the moving treadmill may have 
acted as an external cue to facilitate gait. This may limit the ecological validity of this 
new approach. However, an advantage is that we now have a validated paradigm to 
provoke FOG episodes in a laboratory environment where very detailed assessments 
are possible under well-controlled circumstances, allowing for future studies of the 
underlying pathophysiology. An example of such a new pathophysiology study is 
presented below.
In Chapter 3.4, we used the subtle FOG episodes provoked during obstacle avoidance 
on the treadmill, to investigate which quantitative gait parameters identify such 
subtle FOG episodes. We demonstrated that the occurrence of high frequencies in a 
biomechanical gait signal or a marked reduction in step duration and amplitude can 
detect even very brief FOG episodes, with acceptable sensitivity (75-88%) and 
specificity (>95%). Qualitative frequency analysis showed a characteristic frequency 
pattern. A decreased power in the 0-3 Hz band was seen, representing the actual FOG 
episode (a decrease in normal frequency of stepping). In addition, increased power in 
the 3-8 Hz band was noted, probably representing the trembling in the legs, which 
may be seen as an attempt to overcome the block. This finding corresponded with 
work of others, who also found tremulous leg activity during FOG episodes within a 
similar frequency band.118;164;366 Earlier work showed this same increased ‘Freezing 
Index’ (power 3-8Hz band / 0.5-3 Hz band) during clear FOG episodes of long 
duration.256 We now show that also very brief FOG episodes can be detected using 
the Freezing Index.
The ability to provoke and detect even subtle FOG episodes in a standardized 
environment, where it can be combined with e.g. kinematic measures, accelerometry, 
forceplates or electromyography, offers new opportunities to study the pathophysiol-
ogy of FOG. Eventually, this may allow for possible development of an electrophysio-
logical definition of FOG that could support clinicians in diagnosing or evaluation of 
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FOG. Indeed, the current ‘gold standard’ of clinically based rating is possibly not 
sensitive enough, as very brief and subtle FOG episodes may well escape even an 
experienced clinical eye, particularly in a clinical setting when FOG is often 
paradoxically suppressed.286;341 Adding electrophysiological measures such as 
frequency analysis of biomechanical or electromyographic signals may help in 
detecting even subtle FOG episodes. Our experiments demonstrate the possibility of 
implementing such techniques during treadmill walking, but others are now also 
moving to ambulatory assessments,76;187;256 which is likely more ecologically valid. In 
addition, recording a video of the examination may further improve the sensitivity 
and specificity of FOG rating, by allowing the examiner to observe the episode again. 
However, off-line video rating has the disadvantage that the patient cannot be 
‘debriefed’, by asking whether he or she felt as if the feet were ‘glued’ to the floor. 
Interestingly, the electrophysiological background of ‘feeling glued’ remains to be 
determined.
The main electrophysiological features of FOG – based on work in this thesis, as well 
as the literature93;168;181;187;256;288 – are shown in Box 2. The freezing index is defined as the 
power in the 3-8 Hz frequency band, divided by the power in the 0-3 Hz frequency 
band. Based on our current work, this is probably the most sensitive and specific 
measure to detect even subtle freezing episodes, and this index can be calculated 
using simple accelerometry measures. More work is needed in larger groups of 
ambulatory patients to determine if this approach can be used as a screening test for 
“real life” FOG, and to see whether this is truly related to the risk of falls that occur 
under everyday circumstances. The combination of detection devices for FOG 
coupled with online cueing techniques (i.e. that start cueing immediately after a FOG 
episodes is detected, rather than offering a continuously present cue) is currently 
being piloted.26;112 If proven to be effective, such approaches may offer interesting 
new treatment options. 
Box 2  Electrophysiological definition of FOG 
Freezing episodes are characterised by:
- Increased freezing index: Decreased power in the 0-3 Hz band, increased 
power in 3-8 Hz band 
- Sequence effect: (Progressive) reduction in step duration and amplitude 
- Multiple anticipatory postural adjustments during trembling of the legs
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Understanding the pathophysiology of freezing of gait
The cerebral substrate causing FOG is largely unknown. To unravel what happens in 
the brain during gait planning in patients with FOG, we used motor imagery of 
walking in combination with fMRI (described in Chapter 4.1). During motor imagery a 
particular movement is imagined but not executed.193 This approach exploits the 
large neural overlap that exists between planning and imagining a movement.77;193;251 
In addition, it avoids the confounds introduced by brain responses to altered motor 
performance and somatosensory feedback during actual freezing episodes.12;311 
We included 24 patients with PD (12 patients with FOG, 12 matched patients without 
FOG) and 21 matched healthy controls. Subjects performed two previously validated 
tasks: motor imagery of gait, and a visual imagery control task. During fMRI scanning, 
we quantified imagery performance by measuring the time required to imagine 
walking on paths of different width and length. In addition, we used voxel-based 
morphometry to test whether between-group differences in imagery-related activity 
were related to structural differences. 
We showed that PD patients with FOG performing motor imagery of gait use different 
cerebral structures than matched PD patients without FOG or healthy controls. These 
cerebral differences were observed in the context of matched behavioural 
performance across groups, and could not be explained by brain atrophy. During 
imagined walking, patients with FOG showed increased activity in the mesencephalic 
locomotor region, which was related to subjective FOG severity. In addition, patients 
with FOG tended to have reduced activity in mesial frontal and posterior parietal 
regions. These findings provide new insights into the pathophysiology of FOG: the 
cause of FOG may be altered cortical regulation of movement execution, together 
with a progressively impaired ability of mesencephalic structures to flexibly 
compensate for that alteration. This may explain the manifestation of FOG during 
changes in motor behaviour, such as turning or initiating walking. These gait 
adaptations not only require a switch of motor program, but also more precise 
regulation of step length, gait timing and postural adjustments.
Box 3 shows the take-home message concerning the cerebral substrate of FOG, as 
identified in this thesis. Obviously, the evidence supporting this hypothesis is far from 
complete. To further understand the cerebral substrate of freezing of gait, several 
approaches can be employed. For example, it is possible to extend the motor imagery 
paradigm to other types of relevant movements, such as turning, walking with small 
steps, or cycling, and to use such imagined movements inside an fMRI or MEG scanner. 
Moreover, combining these imagined movements with different levels of urgency 
may help to pinpoint the relation between anxiety and FOG. 
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A disadvantage to the former approach is that mental imagery is only relevant for the 
preparatory phase of movements. To complement motor imagery, it would be helpful 
to study ‘real freezing’ inside an fMRI scanner. However, the simple fact that real 
walking is not possible inside an fMRI scanner complicates this approach. This 
shortcoming can now be circumvented by asking subjects to make repetitive hand 
movements while being scanned, as this may elicit upper limb freezing that bears 
remarkable similarity to leg freezing, and that is correlated to FOG.272;292;374 Functional 
imaging while making bilateral hand movements (thus allowing study of interlimb 
coordination) can reveal the cerebral substrate underlying freezing (and perhaps 
unveil why external influences such as rotating pedals may alleviate this.) One group 
has successfully studied rhythmic stepping leg movements in the scanner in a patient 
with FOG.272 They used this stepping paradigm in combination with a virtual reality 
environment to provoke freezing episodes in a single patient. The leg movements 
simulating ‘walking’ activated a pattern of bilateral sensorimotor cortex, similar to 
prior neuroimaging studies of walking. During freezing episodes, there was a marked 
bilateral activation in the pre-supplementary motor cortex, motor cortices, prefrontal 
cortex and posterior parietal regions. In contrast, there was bilateral deactivation of 
the frontopolar cortices, as well as the precuneus.272 This approach may be a promising 
approach in a larger patient sample. An alternative approach would be to use other 
imaging techniques that do allow for real walking and freezing to occur, such as near-
infrared-spectroscopy or nuclear imaging.30 Near-infrared-spectroscopy can be 
applied during actual gait, and uses near infrared light to measure neural activity in 
superficial cortical areas.254 Nuclear imaging can be applied immediately after a 
Box 3  Understanding FOG 
The cerebral substrate involved in planning of gait in patients with FOG includes:
- Decreased cortical activity in mesial frontal and posterior parietal regions
- Increased activity in the mesencephalic locomotor region
Mechanisms probably playing a role:
- Impaired ability to compensate for altered regulation of movement execution
- Difficulties when more complex motor regulation is needed: 
 o  Switching motor program / preparing another movement
 o  Changes in symmetry, amplitude or timing of stepping
 o   The need for postural adjustments, such as unloading one of the legs to 
prepare for the swing phase of gait
 o  Changing optic flow, such as when approaching a doorway
 o  Distracting attention from gait
 o  Increasing emotional stress
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period of walking, and assesses cerebral activation by e.g. measuring glucose uptake 
(fludeoxyglucose positron emission tomography; FDG-PET, see for an example 
mapping gait213) or cerebral blood flow (e.g. single-photon emission computed 
tomography with technetium-99m-hexamethyl-propyleneamine oxime; SPECT with 
99mTc-HMPAO, see for an example mapping gait137). 
Alternatively, resting state activity can be compared between freezing and non- 
freezing groups, using e.g. nuclear imaging directed at specific neurotransmitter 
activity,55 or resting state connectivity using fMRI.172 Interfering with the defective 
circuitry of freezers, either using deep brain stimulation or transcranial magnetic 
stimulation,39 also offers an interesting opportunity to study the cerebral substrate of 
FOG (and, ultimately, treat FOG which is dealt with below). For example, an interesting 
recent study showed a block to pre-prepared movement in PD patients with severe 
FOG.359 This phenomenon could be restored using deep brain stimulation to the pe-
dunculopontine nucleus.359 Another study combined deep brain stimulation with 
nuclear imaging to study cerebral blood flow changes induced by pedunculopontine 
nucleus stimulation.31 
Cycling and freezing of gait
In this thesis, we presented two patients with PD with an incapacitating FOG, who 
had a remarkably preserved ability to ride a bicycle. In Chapter 5.2, we provide 
evidence that preservation of cycling abilities is not a rare phenomenon in PD. Many 
PD patients can still ride a bicycle without difficulties, even when walking has become 
problematic. If freezing does occur during cycling in a patient with PD, the episodes 
seem less frequent and less severe compared to the freezing episodes during walking.
In Chapter 5.1, we discuss various mechanisms via which cycling may cause this 
striking ‘kinesia paradoxica’:
1. The rotating pedals acting as external pacing cues.25;203;284 Cerebrally, the fixed 
amplitude and timing of leg movement during cycling may decrease the regulatory 
load on defective cortical areas. Then, the mesencephalic locomotor region may 
retain its ability to support a central rhythm generator during cycling.
2. Involvement of a different and better retained motor plans.160;242
3. Much less dependence on unloading of the weight-bearing leg. This unloading can be 
seen as a lateral anticipatory balance adjustment, which is impaired in FOG.187;320
4. Provision of extra optic flow information from the environment, which may act as 
a cue to promote motion. Freezers might over-react to visual information, which is 
normally needed to inform the next motor actions.13;59;80 Why the changing optic 
flow of a doorway elicits FOG, while the rapid optic flow during cycling prevents 
FOG, remains to be determined. 
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5. Capturing the attention of the patient better, because cycling is more task- directed, 
has a faster rhythm and greater ground speed, within a more rapidly changing 
environment.265
Regardless of the explanation, cycling offers a useful approach for rehabilitation and 
exercise training in patients with PD grounded by severe FOG. When balance is a 
problem, a tricycle or a stationary bicycle can be good alternatives, allowing patients 
to mount, dismount and keep balance more easily.
As already stated in chapter 5.1, two lines of research may follow from our observation 
of preserved cycling ability. The first approach involves fundamental work, trying to 
understand why cycling in PD is preserved better than walking. For example, it would 
be interesting to quantitatively assess foot kinetics during cycling in PD patients, to 
test whether their apparently fluent performance contains subtle alterations related 
to FOG. This could be done using ergometers – with or without phase lock4 – and 
combined with electrophysiological or kinematic assessment. Equally relevant would 
be to take the idea of hyper-reactivity to visual information80 to the test, for example 
by having participants cycle in natural conditions (lots of visual flow) or on an exercise 
bicycle facing a wall or with eyes closed (no forwards flow  or lateral flow). Another 
attractive fundamental research approach would involve mimicked cycling 
movements (for example, while lying recumbent), to assess the consequences of 
removing the tactile cues from the rotating pedals. This might further clarify whether 
the motor control program is really different for gait and cycling. Imaging studies 
using mental imagery of cycling movements or real hand movements were already 
discussed on the previous page.
The second approach is more clinically oriented, aiming to evaluate strategies to 
implement cycling into clinical practice in a safe and enjoyable way, thus offering 
patients new possibilities to increase their physical activity levels. This is much 
needed, because PD patients have a strong tendency to become physically less 
active,371 which in turn may negatively affect their symptoms and possibly even their 
disease course.347
Treating freezing of gait
In section 6, we touched upon two pillars of FOG treatment: cueing and medication. 
Visual cues can ameliorate FOG. In Chapter 6.1, we described a patient with severe 
FOG who responded well to three-dimensional (3D) cues, but not to two-dimension-
al (2D) visual cues. We also discussed the potential implications of this interesting 
phenomenon. The main take-home message was that the effect of visual cues is not 
206
CHAPTER 7
mediated solely by focusing attention onto the stepping process, nor by the 
requirement to generate larger stepping amplitudes.25  The addition of an extra (third) 
dimension to the visual cue could enhance visual feedback, resulting in more powerful 
activation of visual cortical areas. Another explanation would be that the added third 
dimension requires patients to really unload their leg, compensating for faulty 
anticipatory postural adjustments.187 Besides, the third dimension changes a simple 
line into an obstacle. Thereby, it may change the action relevance (‘affordance’) of the 
cue. PD patients seem to have an exaggerated response to affordances.80 The 
perceived affordance of the 3D cue may then influence the outcome: for patients 
expecting 3D cues to be helpful, the 3D object will serve as a cue to improve gait. For 
other patients the 3D object may be perceived as an obstacle that threatens gait and 
leads to FOG. 
In chapter 6.2 we introduced a new test protocol to unveil the complex relationship 
between dopaminergic medication effects and FOG, using both supratherapeutic 
medication doses and a ‘practically defined OFF-state’217 to clarify which type of FOG 
the patient is experiencing. Specifically, four different FOG types can be recognized: 
1. “Off” period FOG, which is the most common type, and which diminishes or 
disappears in the ‘ON-state’ (provided that dopaminergic medication is dosed 
sufficiently high).329
2. “Pseudo-on” FOG, which probably represents “off” period FOG, but which 
nevertheless also presents during the ‘ON-state’, due to relatively insufficient 
dopaminergic stimulation.
3. “Unresponsive” FOG, where FOG is present in both the ‘OFF-’ and ‘ON’-states, and 
which is not influenced by dopaminergic medication.49;276
4. True “on” FOG, where FOG is absent during real ‘OFF-state’, but emerges after intake 
of dopaminergic medication and further worsens after successive dose increases.16 
In chapter 6.2, we also offered one of the first detailed accounts of the phenotype of 
“on” FOG, and discussed the underlying pathophysiology. In the current literature, the 
term “on state FOG” is often used for all FOG occurring during the ‘ON-state’, but 
when used as such, this term in fact combines “pseudo-on”, “unresponsive” and true 
“on” FOG.259 However, “off” FOG and “pseudo-on” FOG are probably reflections of the 
same pathology. This probably develops to “unresponsive” FOG with increasing 
disease severity and involvement of non-dopaminergic pathology. In contrast, the 
pathophysiology of true “on” FOG seems to be different. Hence, we propose to avoid 
confusion by reserving the term “on FOG” only for those episodes of FOG that are 
minimal or absent in a practically defined OFF-state, and that progressively worsens 
when successively higher doses of dopaminergic medication are being administered, 
up to the extent where patients may become dyskinetic. In contrast, the term “on” 
FOG  should explicitly not be used for those FOG episodes that also occur during the 
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‘ON-state’, but which are even worse in a practically defined OFF-state, and which 
improve when dopaminergic medication is pushed to supramaximal doses. Note that 
all other research studies in this thesis concern the more classical “off” type of FOG. 
The two issues described in Section 6 (exclusive improvement of FOG with 3-dimensional 
cues, and FOG caused by levodopa) are, although interesting conceptually, not 
representative of the “usual” FOG patient. Therefore, the last part of this ‘Summary & 
Discussion’ summarizes some general take-home messages on treatment-relates 
issues, based on this thesis and on recent research studies.
Short review on treatment of freezing of gait
Medication
•	 Most FOG episodes will improve after initiation (or a dose increase) of dopaminergic 
medication.140;329
•	 A relatively higher dose of dopaminergic medication is generally needed to treat 
FOG symptoms, compared to more appendicular symptoms such as hand 
bradykinesia and tremor (Chapter 6.2, figure 2).156
•	 True “on” freezing (FOG which is caused or deteriorated by dopaminergic 
medication) is rare, and should be treated by reducing dopaminergic medication 
as much as possible (Chapter 6.2).
•	 Although dopamine agonists are associated with a higher prevalence of FOG 
compared to levodopa, stopping the agonist rarely improves FOG. Most patients 
who manifest FOG while on agonist monotherapy are in a suboptimal on-state 
when receiving dopamine agonists, and require a higher dose of dopaminergic 
medication. Some patients develop FOG shortly after start of an agonist, and in 
those selected cases, replacement of the agonist with levodopa should be 
considered.294
•	 A large controlled study showed that MAO-B inhibitors such as rasagiline and 
selegiline may decrease the likelihood of developing FOG.148 However, once FOG 
has developed, there is only a very small effect of MAO-B inhibitors on FOG.294;317
•	 Case reports and open label studies have reported that amantadine, L-threo DOPS, 
methylphenidate, botulinum toxin injections in calf muscles, SSRI’s and SNRI’s can 
reduce FOG.96;97;121;139;141;143;143;191;205;208;260;277;278;295;309;314;384;403 However, there are conflicting 
results and no level A evidence exists. The huge placebo response in FOG should 
certainly be considered. For example, in a recent double-blind study into the effect 
of methylphenidate on FOG, both groups (methylphenidate and placebo) showed 
a marked reduction in self-reported FOG when using a gait diary.113 Double-blind 
controlled studies using objective outcome measures are therefore urgently 
needed.
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Physiotherapy
•	 Rhythmic auditory cues and visual cues can reduce FOG.203;204;266;284 (Level B evidence 
for cues in Parkinson’s disease, and one level B study for auditory cues for FOG290, 
other studies level C)
•	 The effectiveness of cueing depends on selecting the correct cueing parameters, 
otherwise FOG may be paradoxically worsened.76;257;284 Increasing step amplitude 
(bigger steps), retaining rhythm (prevent progressively increasing cadence), making 
lateral weight shifts and directing attention to gait seem to be most important.266;284 
Adding treadmill training on a normal or rotating treadmill may increases effectivity 
of training.131;176;228 (Level C evidence)
•	 The effect of different cueing modalities differs between patients. Hence, an 
individually tailored approach should be used in each patient with FOG, considering 
the specific domestic circumstances, existence of any self-invented cues, the cognitive 
abilities, and every patient’s individual response to specific cueing modalities 
(Chapter 6.1). (Level D evidence)
•	 Using a wide arc while turning, instead of making an axial turn ‘in place’, is effective 
in preventing FOG episodes (Chapter 3.2).339;386 Hence, in the domestic environments 
of the patients, a wide walking space should be created. (Level D evidence)
•	 Ambulatory aids such as walkers are not that useful in freezers. Standard walkers may 
even increase the number of freezes (probably due to an increased attentional load, 
as well as increased asymmetry of gait). If a walker is necessary, a wheeled walkers is 
preferred as it has no effect of FOG.83 Freezers may profit from a rollator with 
‘compression brakes’ which are activated when a patient leans on the rollator. A 
recent open-label study (n=26) showed adding a laser-light cue to a walker may 
modestly improve FOG and decrease the number of falls.101 (Level C evidence)
•	 Dual tasking leads to more FOG episodes (Chapter 3.2; 348). However, it remains an 
open question whether this means that patients should avoid dual tasking, or in 
contrast, be trained to better deal with dual tasking. Increasing evidence now points 
to the residual training capacities of elderly and parkinsonian populations.332;395 Thus, 
Box  Level of evidence 
A1 =  Meta-analysis containing at least some trials of level A2 and of which the results 
of the trials are consistent.
A2 =  Randomized comparative clinical trials of good quality (randomized double- 
blind controlled trials) of sufficient size and consistency.
B =  Randomized clinical trials of moderate (weak) quality or insufficient size or 
other comparative trials (non-randomized, cohort studies, patient-control studies)
C =  Non-comparative trials
D =  Expert opinion
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SUMMARY & DISCUSSION
a randomized controlled trial in elderly patients with dementia showed that dual-task 
based exercise training improves dual-task performance.332 In PD, instructing patients 
to pay specific attention to taking big steps during dual tasking, improves walking 
during dual tasking.58 Recent work from our own group has shown that PD patients 
can safely integrate cueing techniques into complex everyday circumstances, such as 
walking while having to avoid obstacles.275 This again showed that PD patients can 
safely perform complex dual tasks. A recent pilot study in seven PD patients showed 
a dual task training can improve gait speed and gait variability during dual tasking.395 
Taken together (and pending further evidence), patients should probably be 
instructed to be careful while dual tasking, but nonetheless try to practice dual 
tasking under safe circumstances. In this respect, virtual reality gait training may offer 
possibilities in the future.253 (Level C evidence)
•	 Use of a bicycle may help to maintain a sufficient level of physical activity for patients 
grounded by FOG. Note that using a stationary bicycle or a tricycle is recommended 
if balance is affected (Section 5). (Level D evidence)
•	 See also the dutch guideline for physiotherapy in Parkinson’s disease: https://www.
kngfrichtlijnen.nl/654/KNGF-Guidelines-in-English.htm
Deep brain stimulation
•	 Subthalamic nucleus stimulation: (Level C evidence for FOG)
 o   improves FOG, especially FOG that occurs during the OFF-state;86 
 o   generally does not alleviate FOG that previously failed to improve with adequately 
dosed dopaminergic treatment;60;74
 o   may improve true ‘ON-state’ freezing, by allowing tempering of the levodopa 
dosage;123
 o   has been associated with worsening of gait and balance deficits, not only in the 
immediate postoperative phase, but also several years after follow-up.123;210;262;368 
Adjusting the stimulation parameters (e.g. markedly lowering the stimulation 
frequency, or adjusting the asymmetry of bilateral stimulation) may be helpful in 
such patients.119;258
•	 Internal globus pallidus stimulation may offer a better long-term perspective for gait 
and balance deficits compared to subthalamic nucleus stimulation,130;262 but further 
work remains needed to substantiate this assumption. (Level C evidence)
•	 Pedunculopontine nucleus stimulation has hitherto failed to live up to its promises as 
a novel, effective target for gait and balance deficits.122;261 Further work is necessary to 
define the best possible treatment candidates and stimulation site. (Classification C 
studies positive, classification B studies negative)
•	 Adjusting the stimulation parameters (frequency, and perhaps also voltage), optimizing 
the electrode position and better defining patient selection will be important factors 
for improving the outcome after deep brain stimulation.119;258;359
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CHAPTER 8
Samenvatting
Loopstoornissen komen veel voor en hebben vaak een neurologische oorzaak. De 
klinische aanpak bij een patient met een loopstoornis is lasting doordat er een groot 
aantal oorzakelijke aandoeningen is en doordat het moeilijk is om een loopstoornis 
te interpreteren. Bovendien zijn de beschikbare classificatiesystemen verwarrend. 
Loopstoornissen kunnen worden ingedeeld in de categorieën: antalgisch, paretisch-
hypotonisch, spastisch, vestibulair, atactisch, hypokinetisch-rigide, voorzichtig en 
funcitoneel. Een juiste interpretative van een loopstoornis is belangrijk, omdat de te 
overwegen onderliggende aandoeningen, het uit te voeren aanvullend onderzoek en 
de in te stellen therapie hier direct van afhangen.
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Loopstoornissen komen frequent voor. De prevalentie ervan neemt toe met de 
leeftijd: van 15% bij 60-jarigen tot maar liefst 82% bij 85-jarigen.48;192;375 Loopstoornis-
sen kunnen aanzienlijke gevolgen hebben, zoals een verminderde mobiliteit, 
toegenomen hulpbehoevendheid en een verhoogd risico om te vallen, met alle 
consequenties van dien.357;375 Velerlei aandoeningen van zowel het centrale als het 
perifere zenuwstelsel kunnen tot een gestoord looppatroon leiden. Het herkennen 
van karakteristieke neurologische loopstoornissen is belangrijk omdat dit een directe 
aanwijzing kan geven voor de onderliggende aandoening in het zenuwstelsel. In dit 
artikel belichten wij de neurologische loopstoornissen vanuit een praktisch, algemeen 
perspectief.
Classificatie van neurologische loopstoornissen
Bij de classificatie van neurologische loopstoornissen die wij hanteren volgen wij een 
praktijkgerichte benadering die bestaat uit 3 opeenvolgende stappen. De cruciale 
eerste stap gaat uit van het klinisch geobserveerde hoofdkenmerk van de gestoorde 
gang. De tweede stap behelst de herkenning van een aantal nevenkenmerken van 
het looppatroon, al dan niet in combinatie met het effect van een bepaalde 
provocatie, zoals oogsluiting. De derde stap omvat het zoeken naar essentiële 
aanvullende gegevens uit het lichamelijk onderzoek. Tezamen leidt dit tot een 
voorlopige, klinische classificatie van de loopstoornis. Om vervolgens tot een 
etiologische diagnose te komen is meestal, maar niet altijd, aanvullend onderzoek 
nodig. 
In het navolgende bespreken wij kort enkele veel voorkomende of illustratieve loop-
stoornissen.
Antalgische gang. Kenmerkend van de antalgische gang is de verkorte duur van de 
standfase van het aangedane, pijnlijke been (‘manken’). Dit kan gepaard gaan met 
een verminderde knie- en heupflexie tijdens de zwaaifase (‘stijf houden’). Vaak liggen 
hier aandoeningen van het bewegingsapparaat aan ten grondslag, zoals coxartrose. 
Neurologische oorzaken zijn lumbosacrale radiculopathieën of kleine neuromen van 
de Nn. plantares onder de voet (morton-neuralgie). Daarom noopt dit looppatroon 
tot een gedegen onderzoek van het bewegingsapparaat van de benen, tot het zoeken 
naar afwijkingen aan de voeten en tot het uitsluiten van een radiculair syndroom.
Paretische gang. Een paretische of hypotonische gang komt voor bij mensen met 
slappe (synoniem: hypotone) spieren. Er bestaan twee vormen: een distale en een 
proximale variant. 
De distale variant van de hypotone gang treedt op bij zwakte van spieren in de 
onderbenen. Bij geringe zwakte van de voetheffers komt de voet na de zwaaifase van 
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het been met een doffe klap op de grond terecht: ‘klapvoet’ (figuur 1a). Als de zwakte 
van de voetheffers verder toeneemt, moet het been hoog worden opgetild tijdens de 
zwaaifase en wordt het onderbeen als het ware vooruit geschopt om te voorkomen 
dat de tenen over de grond slepen: ‘hanentred’ (zie figuur 1b). Als deze loopstoornis 
éénzijdig aanwezig is, moet men bekijken of de voethefferszwakte berust op een 
neuropathie van de N. peroneus of op een radiculair syndroom van de wortel L5. In 
zeldzame gevallen is deze loopstoornis een eerste uiting van amyotrofe laterale 
sclerose, een ziekte van de motorische voorhoorncellen. Men moet dan verder letten 
op handspieratrofie, fasciculaties, een piramidaal reflexpatroon en regressiereflexen. 
Bij een dubbelzijdige voethefferszwakte kan er polyneuropathie in het spel zijn.
De proximale variant van de paretische of hypotonische gang wordt gekenmerkt 
door een waggelende gang, hetgeen duidt op bilaterale zwakte van de bekkengor-
delspieren. Hierbij kantelt het bekken tijdens het lopen naar de zijde van het 
standbeen. Deze manier van lopen is karakteristiek voor de meeste spierziekten, zoals 
de ziekte van Duchenne. Bij een waggelende gang moet men bij het lichamelijk 
onderzoek letten op proximale spierzwakte bij weerstandtests en bij het opkomen uit 
een stoel, proximale spieratrofie, eventueel lage spierrekkingsreflexen, en een 
positieve uitslag van de proef van Trendelenburg: bij staan op één been ziet men aan 
de andere kant het bekken afzakken (figuur 2). Zwakte van de bekkengordelspieren 
kan ook éénzijdig voorkomen, zoals bij postoperatieve zwakte van vooral de M. 
gluteus medius na een totale heupvervanging, direct door spierletsel of indirect door 
een letsel van de N. gluteus inferior.102 Overigens kan ook een spastische gang een 
waggelend aspect hebben, waarbij de patiënt probeert om de circumductie te 
compenseren (zie hierna). 
Spastische gang. Hierbij wordt onderscheid gemaakt tussen de één- en de twee - 
zijdige spastische gang. De oorzaak voor de spastische gang is een laesie in de tractus 
corticospinalis, dat is de piramidebaan, ergens in het traject tussen de motorische 
hersenschors en de motorische voorhoorncellen in het ruggenmerg. Een laesie van de 
piramidebaan gaat in de benen vooral gepaard met zwakte van de buigspieren en in de 
armen van de strekspieren. De spastische gang wordt vooral gekenmerkt door 
zogenaamde circumductie: het aangedane been is stijf en beschrijft tijdens de zwaaifase 
een soort halve cirkel buiten de looprichting (figuur 3). Wanneer dit tweezijdig voorkomt, 
krijgt de gang een scharend aspect. De unilaterale spastische gang wordt vooral gezien 
bij cerebrale laesies, met name na een herseninfarct of een hersenbloeding, waarbij er 
tijdens het lopen tevens ‘vleugelen’ van de aangedane arm kan zijn, dat wil zeggen 
abductie van de bovenarm bij elke stap, met flexie in de elleboog (zie figuur 3). Een 
bilaterale spastische gang komt voor bij patiënten met een cervicale of thoracale 
myelopathie, maar kan ook worden veroorzaakt door een erfelijke spastische paraplegie 
of een infantiele encefalopathie; dan spreken wij van diplegia spastica. 
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Figure 1   Distale variant van de paretische of hypotonische gang   
(a) Bij een klapvoet komt de voet tijdens de afwikkelfase met een doffe klap op de grond terecht door zwakte 
van de voetheffers; (b) Bij de hanentred heeft de voet door ernstiger zwakte van de voetheffers tijdens de 
zwaaifase een plantaire in plaats van een dorsale flexie, waardoor de patiënt het zwaaibeen hoger optilt om 
struikelen te voorkomen.
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Bij de spastische gang is het belangrijk om klinisch de plaats van de laesie in de tractus 
corticospinalis vast te stellen, omdat dit richting kan geven aan de diagnose en 
bovendien bepalend is voor de keuze van het aanvullend onderzoek. Verworven 
aandoeningen van het ruggenmerg geven vaak een mengbeeld met elementen van 
zowel een spastische gang als een sensore ataxie.
Vestibulaire loopstoornis. Aandoeningen van het vestibulolabyrintaire systeem 
veroorzaken meestal een ernstige balansstoornis met verandering van het 
looppatroon. Patiënten hebben een verbreed gangspoor met deviatie naar één zijde 
en zoeken naar steun om vallen te voorkomen. Bij acute, eenzijdige uitval is de 
deviatie naar de aangedane zijde, terwijl bij prikkeling de deviatie juist optreedt naar 
de contralaterale zijde. In de chronische fase kan de loopstoornis minder uitgesproken 
of zelfs verdwenen zijn. Dit kan wijzen op herstel van de afwijking, maar ook op 
compensatie, met name door visuele correctie. Als men de patiënt vraagt met de 
ogen dicht te lopen, komt die correctie aan het licht. Patiënten met een vestibulaire 
loopstoornis hebben vaak ook last van misselijkheid en braken en bij het lichamelijk 
onderzoek moet men letten op nystagmus. Tot de oorzaken horen neuritis vestibularis, 
ziekte van Ménière, infarcering en traumatische contusie van het labyrint.
Atactische gang. Bij de atactische gang (‘dronkenmansgang’) ziet men een wisselend 
verbreed gangspoor, een variabele staplengte en het afwisselend naar links en rechts 
Figure 2   Proef van Trendelenburg   
Proef van Trendelenburg bij de proximale variant van de paretische of hypotonische gang: wanneer de 
patiënt één been optilt, zakt het bekken naar de kant van dat been als gevolg van zwakte van de M. gluteus 
medius die aan het standbeen zou moeten zorgen voor approximatie van de bekkenkam en de trochanter 
major.
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deviëren van de looprichting (figuur 4). Voor de etiologische differentiaaldiagnose 
onderscheidt men de sensorische, de cerebellaire en de frontale atactische gang. Bij 
de sensorische ataxie wordt de loopstoornis veroorzaakt door een gebrekkige propri-
oceptieve terugkoppeling als gevolg van een laesie ergens in het sensibele systeem, 
meestal de perifere zenuw of de achterstrengen in het ruggenmerg. Patiënten kunnen 
deze loopstoornis gedeeltelijk compenseren door goed naar de benen te kijken 
tijdens het lopen: visuele  compensatie. Typerend is dan ook dat de loopproblemen 
toenemen in het donker of als men de patiënt vraagt met gesloten ogen te lopen. 
Aanvullend lichamelijk onderzoek toont een gestoorde uitslag van de proef van 
Romberg, dat wil zeggen dat de patiënt omvalt bij staan met gesloten ogen, alsmede 
Figure 3   Spastische gang   
Weergegeven is een eenzijdig spastisch beeld met zogenaamd ‘vleugelen’ van de arm, dat wil zeggen flexie 
van de arm in elleboog en pols, en stijf houden van het homolaterale been dat tijdens het zwaaien een halve 
cirkel beschrijft.
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stoornissen in de gnostische sensibiliteit aan de benen, dat wil zeggen verminderde 
fijne tastzin, vibratiezin en bewegingszin. Eventueel zijn de knie- en achillespeesre-
flexen nauwelijks tot niet opwekbaar.
Bij de cerebellaire atactische gang is het effect van oogsluiting veel minder uit- 
gesproken. Bovendien zijn er hierbij andere verschijnselen van cerebellaire disfunctie 
te vinden, zoals oogbewegingsstoornissen, dysartrie of ataxie van de armen: dysmetrie 
en intentietremor bij de wijsproeven. De frontale atactische gang wordt ingedeeld bij 
de hypokinetische gang.
Figure 4   Atactische gang    
De voetstappen vormen een brede basis met een variabele staplengte en -breedte en deviatie van de 
rechte lijn.
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Hypokinetische gang. Hypokinetische of hypokinetisch-rigide gang is waarschijnlijk 
de moeilijkste categorie van de neurologische loopstoornissen doordat velerlei 
aandoeningen met dit type loopstoornis gepaard kunnen gaan.44 Bovendien is de 
klinische uitdaging juist hierbij groot, omdat de nevenkarakteristieken in het 
looppatroon essentiële aanwijzingen geven over de mogelijke onderliggende 
neurologische ziekte.
Het hoofdkenmerk van de hypokinetische gang is het trage, schuifelende looppatroon 
met kleine passen, een verminderde staphoogte en het weinig meebewegen van de 
armen (figuur 5). De bekendste ziekte in deze categorie is de idiopathische ziekte van 
Parkinson. Bij deze aandoening is de romp voorovergebogen, zowel tijdens staan als 
lopen. De verminderde armzwaai vertoont een opvallende asymmetrie. Opvallend 
genoeg is de basis van de gang vrijwel nooit verbreed.
Als de basis van de gang daarentegen wel breed – en variabel – is, moet betrokkenheid 
van de frontaalkwabben overwogen worden, bijvoorbeeld bij frontale tumoren of 
uitgebreide ischemische veranderingen van de witte stof, maar ook bij de zogenaamde 
parkinson-plussyndromen. Onder deze laatste vallen onder andere: multipele 
systeematrofie, corticobasale degeneratie en vasculair parkinsonisme. De ‘frontale’ 
loopstoornis heeft een nogal variabele manifestatie, die veelal afhankelijk is van de 
ziekteduur. Vaak is een ernstige balansstoornis naar achteren waarneembaar, 
bijvoorbeeld bij het uitvoeren van de retropulsietest; daarbij geeft de onderzoeker, 
terwijl deze achter de patiënt staat, een ruk aan zijn of haar schouders. Ook vertonen 
patiënten vaak de neiging spontaan naar achteren te ‘deinzen’. Patiënten met frontale 
stoornissen kunnen soms een zekere mate van roekeloosheid vertonen, hetgeen in 
combinatie met de loopstoornis resulteert in frequente valincidenten met ernstige 
letsels.50 In uitgesproken situaties kan er zelfs gangapraxie bestaan, waarbij de 
patiënten als het ware niet meer weten hoe zij moeten lopen. Hierbij treedt een 
opvallende discrepantie op tussen de ernst van de loopstoornis en het intacte 
vermogen tot normale beenbewegingen in liggende of zittende houding. Ernstig 
aangedane patiënten kunnen zonder hulp zelfs helemaal niet meer staan; dit noemt 
men astasia-abasia. 
Soms wijzen specifieke kenmerken van de loopstoornis al in de richting van de juiste 
diagnose. Zo is een bekend verschijnsel bij vasculair parkinsonisme het relatieve 
sparen van de armen, die zelfs bij patiënten met een ernstige loopstoornis vaak nog 
vrij goed meebewegen tijdens het lopen; men spreekt daarom wel van onderli-
chaamparkinsonisme (‘lower body parkinsonism’).
Een bijzonder fenomeen in deze categorie van loopstoornissen is het optreden van 
‘bevriezen’: het plotseling blokkeren van de benen, waarbij de patiënt zelf het karak-
teristieke gevoel heeft ‘alsof de voeten aan de vloer vastgekleefd raken’.49 Het plotse 
karakter van dit bevriezen is bijzonder invaliderend, omdat de patiënt zich niet goed 
kan aanpassen. Een volledige blokkade van alle bewegingen kan op treden, maar is 
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relatief zeldzaam. Veel vaker ziet men de patiënt als het ware ritmische kleine passen 
maken op de plaats. Typische momenten waarop het bevriezen vaker voorkomt, zijn 
tijdens pogingen tot starten met lopen, tijdens het draaien om de lengteas, wanneer 
de patiënt door een nauwe passage wil lopen zoals een deur, of tijdens het uitvoeren 
van één of meer dubbeltaken tijdens het lopen, bijvoorbeeld praten of iets dragen in 
de handen. Voorovervallen is een berucht gevolg. Bevriezen treedt vaak op bij de 
ziekte van Parkinson, vooral in meer gevorderde stadia van de ziekte, maar wordt ook 
gezien bij vrijwel alle andere vormen van parkinsonisme. De enige uitzondering 
hierop is parkinsonisme dat is veroorzaakt door blootstelling aan medicatie.
Voorzichtige gang. De voorzichtige gang, soms ook seniele loopstoornis genoemd, 
heeft veel overeenkomsten met de hypokinetische gang: de voortbeweging is 
langzaam, met een kleine paslengte, een stijve romp en vaak met een verbreed 
gangspoor. Dit looppatroon is vergelijkbaar met de manier waarop gezonde personen 
over een glad oppervlak of langs een afgrond lopen.48
Bij het neurologisch onderzoek worden weinig tot geen afwijkingen gevonden. De 
oorzaak is voornamelijk gelegen in een angst om te vallen, die soms reëel is, 
bijvoorbeeld na een recente val of bij een daadwerkelijke onderliggende balansstoornis. 
De voorzichtige gang kan dan ook een eerste uiting zijn van onderliggende neuro -
Figure 5   Hypokinetische gang     
Bij de hypokinetische gang is het looppatroon schuifelend, met een smalle basis en kleine stapjes, met 
verminderde of afwezige zwaaibeweging van de armen.
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logische stoornissen, vaak cerebrovasculaire schade, en gaat samen met een hogere 
sterfte aan cardiovasculaire aandoeningen.47
Het voorzichtige looppatroon is weliswaar een redelijk adequate strategie om het 
vallen te voorkomen, maar leidt weer tot een verminderde mobiliteit. Deze is een 
risicofactor voor secundaire cardiovasculaire ziekten, vallen, cognitieve achteruitgang 
en sterfte.2;87;159;218;240
Bij patiënten met een voorzichtige gang is dus specifieke aandacht gewenst voor 
enerzijds de mogelijkheid van onderliggende pathologische afwijkingen en anderzijds 
het voorkómen van immobiliteit.
Functionele loopstoornis. Functionele loopstoornissen zijn niet zeldzaam, zelfs niet 
bij oudere patiënten. De belangrijkste aanwijzing voor een functionele of psychogene 
loopstoornis is een looppatroon dat niet compatibel is met een bekende, organisch 
bepaalde loopstoornis. Opvallend is de vaak ernstig gestoorde gang, echter zonder 
dat de patiënt daadwerkelijk valt, hetgeen op een juist zeer adequate balans wijst 
(figuur 6). Bij het neurologisch onderzoek is het beeld vaak inconsistent. Afleiden van 
de patiënt kan de verschijnselen doen veranderen of verminderen. Bij de beoordeling 
kan men een functionele loopstoornis verwarren met bijvoorbeeld loopstoornissen 
bij frontaalkwabaandoeningen.41
Figure 5   Psychogene gang     
De patiënt neemt oneconomische en bizarre houdingen aan waarvoor zeer goede controle van beweging en 
evenwicht nodig is.
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Praktische benadering bij een patiënt met een loopstoornis
Voor een adequate beoordeling van het looppatroon moet de loopafstand voldoende 
zijn. Een eerste indruk kan men krijgen als men de patiënt observeert als deze uit de 
wachtkamer wordt opgehaald. Het is belangrijk om niet alleen het spontane 
looppatroon te beoordelen, maar ook te kijken naar het effect van ‘interventies’, zoals 
een rollator, waarmee het lopen moet verbeteren, of het opleggen van een dubbeltaak 
tijdens het lopen, waardoor de loopstoornis kan verergeren. Andere voorbeelden van 
provocaties zijn de patiënt met de ogen dicht of achteruit laten lopen. De loop- en 
balansfunctie kan ook op semikwantitatieve
wijze in kaart gebracht worden. Een bekend voorbeeld is het meten van de tijdsduur 
tussen het opstaan uit een stoel, 3 m lopen, omdraaien, teruglopen en weer gaan 
zitten.308
Volgens de klassieke neurologische benadering kan op grond van anamnese en 
lichamelijk onderzoek een goede inschatting gemaakt worden waar de laesie in het 
zenuwstelsel gelokaliseerd moet worden. Voor een uiteindelijke etiologische diagnose 
is echter vaak aanvullend onderzoek noodzakelijk. Bij de voorzichtige en psychogene 
gangstoornis is, naast het uitsluiten van een mogelijke somatische oorzaak, aandacht 
nodig voor de psychische en emotionele context.
Conclusie
Loopstoornissen komen veel voor in de dagelijkse neurologische praktijk. Het aantal 
onderliggende aandoeningen is groot. Toch kan men met een systematische 
benadering en zorgvuldige determinatie van de loopstoornis vaak een anatomische 
of functionele diagnose stellen. Aanvullende gegevens uit de anamnese en het 
gerichte lichamelijke onderzoek sturen de verdere differentiaaldiagnose en daarmee 
het in te zetten aanvullend onderzoek. De behandeling, die wij hier niet bespraken, 
heeft algemene pijlers, zoals lichaamsbeweging, fysiotherapie en een revalidatietra-
ject; daarnaast kunnen, afhankelijk van de onderliggende aandoening, ziektespeci-
fieke interventies nodig zijn.
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Casus
Een man van 68 jaar belt de huisarts omdat hij is gevallen en nu in huis niet goed 
meer durft te lopen.
Vraag 1. Wat kan in deze fase, met zo weinig informatie, al door uw hoofd gaan?
Antwoord A: Ten eerste dient gedifferentieerd te worden tussen het al dan niet aanwezig 
zijn van kortdurend bewustzijnsverlies voorafgaand aan de val. De benadering van 
vallen met of zonder bewustzijnsverlies is namelijk compleet anders. Kortdurende 
 bewustzijnsverlies kan wijzen op epilepsie of syncope. Bij een val zonder bewustzijns-
verlies moet onderscheid gemaakt worden tussen twee hoofdgroepen van vallen. 
Enerzijds kan vallen het gevolg zijn van extrinsieke oorzaken, d.w.z. veroorzaakt door 
een externe factor, zoals struikelen over een drempel of omgeduwd worden. Anderzijds 
kan vallen het gevolg zijn intrinsieke oorzaken, waarbij de patiënt zelf de val veroorzaakt. 
Voorbeelden van intrinsieke (binnen de patiënt zelf gelegen) oorzaken zijn stoornissen 
van het evenwicht of een afwijkend looppatroon.
Anamnese
Door de telefoon lijkt er geen acute situatie te bestaan, zoals bijvoorbeeld een 
gebroken heup. Patiënt is zelf weer opgestaan en loopt ondersteund door zijn 
echtgenote weer door de kamer. U besluit aan het eind van uw spreekuur een 
huisvisite te maken. De patiënt is bekend met de ziekte van Parkinson. Deze diagnose 
is acht jaar geleden gesteld door de huisarts. Het begon met trillen en stijfheid van de 
rechterarm. Later ontstond ook traagheid van het rechterbeen. Na drie jaar breidden 
de verschijnselen zich uit naar de linkerzijde van het lichaam. Momenteel is vooral het 
lopen lastig, en heeft patiënt veel moeite om uit stilstand weer op gang te komen. Hij 
gebruikt 5 maal daags anderhalve tablet levodopa/carbidopa (125/25 mg).
De oorzaak van de val kan de patiënt niet vertellen. Het gebeurde in de woonkamer 
toen hij met een kop koffie in de handen liep. Er lagen geen obstakels op de grond. 
De patiënt is voorover gevallen en – voor zover hij kan nagaan – is hij tevoren niet 
bewusteloos geweest. Hij is op zijn knieën gevallen, en heeft zich bewust opgevangen 
met de handen. Er zijn geen andere nieuwe klachten. Er waren geen ooggetuigen.
Vraag 2: Wat zijn uw overwegingen op basis van de anamnese?
Vraag 3: Is de valrichting van belang?
Vraag 4: Waar zou u bij het lichamelijk onderzoek vooral aandacht aan besteden? Waarom?
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Antwoord 2: De patiënt ontkent dat er voorafgaand bewustzijnsverlies was. Het blijkt 
echter dat dit antwoord niet altijd volledig betrouwbaar is, omdat kortdurend be-
wustzijnsverlies vooral door ouderen gemakkelijk gemist wordt. Oorzaken van 
kortdurend bewustzijnsverlies zijn onder andere orthostatische hypotensie, cardiale 
syncope en sinus caroticus overgevoeligheid. Zeker orthostatische hypotensie valt te 
overwegen; dit kan veroorzaakt worden door de ziekte van Parkinson zelf of door een 
bijwerking van de dopaminerge medicatie. Het ontbreken van postictale verwardheid 
maakt epilepsie veel minder waarschijnlijk. Drie methoden zijn behulpzaam om te 
beoordelen of er toch voorafgaand bewustzijnsverlies was. Ten eerste helpt het om te 
vragen of patiënt zich bewust was van het moment waarop het lichaam de grond 
raakte. Ten tweede is het goed om te kijken naar de zogenaamde opvangreacties: als 
een patiënt de armen uitstrekte om de val op te vangen was hij vermoedelijk niet 
bewusteloos ten tijde van de val. Ten derde is het belangrijk om ooggetuigen te 
interviewen. Helaas zijn deze vaak, net als bij onze patiënt, niet voorhanden.
Al met al lijkt er bij deze patiënt geen voorafgaand bewustzijnsverlies te zijn geweest. 
Er zijn evenmin aanwijzingen voor een extrinsieke oorzaak van het vallen. Een 
intrinsieke oorzaak is daarom het meest waarschijnlijk, vermoedelijk een stoornis van 
het lopen of het evenwicht als gevolg van de ziekte van Parkinson. Deze treden 
regelmatig op bij de ziekte van Parkinson, en kunnen vooral in de meer gevorderde 
ziektestadia bijzonder invaliderend zijn. Opmerkelijk is dat de val optrad toen de 
patiënt kennelijk meerdere dingen tegelijk deed (lopen en een kop koffie dragen). Dit 
ondersteunt de gedachte dat het hier gaat om een intrinsieke val, omdat het 
vermogen om meerdere activiteiten tegelijk uit te voeren (het zogenaamde “multi-
tasken”) is verminderd bij de ziekte van Parkinson. Als patiënten dit toch proberen 
neemt de loopstoornis of het balansprobleem verder toe, resulterend in valincidenten.
Antwoord 3: De valrichting kan belangrijke aanwijzingen geven voor de onderliggende 
oorzaken. Patiënten met de ziekte van Parkinson vallen meestal naar voren. Dit wordt 
veroorzaakt door een combinatie van de voorovergebogen houding, en met name 
door het fenomeen “bevriezen”: plotselinge episodes waarbij de voeten als het ware 
aan de grond vastgeplakt zitten. Als dit optreedt tijdens het lopen ontstaat een 
voorwaartse val omdat de romp nog doorgaat met de voorwaartse beweging. Als 
patiënten juist naar achteren vallen (en vooral als dit bijna spontaan lijkt te gebeuren) 
vormt dit een aanwijzing voor het bestaan van de ziekte progressieve supranucleaire 
parese (PSP), één van de vormen van atypisch parkinsonisme (zie hoofdstuk 26). 
“Verticaal” naar beneden vallen treedt op bij zogenaamde “drop attacks”, een nog 
goeddeels onbegrepen aandoening van vooral vrouwen op middelbare leeftijd die 
plotseling door de knieën zakken zonder bewustzijnsverlies.
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Antwoord 4: Algemeen lichamelijk onderzoek: De bloeddruk liggend en staand 
(orthostatische hypotensie?), auscultatie van het hart (ritmestoornis?). Kijk ook naar de 
verwondingen, niet alleen om deze zo nodig te behandelen, maar ook omdat de aard 
van de verwondingen een aanwijzing kan vormen voor de oorzaak van de val. 
Fracturen van de pols of clavicula suggereren dat de patiënt zich had opgevangen, 
hetgeen een voorafgaand bewustzijnsverlies onwaarschijnlijk maakt. Neurologisch 
onderzoek: Een indruk van de cognitie, onder andere ter beoordeling van de be-
trouwbaarheid van de anamnese, maar ook omdat cognitieve stoornissen een sterke 
associatie met val incidenten vertonen. Kracht, in het bijzonder in de benen 
(krachtsverlies bijdragend aan de valneiging?). Bij het sensibiliteitsonderzoek is de 
proef van Romberg belangrijk, evenals de gnostische sensibiliteit (polyneuropathie of 
achterstrengstoornis?). Natuurlijk ook een beoordeling van de ernst van de Parkinson 
symptomen. Het lopen moet uitgebreid onderzocht worden, met het oog op de 
veiligheid van bewegen. Daarnaast gericht onderzoek naar het bevriezen als mogelijke 
oorzaak voor het vallen; de beste methode hiervoor is om de patiënt zo snel mogelijk 
volledig om zijn as te laten draaien, zowel linksom als rechtsom. Tenslotte balanson-
derzoek middels de “retropulsietest”, waarbij de onderzoeker achter de patiënt staat 
en een korte ruk geeft aan de schouders van de patiënt. Hierbij wordt beoordeeld of 
de patiënt zelfstandig de balans kan bewaren.
Onderzoek
U meet een liggende bloeddruk van 120/85, staand 110/65, zonder begeleidende 
klachten van duizeligheid. Daarnaast ziet u een schaafwond op de linkerknie en op de 
linkerhand. Bij neurologisch onderzoek vindt u geen paresen of sensibiliteitsstoornis-
sen. Wel is er een “geldtel” rusttremor van de rechterhand, met matige rigiditeit aan 
alle ledematen, rechts meer dan links. Het lopen gaat wat hinkend (waarschijnlijk 
antalgisch, als gevolg van het knieletsel). Tevens vallen de kleine, langzame pasjes op, 
waarbij de voeten niet hoog worden opgetild. Patiënt loopt voorovergebogen en 
met een verminderde armzwaai, vooral rechts. Als u de patiënt zo snel mogelijk om 
de as laat draaien haperen de voeten, wiebelt hij met zijn knieën alsof hij probeert 
alsnog passen te maken, en valt hij bijna opzij. Bij de retropulsietest maakt hij vijf 
kleine, langzame achterwaartse stappen, maar hij handhaaft wel zelfstandig zijn 
balans.
 
Vragen:
Vraag 5: Wat is nu de meest waarschijnlijke oorzaak van het vallen?
Vraag6: Zijn er andere opties, en waarom zijn die minder waarschijnlijk?
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Antwoord 5: De werkhypothese is nu dat de patiënt tijdens een episode van bevriezen 
voorover gevallen is. Het bevriezen is een beruchte oorzaak van vallen bij de ziekte 
van Parkinson, vooral als patiënten zeggen voorover te vallen. U moet zich realiseren 
dat veel patiënten het bevriezen als zodanig niet herkennen! Net als onze patiënt 
denken zij zelf dat ze spontaan zijn gevallen, en het bevriezen komt vaak pas aan het 
licht als u vraagt naar het karakteristieke subjectieve gevoel “alsof de voeten aan de 
grond blijven plakken”. Dit kan alleen opgespoord worden door hier gericht naar te 
vragen. Ook is het behulpzaam om te vragen naar specifieke momenten waarop het 
bevriezen meestal optreedt. Het doet zich vooral voor bij bewegen in nauwe ruimtes 
zoals een toilet, bij het passeren van deuropeningen of bij het draaien om de lengteas. 
Ook het uitvoeren van dubbeltaken tijdens het lopen is een beruchte oorzaak voor 
bevriezen, net zoals dit bij onze patiënt het geval was. Een zorgvuldige anamnese is 
in dit geval extra belangrijk, omdat de kans groot is dat het bevriezen niet optreedt 
tijdens het neurologisch onderzoek. Kennelijk wordt het bevriezen onderdrukt in de 
‘spannende’ setting van een doktersbezoek, mogelijk omdat de patiënt specifiek de 
aandacht richt op goed lopen. De meest gevoelige manier om bevriezen op te 
wekken tijdens het neurologisch onderzoek is om patiënten een snelle en nauwe 
draai om de as laten maken (het maken van een ruimere draai geeft vaak veel minder 
moeilijkheden). Hierbij moet u goed kijken naar verschillende verschijningsvormen 
van bevriezen. Het meest kenmerkend is een onvermogen om effectief voorwaarts te 
stappen, waarbij de voeten snelle en bijna ritmische pasjes op de plaats maken. Vaak 
staat de voorvoet aan de grond genageld, en wijst de hiel omhoog. Ook wiebelt de 
patiënt vaak met de knieën, in een poging alsnog passen te maken. Een minder 
frequente verschijningsvorm is het geheel ontbreken van stappen of andere 
bewegingen. Onze patiënt vertoonde inderdaad het kenmerkende bevriezen tijdens 
het draaien.
Antwoord 6: Een andere optie is een val als gevolg van de balansproblemen bij de 
ziekte van Parkinson. Meestal is hierbij echter ook een extrinsieke oorzaak van de ba-
lansverstoring aanwezig, zoals het struikelen over een los vloerkleed. En natuurlijk kan 
het vallen ook multifactorieel bepaald zijn, vooral bij oudere mensen. Hierbij kunnen 
meerdere factoren samen resulteren in een val, of kan het vallen op verschillende 
momenten door andere factoren veroorzaakt worden. Vooral medicatiegebruik moet 
altijd als uitlokkende factor overwogen worden (Tabel 1). In ons geval kan de patiënt 
bijvoorbeeld door een bevriezingsepisode uit balans geraakt zijn, en was hij door zijn 
balansprobleem onvoldoende in staat dit weer te corrigeren.
Vraag 7: Wat zijn medicamenteuze opties om het bevriezen te verminderen? 
Antwoord 7: Er is geen specifieke medicatie voor het bevriezen. Meestal helpt het om 
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de dosering van de Parkinson medicatie te verhogen, omdat veruit de meeste vormen 
van bevriezen een uiting zijn van een tekort aan dopamine in de hersenen. Voor het 
verbeteren van het bevriezen zijn vaak hogere doseringen medicatie nodig dan voor 
het corrigeren van de andere Parkinson symptomen, dus geef niet te snel op! Bij een 
minderheid van de patiënten wordt het bevriezen echter juist veroorzaakt door de 
medicatie. Kennelijk kan overmatige stimulatie van het dopaminerge systeem soms 
leiden tot de typerende blokkades tijdens het lopen. Het mechanisme hierachter is 
nog niet goed bekend. Wel is duidelijk dat dit zich kan voordoen bij het gebruik van 
zowel levodopa als dopamine agonisten. Het is dus belangrijk om zorgvuldig na te 
vragen wat de relatie is tussen het bevriezen en het tijdstip van inname van de 
medicatie. Het is hierbij behulpzaam om goed uit te vragen of de patiënt al in de 
vroege ochtend last heeft van bevriezen (nog vóór inname van de eerste medicatie 
gift), of dat dit juist pas optreedt ná inname van de ochtendmedicatie (in dit laatste 
geval is de medicatie vermoedelijk als schuldige aan te wijzen). Niet-medicamenteuze 
middelen kunnen ook helpen tegen bevriezen (zie hieronder). 
Table 1   Medicatie met een negatief effect op lopen en balans
Type medicatie Commentaar
Neuroleptica Treedt op bij zowel typische als atypische neuroleptica.
Antidepressiva Treedt op bij selectieve serotonine reuptake inhibitors 
(SSRI’s) en tricyclische antidepressiva (TCA’s).
Anti-epileptica Treedt op bij zowel oudere (bijvoorbeeld fenobarbital) als 
nieuwere (bijvoorbeeld lamotrigine) anti-epileptica, maar 
mogelijk minder frequent bij de nieuwe anti-epileptica.
Medicatie tegen ziekte van Parkinson Treedt op bij alle klassen Parkinson medicatie. 
Onderliggend mechanisme is complex, met o.a. 
excessieve dyskinesieën, orthostatische hypotensie en 
gedragsstoornissen.
Benzodiazepines / andere hypnotica Zowel kort als lang werkende benzodiazepines. Nieuwere 
medicatie als zopiclon wordt veiliger geacht.
Analgetica Opiaten, NSAIDs en paracetamol.
Antihypertensiva Diuretica, beta-blokkers, ACE remmers en nitraten. Meest 
sterke effect bij opgenomen patiënten, waarschijnlijk door 
grotere ernst orthostase na bedrust.
Anticholinergica Via een effect op de cognitie, of via orthostase.
Anti-diabetica Mogelijk door onderliggende aandoening 
(polyneuropathie, retinopathie, cerebrovasculaire ziekte).
Anti-arrhythmica Mogelijk door onderliggende pathologie (cardiale 
syncope).
Voor alle medicamenten geldt dat het niet altijd duidelijk is of de medicatie zelf de oorzaak is van het 
vallen, of slechts een “marker” is van onderliggende aandoening die zelf verantwoordelijk is.
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Huisbezoek
Om te kijken hoe het verder gaat bezoekt u patiënt twee weken later opnieuw thuis. 
Het valt u op dat in de woonkamer een schuivend vloerkleed ligt. De patiënt is echter 
nooit meer gevallen. Hij zit voornamelijk in zijn stoel, en laat zich volledig door zijn 
echtgenote verzorgen. Bij navragen blijkt hij zo bang te zijn om weer te vallen dat hij 
nauwelijks nog ergens komt. Hij gaat niet meer naar zijn wekelijkse biljartuitje, en 
heeft ook zijn dagelijkse ‘blokje om’ opgegeven.
Vraag 8: Wat kan dit huisbezoek bijdragen aan uw beleid?
Vraag 9: Wat stelt u voor aan verdere maatregelen?
 
Antwoord 8: Middels dit huisbezoek krijgt u een beter inzicht in de omgevingsfactoren 
die vallen in de thuissituatie kunnen veroorzaken. Voorbeelden zijn niet alleen het 
losse vloerkleedje of slechte verlichting, maar ook bijvoorbeeld factoren die bevriezen 
kunnen veroorzaken, zoals een volgestouwde huiskamer. Daarnaast levert dit huis - 
bezoek bijzonder waardevolle inzichten op in een nieuwe complicatie die is 
opgetreden als gevolg van het vallen: de patiënt heeft een pathologische valangst 
ontwikkeld, en heeft hierdoor zijn activiteiten drastisch beperkt, met alle nadelige 
gevolgen van dien voor zijn sociale leven en zijn fysieke en geestelijke gezondheid. 
Het louter stellen van de vraag ‘Bent u nog gevallen?’ is in dit geval misleidend, omdat 
de afname van de valneiging in dit geval verklaard wordt door de valangst, die ertoe 
heeft geleid dat de patiënt volledig is geïmmobiliseerd. En wie niet beweegt valt ook 
niet meer!
Antwoord 9: U wilt patiënt stimuleren om meer te bewegen, om zo zijn sociaal 
isolement te doorbreken. Ook leidt immobiliteit op langere termijn tot cognitieve 
achteruitgang, cardiovasculaire ziekten en uiteindelijk tot vroeger overlijden. Maar het 
is natuurlijk wel essentieel dat patiënt op een veilige manier gaat bewegen. Fietsen is 
bijvoorbeeld een manier om meer te bewegen; veel Parkinson patiënten kunnen dit 
vaak beter dan lopen. Als veilig fietsen niet meer mogelijk is het gebruik van een 
hometrainer een goed alternatief. Ook het lopen op een loopband gaat vaak beter 
dan gewoon lopen. Fysiotherapeuten kunnen goed bijdragen aan het stimuleren tot 
bewegen. Ook kunnen zij gerichte behandelstrategieën toepassen die helpen om het 
bevriezen te voorkomen, en zo nieuwe valincidenten te voorkomen. Een voorbeeld 
hiervan is het aanleren van het gebruik van externe prikkels (de zogenaamde “cues”) 
die het loopritme kunnen ondersteunen, zoals ritmische geluidsprikkels (via een 
draagbaar metronoom) of visuele prikkels (het plakken van strepen op de huis- 
kamervloer). Daarnaast kan de patiënt worden aangeleerd om in ruime bochten te 
draaien, omdat dan minder vaak bevriezen optreedt dan bij een draaien in een krappe 
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ruimte. Ook het leren om minder haastig willen bewegen helpt om het bevriezen te 
voorkomen. Dergelijke specifieke behandelmethoden vergen wel een grote mate van 
ervaring met de ziekte van Parkinson. U kunt uw patiënt hiervoor het beste verwijzen 
naar een gespecialiseerde ParkinsonNet fysiotherapeut (de adressen in uw regio vindt 
u via www.parkinsonnet.nl). In het ParkinsonNet werken ook gespecialiseerde ergo-
therapeuten, die kunnen helpen om de thuissituatie aan te passen. Dit kan bijvoorbeeld 
door de ruimtes minder vol te maken, of door in huis visuele “cues” aan te brengen op 
drempels of andere obstakels.

Nederlandse samenvatting
8.3
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Dit hoofdstuk geeft een Nederlandse samenvatting van dit proefschrift, waarbij we 
ons in lekentaal primair richten op lezers zonder uitgebreide ervaring met de ziekte 
van Parkinson. De Engelse ‘Summary & Discussion’ bediscussieert de resultaten in 
meer detail voor de professioneel geïnteresseerde lezer. 
Dit proefschrift gaat over loopstoornissen, en in het bijzonder over ‘bevriezen’ van het 
lopen, bij patiënten met de ziekte van Parkinson. Loopstoornissen komen veel voor, met 
name bij ouderen. Het herkennen van karakteristieke neurologische loopstoornissen is 
belangrijk omdat dit een directe aanwijzing kan geven over de aard van de onderliggende 
aandoening in het zenuwstelsel (zie hoofdstuk 2.1 ‘Gait disorders’ en hoofdstuk 7.1 
‘Loopstoornissen’). Neurologische loopstoornissen kunnen aanzienlijke gevolgen hebben 
op de gezondheid, zoals een verminderde mobiliteit, een toegenomen hulpbehoe-
vendheid en een verhoogd risico om te vallen, met alle consequenties van dien.  
Sommige loopstoornissen zijn niet consistent aanwezig, maar treden plots en 
‘episodisch’ op (als het ware in aanvallen). Een voorbeeld van dergelijke episodische 
loopstoornissen is het bevriezen tijdens het lopen, een veelvoorkomend symptoom 
bij de ziekte van Parkinson (Box 1). Hierbij hebben patiënten het gevoel alsof hun 
Box 1  Ziekte van Parkinson 
De ziekte van Parkinson is een degeneratieve hersenziekte met zowel motorische 
verschijnselen als een breed scala aan non-motorische verschijnselen. De belangrijkste 
motorische kenmerken van de zieke van Parkinson zijn trillen (tremor), stijfheid 
(rigiditeit), vertragen van bewegingen (bradykinesie) en verminderd aanwezig zijn 
van bewegingen (hypokinesie). Niet- motorische symptomen van de ziekte van 
Parkinson worden ook steeds meer onderkend: onder andere vermoeidheid, minder 
reukvermogen, pijn, problemen met plassen en bloeddruk regulatie, stemmings-
stoornissen, slaapstoornissen en cognitieve problemen (onder andere moeite met 
logisch overzicht en dubbeltaken). Deze verschijnselen komen aanvankelijk vooral 
door dopamine gebrek in  de substantia nigra (een onderdeel van de basale kernen, 
die diep in de hersenen zijn gelegen). Met het voortschrijden van de ziekte raken 
steeds meer additionele ‘non-dopaminerge’ en ‘extranigrale’ structuren betrokken 
bij het neurodegenerative proces. Voor de behandeling van de ziekte van Parkinson 
zijn vooral medicamenten (onder andere levodopa en dopamine agonisten) en her-
senoperaties (diepe hersenstimulatie) belangrijk. Deze behandelingen zijn allen 
symptomatisch: ze onderdrukken de klachten, maar stoppen de neurodegeneratie 
(afbraak van neuronen) en dus de progressie van de ziekte zelf niet. Er is tot nu toe 
geen behandeling die de ziekte afremt of stilzet.1;53;322
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voeten plotseling ‘aan de grond geplakt’ raken. De patiënt kan hierdoor niet meer 
vooruit stappen, en daarbij maken de voeten vaak snelle en bijna ritmische pasjes op 
de plaats. Ook wiebelt de patiënt vaak met de knieën, in een poging alsnog passen te 
maken. Een minder frequente verschijningsvorm is het geheel ontbreken van stappen 
of andere bewegingen. Doordat bevriezen opeens en onvoorspelbaar optreedt, leidt 
het vaak tot vallen. Bevriezen is dan ook een zeer invaliderend symptoom van de 
ziekte van Parkinson. In hoofdstuk 8.2 ‘Wankel op de benen en vallen’ bespreken we 
in het Nederlands de ziektegeschiedenis van een patiënt die viel ten gevolge van dit 
bevriezen tijdens het lopen. In hoofdstuk 2.2 wordt een Engels algemeen overzicht 
van bevriezen tijdens het lopen gegeven. Daarnaast geeft hoofdstuk 8.4 een 
Nederlands overzicht van de huidige behandelingsmogelijkheden van bevriezen.
Dit proefschrift behandelt verder de volgende vragen betreffende bevriezen van lopen:
•	 	Wat is de beste manier om het episodische fenomeen ‘bevriezen van lopen’ te 
provoceren, zowel in de kliniek als in een experimentele onderzoekssetting?
•	 	Kunnen we bevriezen van lopen beter begrijpen door te kijken naar de hersen-
activiteit tijdens motorische verbeelding van lopen?
•	 	Hoe kan het dat sommige patiënten met bevriezen van lopen niet meer kunnen 
lopen maar nog wel kunnen fietsen?
•	 	Hoe kunnen we bevriezen van lopen het beste behandelen?
Provocatie van bevriezen van lopen
Om bevriezen van lopen goed te kunnen herkennen en behandelen, is het nodig dit te 
kunnen opwekken in een experimentele setting of in de kliniek (zie hoofdstuk 3.1 voor 
een overzicht). We hebben onderzocht wat de beste manier is om klinisch bevriezen 
van lopen op te wekken (hoofdstuk 3.2). De meest effectieve manier om bevriezen op 
te wekken bleek het verrichten van simpele snelle draaien om de as (‘360 graden test’). 
Wij hebben daarnaast gekeken of het vermijden van obstakels op een loopband het 
bevriezen van lopen kan opwekken (hoofdstuk 3.3). Onze resultaten laten zien dat de 
noodzaak om plotse obstakels op een loopband te vermijden inderdaad bevriezen kan 
opwekken in een looplaboratorium. De bewegende loopband en het vallende obstakel 
werken echter ook als een ‘cue’ (een uitwendige prikkel) die de optredende bevrie-
zingsepisode meteen weer doorbreekt. Hierdoor waren de opgewekte episodes erg 
kort. Om zulke korte episodes kwantitatief te detecteren bleek frequentie analyse van de 
beenbewegingen de juiste benadering (hoofdstuk 3.4). Normaal lopen gaat vaak met 
een frequentie van ongeveer 1 tot 2 stappen per seconde (1 tot 2 Hz). Bij bevriezen 
neemt de hoeveelheid normale stappen echter af, waardoor er minder langzame 
bewegingen van <3 Hz zijn. De hoeveelheid bewegingen met een abnormaal snelle 
frequentie (3-8 Hz) neemt echter toe, mogelijk omdat de patiënt snelle (doch 
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ineffectieve) bewegingen maakt in een poging om uit de blokkade te komen. Hierdoor 
stijgt de ‘freezing index’ (hoeveelheid bewegingen 3-8 Hz/hoeveelheid bewegingen 
0-3 Hz). Deze ‘freezing index’ bleek in staat korte episodes te detecteren. Dit kan in de 
toekomst belangrijk zijn om bijvoorbeeld in de thuissituatie korte episodes (die zouden 
kunnen leiden tot vallen) op te sporen en eventueel zelfs te doorbreken.
Begrijpen van bevriezen van lopen 
Wat gaat er nu mis de hersenen bij patiënten met bevriezen van lopen? Gebruiken zij 
andere hersenstructuren als ze het plan maken om te gaan lopen? We hebben in 
hoofdstuk 4.1 gebruik gemaakt van functionele MRI om hersenactiviteit tijdens 
motorische verbeelding van lopen te bestuderen. Tijdens motorische verbeelding 
verbeeldt een persoon zich dat hij een bepaalde beweging maakt, zonder hem 
daadwerkelijk uit te voeren. Er zit een grote overlap in functie en hersenactiviteit 
tussen motorische planning van een daadwerkelijke actie en motorische verbeelding. 
Wij onderzochten drie groepen: Parkinson patiënten met bevriezen, Parkinson patiënten 
zonder bevriezen, en gezonde controles.
Er werd bij bevriezers een combinatie gevonden van twee verschillende veranderingen 
in de hersenen. Om te beginnen ontstaat in de hersenschors een probleem in het 
gedeelte dat betrokken is bij het selecteren van de juiste beweging (hier werd te 
weinig activiteit gezien bij Parkinson patiënten). Daarnaast treden haperingen op in 
een specifiek gebied in de hersenstam (en wel teveel activiteit in het zogenaamde 
‘mesencefale locomotorische gebied’), dat wellicht de problemen van de hersenschors 
probeert te compenseren. Dit zou kunnen verklaren waarom bevriezen vooral 
optreedt tijdens situaties waar snelle aanpassingen van het looppatroon verwacht 
worden, zoals draaien of tijdens het vermijden van obstakels; tijdens dat soort 
complexe omstandigheden schiet de compensatie vanuit de hersenstam mogelijk 
tekort. Deze twee gebieden zijn mogelijk nieuwe doelwitten voor diepe hersenstimu-
latie of voor transcraniële magnetische stimulatie, als nieuwe behandeling om het 
bevriezen beter te gaan behandelen. 
Fietsen en bevriezen van lopen
We beschrijven twee interessante ‘case reports’ over patiënten met de ziekte van 
Parkinson, die enerzijds nauwelijks zelfstandig konden lopen, maar anderzijds zonder 
problemen een fietstocht konden maken. Ook toen we gestructureerd bij 53 patiënten 
met de ziekte van Parkinson vroegen naar problemen tijdens het fietsen, bleek dat 
bevriezen van de beenbewegingen nauwelijks voorkomt bij fietsen – in tegenstelling 
tot bij lopen.
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Deze observatie heeft verschillende wetenschappelijke en klinische betekenissen. 
Eén mogelijke verklaring voor dit opmerkelijke verschijnsel zou kunnen zijn, dat de 
draaiende beweging van de pedalen fungeert als extern feedbackmechanisme. De 
fiets geeft als het ware het ritme terug aan de patiënt. Een andere verklaringsmoge-
lijkheid is dat voor lopen en fietsen in het brein verschillende controlemechanismen 
bestaan. Daarbij is het bij fietsen minder nodig om het gewicht zijwaarts te 
verplaatsen, van het ene been naar het andere been. Patiënten met bevriezen van 
lopen hebben juist moeite om hun gewicht zijwaarts te verplaatsen voordat ze een 
stap kunnen zetten. Ook geeft fietsen veel visuele informatie, wat een krachtige 
stimulans voor beweging is. Bevriezers zouden anders op deze visuele informatie 
kunnen reageren, wat invloed heeft op het voorbereiden van de volgende beweging. 
Tenslotte zou fietsen de aandacht van de patiënt beter kunnen vasthouden, gezien er 
meer focus op een bepaalde taak is, er een sneller ritme en grotere snelheid bestaat, 
met een sneller veranderende omgeving.
Onafhankelijk van de verklaring, kunnen patiënten met bevriezen van lopen dus 
prima gebruik maken van de fiets. Dit kan onder andere bij wijze van therapie, 
bijvoorbeeld om in conditie en in beweging te blijven. Voor Parkinsonpatiënten die 
(ook) balansproblemen hebben, is fietsen op een gewone tweewieler uiteraard geen 
veilige optie. Dan kan een home-trainer of driewieler echter uitkomst bieden. 
Behandelen van bevriezen van lopen 
(zie voor een uitgebreider overzicht het volgende hoofdstuk 8.4)
Er is geen specifieke medicatie voor het bevriezen. Meestal helpt het om de dosering 
van de Parkinson medicatie te verhogen, omdat veruit de meeste vormen van 
bevriezen een uiting zijn van een tekort aan dopamine in de hersenen. Voor het 
verbeteren van het bevriezen zijn vaak hogere doseringen medicatie nodig dan voor 
het corrigeren van de andere Parkinson symptomen. Hierdoor kan het lijken alsof het 
bevriezen medicatie-resistent is, terwijl er simpelweg hoger gedoseerd moet worden. 
Bij een minderheid van de patiënten wordt het bevriezen echter juist veroorzaakt 
door de medicatie. Dit beschrijven we in hoofdstuk 6.2. Kennelijk kan overmatige 
stimulatie van het dopaminerge systeem soms leiden tot de typerende blokkades 
tijdens het lopen. Het mechanisme hierachter is nog niet goed bekend. Het is dus 
belangrijk om zorgvuldig na te gaan wat de relatie is tussen het bevriezen en het 
tijdstip van inname van de medicatie.
Daarnaast zijn er een aantal niet-medicamenteuze behandelingsopties. De patiënt 
kan worden aangeleerd om in ruime bochten te draaien, omdat dan minder vaak 
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bevriezen optreedt dan bij een draaien in een krappe ruimte. Ook het leren om minder 
haastig te willen bewegen helpt om het bevriezen te voorkomen. (Hoofdstuk 3.2)
Een andere pijler van de huidige behandeling van bevriezen is het aanleren van 
gebruik van externe prikkels (zogenaamde ‘cues’). Dit kunnen ritmische geluidsprik-
kels zijn (via een draagbare metronoom) of visuele prikkels (het plakken van strepen 
op de huiskamervloer). In hoofdstuk 6.1 beschrijven we een patiënt met ernstig 
bevriezen van lopen die goed reageerde op driedimensionale –en niet op tweedi-
mensionale - visuele cues. Dit laat zien dat niet alleen het focussen van de aandacht 
op het lopen of het laten zetten van grotere stappen belangrijk is voor de 
werkzaamheid van cues. De derde dimensie van de visuele cue zou de visuele 
feedback kunnen vergroten, waardoor de visuele cortex sterker geactiveerd wordt. 
Een andere verklaring is dat de derde dimensie ervoor zorgt dat de patiënten met 
aandacht echt hun gewicht moeten verplaatsen voor ze een stap zetten. In ieder 
geval bepalen de specifieke eigenschappen van een cue of deze werkzaam is, wat per 
patiënt en afhankelijk van de ernst van de ziekte kan verschillen. Een individuele 
aanpak is dus noodzakelijk.

Overzicht van de behandeling 
van bevriezen van lopen
8.4
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Hier vatten we de behandeling van bevriezen van lopen samen, gebaseerd op de 
bevindingen van dit proefschrift en op recente literatuur.
Medicatie
•	 	De meeste episodes van bevriezen zullen verbeteren na het beginnen met (of 
verhogen van de dosis van) dopaminerge medicatie.140;329
•	 	Om symptomen van bevriezen te behandelen, is over het algemeen een relatief 
hogere dosis dopaminerge medicatie nodig, vergeleken met klassieke symptomen 
als hand bradykinesie en tremor (hoofdstuk 6.2, figuur 2).156
•	 	Echt “on” bevriezen (bevriezen dat veroorzaakt wordt of verslechtert door 
dopaminerge medicatie) is zeldzaam, en moet behandeld worden door de 
dopaminerge medicatie zoveel mogelijk te verminderen (Hoofdstuk 6.2).
•	 	Alhoewel dopamine agonisten geassocieerd zijn met een hogere prevalentie van 
bevriezen vergeleken met levodopa, heeft het stoppen van dopamine agonisten 
zelden effect.294 De meeste patiënten die bevriezen ontwikkelen terwijl ze 
monotherapie met een dopamine agonist krijgen, zijn onderbehandeld en hebben 
een hogere dosis dopaminerge medicatie nodig. Sommige patiënten ontwikkelen 
bevriezen kort na de start van een agonist, en in deze specifieke gevallen dient 
vervanging van de agonist door levodopa overwogen te worden.
•	 	Een grote gecontroleerde studie liet zien dat MAO-B remmers zoals rasagiline en 
selegiline de kans om bevriezen van lopen te ontwikkelen mogelijk vermindert.148 
Als er echter eenmaal bevriezen van lopen optreedt, is er slechts een minimaal 
effect van het toevoegen van een MAO-B remmer op bevriezen.294;317
•	 	Case reports en open label studies hebben beschreven dat amantadine, L-threo 
DOPS, methylfenidaat, botuline toxine injecties, SSRI’s and SNRI’s bevriezen kunnen 
verminderen.96;97;121;139;141;143;143;191;205;208;260;278;279;295;309;314;384;403 Er zijn echter tegenstrijdige 
bevindingen en er is geen level A bewijs (zie Box 1). Daarbij moet een grote reactie 
op placebo bij bevriezen van lopen zeker in het achterhoofd gehouden worden. 
Een recente dubbel blinde studie naar het effect van methylfenidaat op bevriezen 
liet bijvoorbeeld voor beide groepen (methylfenidaat en placebo) een behoorlijke 
vermindering in zelfgerapporteerd bevriezen zien aan de hand van een 
‘loopdagboek’.113 Dubbelblinde gecontroleerde studies met objectieve 
uitkomstmaten zijn dus hard nodig.
Fysiotherapie
•	 	Ritmische auditieve en visuele cues kunnen bevriezen verminderen.203;204;266;284 
(Bewijsniveau 2 voor effect op lopen, bewijsniveau 3 voor effect op bevriezen)
•	 	De effectiviteit van de cues hangt af van de keuze van de juiste parameters, anders 
kan bevriezen paradoxaal zelfs verergeren.76;257;284 Het vergroten van de stap 
amplitude (grotere passen), het behouden van ritme (progressief versnellen van 
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stappen vermijden), het verplaatsen van het gewicht naar opzij en het richten van 
de aandacht op het lopen lijken de belangrijkste interventies. 266;284 Training op een 
loopband of zelfs een roterende loopband zou de effectiviteit van cue training 
kunnen verbeteren.131;176;228 (Bewijsniveau 3)
•	 	Het effect van verschillende cueing vormen is verschillend per patiënt. Een 
individuele aanpak is dus noodzakelijk, met aandacht voor de thuissituatie, 
aanwezigheid van zelf bedachte cues, de cognitieve capaciteiten en de individuele 
respons op verschillende cue vormen (Hoofdstuk 6.1). (Bewijsniveau 4)
•	 	Draaien met een wijde boog in plaats van ‘om de as / op de plaats’ is effectief om 
bevriezen te voorkomen (Hoofdstuk 3.2).339;386 Zorg dus ook in de thuissituatie voor 
een brede draai-ruimte. (Bewijsniveau 4)
•	 	Alhoewel we in hoofdstuk 6.2 een man presenteren met een geweldige respons op 
een looprek, zijn over het algemeen hulpmiddelen bij het lopen niet altijd 
behulpzaam bij bevriezen van lopen. Gebruik van een stok of looprek kan de 
frequentie van bevriezen zelfs doen toenemen83 (waarschijnlijk doordat meer 
aandacht vereist wordt, en door het vergroten van asymmetrie van lopen). Een 
rollator heeft geen effect of bevriezen.83 Bevriezers hebben dan waarschijnlijk het 
meeste baat bij een rollator met ‘drukremmen’ die geactiveerd worden wanneer 
de patiënt op de rollator leunt.  Een recente open-label studie laat zien dat gebruik 
van een laserlicht bij een rollator of stok een kleine verbetering van bevriezen zou 
kunnen geven.101 (Bewijsniveau 3)
Box 1  Bewijsniveau
Classificatie studies:
A1 =  Systematische reviews (meta-analysis)
A2 =  Gerandomiseerd vergelijkend onderzoek
B =  Gerandomiseerd vergelijkend onderzoek van matige kwaliteit of onvoldoende 
omvang
C =  Niet-vergelijkend onderzoek
D =  Mening van deskundigen
Bewijsniveaus in Nederlandse richtlijnen:
Niveau 1 =  gebaseerd op A1 of ten minste twee onafhankelijk van elkaar uitgevoerde 
onderzoeken op niveau A2
Niveau 2 =  gebaseerd op ten minste twee onafhankelijk van elkaar uitgevoerde 
onderzoeken van niveau B
Niveau 3 =  gebaseerd op een onderzoek van niveau A2 of B, of op onderzoek van 
niveau C
Niveau 4 =  mening van deskundigen
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•	 	Dubbeltaken zorgen voor meer bevriezingsepisodes (Hoofdstuk 3.2; 339;348). Het is 
echter onduidelijk of dat betekent dat patiënten dubbeltaken moeten vermijden, 
of juist oefenen. Er lijkt sprake van een residu training capaciteit van ouderen en PD 
patiënten.332;395 Een gerandomiseerde gecontroleerde studie bij oudere patiënten 
met dementie liet zien dat oefeningen met dubbeltaken het uitvoeren van 
dubbeltaken verbetert.332 Parkinson patiënten lopen beter tijdens dubbeltaken als 
ze de instructie krijgen om grote stappen te nemen tijdens de dubbeltaken.58 Een 
recente studie van onze groep liet zien dat Parkinson patiënten veilig cueing 
technieken kunnen integreren in complexe alledaagse handelingen zoals het 
vermijden van obstakels.275 Een recente pilot studie bij 7 Parkinson patiënten liet 
zien dat dubbeltaak training de snelheid en variabiliteit van lopen verbetert.395 Tot 
hier meer over bekend wordt, zullen patiënten waarschijnlijk geïnstrueerd moeten 
worden voorzichtig te zijn tijdens het uitvoeren van dubbeltaken, maar ze 
tegelijkertijd in veilige omstandigheden te oefenen. In de toekomst zou virtuele 
realiteitstraining daarbij kunnen helpen.253 (Bewijsniveau C)  
•	 	Fietsen kan bevriezers helpen mobiel te blijven (Hoofdstuk 5). Als de balans gestoord 
is, kan een ergometer fiets of een driewieler uitkomst bieden. (Bewijsniveau 4)
•	 	Zie ook richtlijn fysiotherapie Parkinson 2006:
 https://www.kngfrichtlijnen.nl/index.php?NODE=2004&richtlijn=2 of 
 http://www.parkinsonnet.nl/media/5357/rlparkinson_vtencover_151206.pdf 
Diepe hersenstimulatie
•	 	Stimulatie van de subthalame nucleus (specifiek voor bevriezen: Bewijsniveau 3)
 o  verbetert bevriezen, met name bevriezen tijdens “Off”.86 
 o   verbetert over het algemeen bevriezen niet als dat ook niet verbetert met 
dopaminerge medicatie.60;74  
 o   zou ook “On state” bevriezen kunnen verbeteren, met name doordat het mogelijk 
is de levodopa dosering te verlagen.123
 o   is soms geassocieerd met verslechtering van lopen en balans, niet alleen direct 
post-operatief, maar ook pas na enkele jaren.123;210;262;368 Aanpassen van de 
stimulatie parameters (bijvoorbeeld sterk verlagen van de frequentie van 
stimulatie of het aanpassen van de asymmetrie van bilaterale stimulatie) kan in 
zulke gevallen helpen.119;258
•	 	Interne globus pallidus stimulatie zou betere lange termijn resultaten kunnen 
bieden voor loop- en balansstoornissen,130;262 maar vervolgstudies zijn nodig om dit 
te bewijzen. (Bewijsniveau 3)
•	 	De resultaten van pedunculopontine nucleus stimulatie zijn tot nu niet wat er van 
gehoopt werd als nieuw effectief target voor loop en balans stoornissen.122;261 
Vervolgstudies zijn nodig naar selectie van de beste kandidaten en de beste plaats 
van stimulatie. (Classificatie C studies: positief, classificatie B studies: negatief)
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•	 	Het aanpassen van stimulatie parameters (frequentie en wellicht ook voltage), 
optimale electrode plaatsing en betere patiënt selectie zijn belangrijke factoren 
om de resultaten van diepe hersenstimulatie in de toekomst te verbeteren.119;258;359
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FREEZING OF GAIT SCORING FORM 
Appendix 1: Freezing of Gait Scoring Form
Patient number / Code: ________________________________
Birthday: ________________________________
Probable diagnosis: ________________________________
Most affected side: ________________________________
Disease duration (years): ________________________________
Date examination:     ________________________________
Examiner:      ________________________________
----------------------------------------------------------------------------------------------
Freezing on history: Yes / No  
Start freezing (year): _______
FOG during: OFF / ON / both
FOG more often during: OFF / ON / both   
Severity of FOG according to patient (0-10): 
Freezing of Gait Questionnaire score: FOGQ / NFOGQ 
-----------------------------------------------------------------------------------------------
Freezing during examination: Yes / No  
Last intake of medication (hours ago): _______________
State during examination: OFF / ON   
FOG during walking 4 m back and forth:   +/–  during: start / straight walking / turn
FOG during 360° turns from standstill, as rapidly as possible:  
To the left 1:  +/–     To the right 1:  +/–      To the left 3:  +/–     To the right 3:  +/–
To the left 2:   +/–     To the right 2:  +/–     To the left 4:  +/–     To the right 4:  +/–
FOG during walking with small steps (4 m back and forth): 
Preferred speed, 25% step length: 1st time:  +/–  2nd time:  +/–  during: start / straight walking / turn
As rapidly as possible, 25% step length: 1st time:  +/–  2nd time:  +/–  during: start / straight walking / turn
Clear FOG seen, other than during above examination   +   /   - 
Being FOG during ________________________________
Severity of FOG according to examiner (0-10): 
Assessment not possible, due to other reason than FOG: Yes / No
Comments: 
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Freezing of Gait Score Form: Explanation 
Complete right answers and fill in score in squares.
History:
Explanation to patient: Freezing is the feeling that your feet are transiently glued to 
the floor while trying to initiate walking, making a turn or when walking through 
narrow spaces or in crowded places. Sometimes it can be accompanied with trembling 
of the legs and small shuffling steps. (demonstrate if necessary)
Fill in year in which FOG occurred the first time (e.g. 2008).
State during FOG: Complete which states patients are freezing and also when most 
FOG appears (‘OFF’: mainly in the morning before medications are working/ mainly 
when patient is undermedicated; ‘ON’: mainly when medications are working well. 
May be together with dyskinesias. Increasing medication dose will lead to more FOG. 
Complete ‘BOTH’ when there is truly no difference between OFF and ON, with 
adequate dopaminergic medication. 
Severity FOG according to patient (0-10): Let patients indicate severity of FOG, 
from 0 = no FOG to 10: worst FOG they can imagine. 
Fill in score van FOG questionnaire (if known). Complete whether this is Giladi version 
of 2000 (FOGQ) or Nieuwboer version of 2009 (NFOG).
Examination:
Preferably during OFF (> 12 hour after last intake of medication)
Definition of FOG: Episodic inability to generate effective forward stepping. Can 
take different forms: ineffective ‘shuffling’, ‘trembling in place’ to try to move forward, 
or episodic akinesia. Often preceded by reductions of amplitude or increased/
irregular cadence, in contrast to a voluntary stop.
NB: (non-episodic) generalised akinesia due to deep OFF is NOT freezing of gait! 
If something happens that is not clear freezing, comment on this. Only complete as 
‘FOG’ when it is unequivocal FOG.
Walking back and forth: Without further instruction have patients walk 4 meter 
back and forth. Complete ‘+’ if FOG occurs, ‘-’ when there is no FOG. If ‘+’, indicate 
when FOG occurs: during initiation of gait, straight walking or turning.
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360° turns: Have patients turn from standstill 360° axial turns as rapidly as possible. 
Repeat four times to the right, four times to the left. EVERY time from standstill! Watch 
out for losing balance. Every time 2 turns from standstill to one side, then 2 to the 
other side, to prevent dizziness.  Complete ‘+’ if FOG occurs, ‘-’ when there is no FOG.
Walking with short steps: Let the patients walk 4 meter back and forth with 
instruction to make short steps of 25% of normal step length. Repeat this twice. 
Repeat again twice, with instruction to make short steps of 25% of normal step length, 
but walk as rapidly as possible.
Complete ‘+’ if FOG occurs, ‘-’ when there is no FOG. If ‘+’, indicate when FOG occurs: 
during initiation of gait, straight walking or turning.
Please also indicate when there was clear FOG but outside the formal examination, 
with a comment (e.g. in dooropening, when initiating walking).
Severity FOG as seen by examiner (0-10): Indicate severity of FOG as SEEN by 
examiner, so not according to history. 
0 = no FOG seen, 10 = examination not possible at all due to severe FOG
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Appendix 2: Abbreviations
2D  = Two-dimensional
3D  = Three-dimensional
ACA  = Anterior cerebral artery
ADL  = Activities of Daily Living
ANOVA  = Analysis of variance 
C  = Controls 
CBD  = Corticobasal degeneration
CT  = Computed tomography
DBS = Deep brain stimulation
DLB  = Diffuse Lewy body disease
EMG  = Electromyography
fMRI  = Functional magnetic resonance imaging
F  = Freezers (Patients with Parkinson’s disease and freezing of gait)
FAB  = Frontal Assessment Battery 
FOG  = Freezing of gait
H&Y = Hoehn and Yahr stage 
L-threo DOPS  = L-threo-dihydroxyphenylserine
MAO-B = Monoamine oxidase B
MI  = Motor imagery
MMSE  = Mini Mental State Examination 
MLR  = Mesencephalic locomotor region
MSA  = Multiple system atrophy
MSA-P  = MSA, parkinsonian subtype
MSA-C  = MSA, cerebellar dysfunction subtype
NFOG-Q = New Freezing of Gait Questionnaire
NF = Non-freezers (Patients with Parkinson’s disease without freezing of gait)
NPH  = Normal pressure hydrocephalus
P  = Patients (with Parkinson’s disease)
PD  = Parkinson’s disease
PPN  = Pedunculopontine nucleus
PSP  = Progressive supranuclear palsy
SD  = Standard deviation 
SEM = Standard error of the mean
SSRI = Selective seretonine reuptake inhibitor
STN  = Subthalamic nucleus
SNRI = Seretonine noradrenaline reuptake inhibitor
VI  = Visual imagery
UPDRS = Unified Parkinson’s Disease Rating Scale 
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Appendix 4: Video contents
3|  Provocation of freezing of gait
Video vignette 1:  The challenge of provoking FOG
Chapter 3.3  Video 1:  FOG evoked just after obstacle crossing 
  Video 2:  FOG between just before obstacle crossing
  Video 3:  FOG evoked by the threat of a coming obstacle
4|  Understanding of freezing of gait
Video vignette 2A:  No effect of PPN stimulation
Video vignette 2B:  Good effect of PPN stimulation
5|  Cycling and freezing of gait
Video vignette 3:  Case 1: marked FOG but preserved cycling abilities
Chapter 5.1 Video 1:  Case 2: marked FOG but preserved cycling abilities
6|  Treatment of freezing of gait
Video vignette 4A:  Marked FOG in ‘OFF-state’
Video vignette 4B:  No FOG after intake of levodopa/benserazide
Chapter 6.1  Video 1:  At home: Severe FOG in the absence of cues
  Video 2:  At home: Improvement of FOG with walking tripod
  Video 3:  At home: Improvement of FOG with 3D bars 
  Video 4:  At home: Improvement of FOG with walking stairs
  Video 5:  In hospital: Severe FOG, improvement on 3D bars
  Video 6:  In hospital: Hardly any improvement with 2D cues
Chapter 6.2 Video 1:  Case 2: ‘OFF-state’ without FOG
  Video 2:  Case 2: ‘ON-state’ with moderate FOG
  Video 3:  Case 2: ‘Supra-ON-state’ with severe FOG
  Video 4:  Case 3: ‘OFF-state’ without FOG
  Video 5:  Case 3: ‘ON-state’ with moderate FOG
  Video 6:  Case 3: ‘Supra-ON-state’ with severe FOG
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Appendix 5: Video legends
3| Provocation of freezing of gait
Video vignette 1:  The challenge of provoking FOG
Freezing is a frustrating phenomenon for patients, family, physicians and researchers, 
as ‘sometimes it’s there, sometimes it isn’t.’ As an example, video vignette 1 shows a 
patient with Parkinson’s disease. He reported to have marked freezing of gait at home, 
interfering with his daily activities. Yet, when he walked through the corridor of the 
outpatients department, no freezing of gait was seen at all. When he turned to come 
back, very slight freezing of gait was elicited. Asking the patient to turn to the other 
direction indeed provoked marked freezing of gait. (Greatly to relieve of his spouse, 
who kept telling us that he really did have marked freezing at home.)
Chapter 3.3 Obstacle avoidance to provoke freezing of gait on a treadmill
 Video 1:  A typical FOG episode evoked just after obstacle crossing
 Video 2:   A typical FOG episode evoked between obstacle release and obstacle 
cross
 Video 3:   A more severe FOG episode evoked by the threat of a coming obstacle, 
needing an emergency stop. Hereafter, the patient shows a very subtle 
FOG episode just before obstacle cross.
4| Understanding of freezing of gait
Video vignette 2A and 2B:  Dual effect of pedunculopontine nucleus stimulation
Based on animal studies and open label studies, the pedunculopontine nucleus has 
been proposed as a promising new target for deep brain stimulation, specifically 
directed at improving gait.299 However, double blind studies have failed to live up to 
these expectations.122;261 Video vignette 2A and 2B show two patients with Parkinson’s 
disease who received pedunculopontine nucleus stimulation (4 years after subthalamic 
nucleus stimulation).122 In video vignette 2A, surgery did not have any effect on FOG 
(woman, age 68 years, disease duration 18 years, location contact relative to ponto-
mesencephalic line: 6.7, 9.5, 0.8). In contrast, video vignette 2B shows a patient with a 
remarkable response of his FOG on pedunculopontine nucleus stimulation (man, age 
68 years, disease duration 13 years, location contact 5.3, 8.7, 1.5). Interestingly, the 
electrodes of both patients were located posterior to the pedunculopontine nucleus.122 
I’m thankful to Muriel Ferraye and Bettina Debu for the use these videos.
5|  Cycling and freezing of gait
Video vignette 3:  Case 1: marked FOG but preserved cycling abilities
A 58-year old man with a 10-year history of idiopathic Parkinson’s disease presented 
with an incapacitating freezing of gait (video vignette 3). The patient had severe 
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difficulties initiating gait and was merely able to take a few shuffling steps when 
provided with a visual cue (the examiner’s foot placed in front of the patient). Attempts 
to walk evolved rapidly into forward festination, and a fall towards the ground. Axial 
turning was impossible. However, his ability to ride a bicycle was remarkably preserved 
(video vignette 3). Gait freezing re-occurred instantaneously after dismounting the 
bicycle. This striking ‘kinesia paradoxica’ may be explained by the rotating pedals that 
possibly acted as an external pacing cue. Alternatively, the motor control mechanisms 
involved in gait and cycling could be affected differentially in Parkinson’s disease. 
Regardless of the explanation, cycling offers a useful approach for rehabilitation and 
exercise training in Parkinson patients grounded by severe freezing of gait.
Chapter 5.1  Cycling breaks the ice for freezing of gait 
 Video 1:   This home video shows the patient’s severe gait disorder, caused mainly 
by freezing of gait of the akinetic type, although some leg trembling 
is occasionally seen. The patient is only able to move forward by letting 
himself fall forward on his knees. However, he is able to generate 
smooth cycling movements with the legs as soon as he mounts his 
bicycle.
6|  Treatment of freezing of gait
Video vignette 4A and 4B:  Effect of levodopa on ‘off’ freezing of gait
The most common form of FOG occurs most frequently during the ‘OFF-state’ (“off” 
freezing). Hence, freezing is often alleviated by taking an adequate dose of 
dopaminergic medication. An illustration is seen in video vignette 4A and 4B. These 
videos show a woman with Parkinson’s disease while walking and turning. On video 
vignette 4A she has not taken her morning medication of levodopa, leading to severe 
freezing of gait. After taking 200 mg levodopa/50 mg benserazide, she is able to walk 
and turn without freezing of gait (video vignette 4B).
I’m thankful to Martin Amarell, Michael Barbe and Lars Timmermann for the use of these 
videos.
Chapter 6.1:  Cueing for freezing of gait: a need for 3D cues?  
 Video 1:   Severe freezing of gait (FOG) in the absence of cues (videotaped at 
home), during straight walking and when making turns.
 Video 2:   Marked improvement with a self-modified walking tripod (videotaped 
at home), during straight walking and when making turns.
 Video 3:   Marked improvement when stepping over 3D bars attached at regular 
distances on the grass. Note the reoccurrence of FOG when the patient 
tries to negotiate the turn; apparently, the turning cycle is too tight. 
Walking immediately improves once the turn has been completed.
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 Video 4:  Marked improvement when walking up and down stairs.
 Video 5:   Severe FOG in the absence of cues, but marked improvement with 3D 
bars placed on the floor (videotaped in the hospital). 
 Video 6:   Severe FOG, with hardly any improvement with 2D cues, namely stripes 
taped to the floor (videotaped in the hospital).
Chapter 6.2:  ‘ON-state’ freezing of gait in Parkinson’s disease
 Video 1:   Case 2: ‘OFF-state’ gait (task completion = 32 seconds) shows no freezing. 
 Video 2:   Case 2: ‘ON-state’ gait, after 150 mg of levodopa (task completion = 47 
seconds) shows moderate FOG. 
 Video 3:   Case 2: ‘Supra-ON-state’, after 300 mg of levodopa (task completion = 
94 seconds) shows severe FOG with motor blocks during turns.
 Video 4:   Case 3: Walking while in ‘OFF-state’ shows a hypokinetic gait with small 
steps and shuffling, but no real FOG episodes. 
 Video 5:   Case 3: Walking in the ‘ON-state’ (after 375 mg levodopa) shows 
moderately severe freezing. 
 Video 6:   Case 3: Severe freezing with almost complete inability to walk during 
‘supra-ON-state’ (after 1250 mg of levodopa in 3 hours).
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“Ne marche pas devant moi, je ne suivrai peut-être pas. 
Ne marche pas derrière moi, je ne te guiderai peut-être pas. 
Marche juste à côté de moi et sois mon ami.”
(Albert Camus)
Allereerst gaat mijn grote dank uit naar alle patiënten die aan dit proefschrift hebben 
meegewerkt. Fantastisch hoe jullie je best hebben gedaan, en steeds volhielden om 
obstakels te vermijden of in de MRI te blijven liggen, denkend aan lopen. Ook veel 
dank voor het meedenken over hoe het nu precies zit en het delen van jullie 
ervaringen, met of zonder video. Als ervaringsdeskundigen zijn jullie onmisbaar is het 
verder ontrafelen van bevriezen. Sorry dat ik juist wilde opwekken wat jullie het liefst 
wilden vergeten…
En dan natuurlijk Bas. Jij bent echt dé promotor van dit proefschrift. Toen ik laatst in 
de trein over de schouder van een gelikte bedrijfskundige meelas in een boekje over 
wat een onderneming succesvol maakt, las ik over ‘de superpromoter’: “De super -
promoter is de personificatie van de kracht van het enthousiasme. Het aanstekelijk 
enthousiasme van de superpromoter is voor bedrijven van levensbelang omdat het 
zorgt voor aanwas van nieuwe klanten en omzetgroei. Bovendien zijn superpromoters 
ideale co-creators en motiveren ze het personeel.” (uit ‘de Superpromoter’ van Rijn 
Vogelaar) Nou Bas, jij bent absoluut een superpromotor, en niet alleen wat betreft 
onderzoek. Ik heb ontzettend veel van je geleerd, variërend van het opzetten van 
onderzoek, schrijven en aan de man brengen van artikelen tot klinisch omgaan met 
patiënten en met bewegingsstoornissen. Ondanks (of dankzij?) dat we twee best 
verschillende persoonlijkheden zijn, kunnen we heel goed met elkaar samenwerken. 
Ik hoop nog veel van je te blijven leren.
Ivan, many thanks for your help and effort, especially for the fMRI study but also for 
the bicycling paper. Your critical vision and expertise were invaluable. And your emails 
always let me smile (or sigh if they involved more analysis ;-) Thank you for giving me 
the impression that you valued my opinion –notwithstanding my rudimentary fMRI 
expertise. 
Dank aan de manuscript commissie, Guillen Fernandez, Sander Geurts en Alice Nieuwboer 
voor het lezen van mijn manuscript. Een speciaal woord van dank voor Alice voor de 
goede samenwerking en uitwisseling van ideeën, ook met Joke en Sarah.
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Professor Padberg, dank voor de plek als neuroloog in opleiding, en de steun in de 
rug bij het afbakenen van onderzoek. ‘Je kan er ook nu al een nietje doorheen doen’, 
toen ik nog nauwelijks begonnen was, en ‘maar wat is freezing nu eigenlijk’, zijn twee 
uitspraken die me goed zijn bijgebleven. Ook verder dank aan stafleden, (oud)-AIOS 
en onderzoekers van de afdeling neurologie: In het kader van dit proefschrift met 
name voor de inspirerende opmerkingen tijdens de researchbespreking, en voor het 
aanleveren van patiënten. Medebewoners van de vele verschillende onderzoekerska-
mers waar ik verbleven heb (met name te noemen Ilse, Bram, Bart, Karlijn, Charlotte, 
Catherine, Willemijn, Loes en Femke, maar zeker ook de anderen!):  dank voor ‘samen 
goed werken’, de kruisbestuiving, voor de peptalk, voor de afleiding en vele lunch, 
thee en GFT momenten. 
BANK-ers, ver zijn we niet gekomen in V&A, maar gezellig was het wel!
Het secretariaat dank voor de ondersteuning. Met name dank aan Noortje voor alle 
hulp, wellicht het meest nog met het inplannen van afspraken met Bas..
The Intention and Action Group, thanks for allowing me as a ‘ghost-clinician’ into your 
midst, for fruitful discussions and help with analysis (with a special thanks to Rick and 
Lennart). ‘Donders’ itself, thanks for the inviting and inspiring environment. And of 
course many thanks to Paul Gaalman for his assistance with scanning.
Dan dank aan de mensen van de revalidatiegeneeskunde, voor de prettige samen -
werking. Jacques, dank voor de aanzet van het obstakel experiment, het meedenken 
en genereren van hypotheses. Vivian, dank voor het ‘sparren’ en de praktische hulp: 
niet alleen met analyses maar ook met het sturen van het onderzoek naar meer 
haalbare hoogte. Roland natuurlijk heel veel dank voor je technische ondersteuning! 
Arnaud, many thanks for your help with the obstacle analysis paper and the ongoing 
split belt paper. You have done a lot of analyses (and gave me some work deciphering 
it ;-), and are a star in suddenly handing in a rough draft of a manuscript. Thank you for 
all your work! 
Maaike, zonder jou bestond het fMRI stuk überhaupt niet. Dank voor je ontzettend 
gestructureerde opzet, waardoor het voor mij erg makkelijk was het over te nemen. 
Daarnaast dank voor al je werk, van het opzetten van onderzoek en analyse, het mensen 
scannen tot het eerste gait-stuk schrijven. Geweldig! En daarnaast ben je gewoon 
heel fijn om mee samen te werken!  
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Er waren een aantal studenten betrokken bij dit onderzoek. Christel, dank voor je hulp 
bij de start van het obstakel experiment. Yolien, ook dank voor de hulp bij het obstakel 
experiment, daarnaast voor het enthousiast meedenken over het draaien. Wandana, 
jij begon als student maar bent inmiddels zelf ook al bijna klaar met je boekje. Ik vond 
het erg leuk deze ontwikkeling van dichtbij mee te maken. Dank voor de goede 
samenwerking, niet in de laatste plaats recent bij de e-learning! Inge, jij bent onmisbaar 
geweest voor het fMRI stuk. Als student ben je bij Maaike begonnen, en daarna heb 
je ook mij goed geholpen met het scannen en analyseren. Super dat je, toen ik net 
met verlof was en jij al in Leuven zat, nog zoveel gedaan hebt voor de Brain revisie.
Dank aan alle andere mede-auteurs voor het commentaar en het meedenken of 
het kijken van vele videos, met name Nir Giladi (thanks for sharing your expertise in 
gait disorders, and especially for watching all those videos together!), Marten (de 
epidemio logische-blik), Maarten (de fysiotherapie-blik) en Charlotte (de heel-veel- 
videos blik). 
Dank aan Michel Verbruggen voor het bewerken van de videos.
Rick, jij bent niet zomaar paranimf. Dank voor je goede vriendschap, voor de discussies 
over onderzoek en Parkinson maar vooral over van-alles en het leven. Super dat je zo 
dichtbij staat in het leven, in onderzoek (van bedenken van wilde ideeën, hulp bij 
analyses tot als mede-auteur) en nu ook als collega-AIOS. Op nog vele goede 
momenten samen, en niet te vergeten op nog veel gezellige etentjes, borrels en 
reisjes - ook met Tom!
Tineke, in de buik, op school, studeren, Groningen, Nijmegen, hersenen, onderzoek, 
twijfelen, zwanger, mamma, paranimf, promoveren begin juni. Gelukkig mogen we 
inmiddels lekker op elkaar lijken, ik vind het heerlijk zo’n dierbaar vriendinnetje dichtbij 
te hebben! 
Lieve vrienden en (schoon)familie, dank voor alle belangstelling en nog belangrijker, 
alle afleiding. Dank voor alle gezelligheid, alle leuke kleine en grote uitjes, maar vooral 
voor jullie vriendschap. Ik spreek de meesten van jullie niet zo vaak als ik wel zou 
willen, maar gelukkig gaan we dan gewoon weer verder waar we gebleven waren!
In het bijzonder wil ik noemen: Guusje, wat zit je ver weg maar je blijft dichtbij! Rianne 
en Floor, onderzoek kan jullie gestolen worden, maar vriendschap zeker niet. En 
natuurlijk lieve vriendinnetjes Brigit, Barbara, Anke, ‘huisgenootjes’ en FIC (hebben 
we al een date?). Paul, dank voor jouw heerlijk verfrissende ‘wat-maakt-het-uit’ kijk op 
de wereld. Marga dank voor de warme belangstelling en natuurlijk de super-omi die 
je bent.
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Lieve Tom en Lieve Lonnie, dank voor het warme nest waaruit ik mocht groeien en me 
nog steeds in mag nestelen. Van jullie leerde ik mezelf zijn, empathisch zijn, na te 
denken over de wereld, en wellicht ook om heel veel ballen tegelijk in de lucht te 
houden. Ik vind het heel leuk ook af en toe ‘professioneel’ met jullie te kunnen praten 
als dokter of onderzoeker! (of als fietser cq fotograaf..) En dat jullie als echte papa en 
mama - wat ik ook doe- het altijd prachtig vinden..
Arjen, mijn lief, vriendje, papa van mijn kinderen, steun en afleider in al heel wat 
tropen - jaren; wat ben ik blij met jou! Nora en Max, jullie zijn de liefsten! Ik geniet van 
jullie ontdekken van de wereld, jullie kunstwerken, geklets, dansen, zingen, klimmen 
en lachen. Dikke knuffel!
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